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Osteoarthritis (OA) is the most common joint disease and the leading cause of
disability among Americans. OA afflicts 20 million Americans and costs $128 billion
in direct medical and work-related losses each year. Nearly 1/3 of OA patients in the
United States are over 65 years of age and given the aging population of the “baby
boomer” generation, the prevalence of this disease is predicted to increase dramatically
in the coming decades. The disease is characterized by the degeneration of cartilage
and progressive loss of normal structure and function. However, the harsh loading
environment and the avascular nature of mature cartilage lead to a poor intrinsic healing
capacity after injury. As a result, cell-based therapies, including tissue engineering
strategies for growing clinically relevant grafts, are being intensively researched.
An autologous cell source would be ideal for growing clinically relevant engineered
cartilage; however, using cells from an osteoarthritic or injured tissue to grow engi-
neered cartilage with mechanical and biochemical properties similar to healthy native
tissue poses several challenges, including lack of healthy donor tissues and donor site
morbidity. As a result, the clinical potential of mesenchymal stem cells (MSCs) has
driven forward efforts toward their optimization for tissue engineering applications. Of
these MSCs, synovium-derived stem cells (SDSCs) are being intensively researched due
to their proximity to the defect site and high chondrogenic potential.
To address the need for cell-based therapies, functional tissue engineering aims to
restore cartilage function by culturing grafts in vitro that recapitulate the mechanical,
biochemical, and structural framework of the tissue in order to have an increased chance
of integration and survival upon in vivo implantation. While previous work in the lab
has explored the utility of physiologically relevant stimuli for creating tissue grafts
with chondrocytes, it has not yet been investigated for SDSCs. Therefore, in order to
determine the potential of SDSCs as a tissue engineering strategy for growing clinically
relevant cartilage grafts, this dissertation had four primary aims: (1) to initially produce
tissue growth utilizing synovium-derived stem cells, (2) to utilize additional chemical,
physical, and physico-chemical factors to further optimize growth of tissue engineered
cartilage using SDSCs, (3) to characterize the response of SDSCs to the factors applied,
and (4) to utilize the optimized culture techniques to translate the findings to clinically-
relevant human cells.
Our initial studies investigated the potential of using physiologically relevant growth
factors during both 2D expansion and 3D culture conditions, from which a baseline
culture protocol was established. We then sought to explore additional strategies to
further optimize tissue growth. Motivated by the discrepancy in osmolarities between
native and in vitro culture conditions, we first assessed the influence of adjusting the
osmolarity of the baseline culture media. We found that culturing constructs under
a more physiologic osmolarity (400 mOsM) was beneficial for tissue growth. Based
on these findings implicating osmolarity as a key influencer of growth potential, we
sought to determine and potentially manipulate some of the pathways involved in the
osmotic response in an effort to further optimize and characterize our tissue-engineered
cartilage constructs. Our results supported the role of the TRPV4 ion channel in our
SDSC-seeded constructs as a key mechano-osmosensing mechanism. Through the cul-
turing techniques evaluated, we were able to achieve native mechanical and biochemical
measures of juvenile bovine cartilage using SDSCs.
As has been shown in the literature, observed results in other species (bovine or ca-
nine) may not always correlate to findings using human cell sources, thereby prompting
the emphasis for more relevant pre-clinical models. Therefore, our final studies sought
to translate our treatment strategies to clinically relevant human cells from normal
(non-diseased) and diseased (OA) SDSCs and chondrocytes in order to determine their
utility. We were able to create a complete set of micropellet data for both SDSCs and
chondrocytes to allow for comparisons. Overall, our micropellet results indicate that
tissue condition (non-diseased vs OA) is the primary determinant of matrix synthesis.
The research described in this dissertation has demonstrated the utility of SDSCs
for strategies aimed at cartilage regeneration. We present the first studies to grow
SDSC-seeded constructs to native properties of juvenile bovine chondrocytes. There-
fore, utilization of the culture techniques presented here and other optimization strate-
gies may hold key insights to developing a tissue using autologous/allogeneic SDSCs
that can fully recreate native cartilage. In addition, the findings support the clinical
potential of human SDSCs as a cell source for cartilage repair strategies.
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The poor healing potential of damaged cartilage has led to investigating the potential
of mesenchymal stem cells (MSCs) for growing clinically relevant cartilage tissue grafts
[Ronziere et al., 2010,Moutos et al., 2010,Huang et al., 2010,Gong et al., 2010,Buxton
et al., 2010,Pei et al., 2008b,Pei et al., 2008a]. Of these MSCs, synovium-derived stem
cells (SDSCs) are being intensely researched due to their proximity to the defect site
and high chondrogenic potential [Pei et al., 2008a, Pei et al., 2008b, Sakaguchi et al.,
2005]. In order to determine the potential of SDSCs as a tissue engineering strategy for
growing clinically relevant cartilage grafts, this dissertation had four primary aims: (1)
to initially produce tissue growth utilizing synovium-derived stem cells, (2) to utilize
additional chemical, physical, and physico-chemical factors to further optimize growth
of tissue engineered cartilage using SDSCs, (3) to characterize the response of SDSCs
to the factors applied, and (4) to utilize the optimized culture techniques to translate
the findings to clinically-relevant human cells.
The hypotheses and specific aims are presented first, followed by the significance
of the conducted studies. In addition, an overview of literature related to diarthrodial
joint structure/function, as well as functional tissue engineering of cartilage as it relates
to cell sources, scaffold material, and exogenous factors (chemical, physical, physico-
chemical) to promote tissue development, is provided.
1.1 Hypotheses and Specific Aims
This dissertation utilized several physiologically relevant exogenous factors, including
chemical, physical, and physico-chemical, to promote functional tissue growth of SD-
SCs. These stimuli were either used separately or in combination for purposes of each
study and are outlined in Figure 1.1. Utilizing these factors to optimize growth and
characterize the resulting tissue, the following hypotheses and specific aims were devel-
oped:
Hypothesis 1: SDSCs that have been primed in 2D with growth factors
will result in superior mechanical and biochemical properties compared to
unprimed engineered tissue constructs.
 Specific Aim 1a: Investigate the influence of growth factor priming of SDSCs
in 2D culture on the subsequent properties of tissue formed by these cells after
seeding in 3D agarose hydrogel scaffolds.
 Specific Aim 1b: Determine the impact of transient (21 day ‘release’) or continu-
ous exposure of SDSC constructs to TGF-β3 growth factor in 3D culture.
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 Specific Aim 1c: Use comparative proteomics to investigate the impact of growth
factor priming on 2D canine chondrocyte and SDSC cultures, by identifying dif-
ferentially regulated cartilage proteins.
We analyzed the potential of SDSCs as part of a tissue engineering strategy for growing
clinically relevant cartilage grafts. SDSCs can be expanded in culture for 3D encap-
sulation and the expansion media can be optimized to promote chondrogenesis [Pei
et al., 2008b, Bilgen et al., 2007]. While previous studies have induced chondrogenesis
of SDSCs, few studies have demonstrated that SDSCs can be used to achieve a tissue-
engineered material with mechanical properties similar to native cartilage [Pei et al.,
2008b, Pei et al., 2008a]. In order to create functional tissue, we used a growth factor
expansion protocol previously observed in the lab to be efficacious for expanding juve-
nile bovine and adult canine chondrocytes [Ng et al., 2009b]. The growth factor cocktail
has previously shown to rapidly expand cell number, prime the cells to reactivate rapid
matrix synthesis when cultured in a 3D scaffold environment, and prevent phenotype
dedifferentiation, which is typically seen in monolayer culture and provides rationale
for Hypothesis 1 [Ng et al., 2009b,Francioli et al., 2007]. We also investigated the effect
of TGF-β3 growth factor introduction on chondrogenesis when cells are encapsulated
in 3D culture. In addition, in order to understand the effects of this growth factor
cocktail on adult canine chondrocytes and SDSCs in 2D culture, a more relevant pre-
clinical model, we undertook comparative proteomics analysis to identify differentially
regulated cartilage proteins. This technique is potentially powerful for this effort, since
it quantifies differences in expression of proteins among different biological states. It
also allows for the detection of proteins with post-translational modifications.
3
Figure 1.1: Schematic describing the chemical, physical, and physico-chemical factors
utilized to promote tissue growth as well as characterize tissue response of engineered
constructs. Studies are grouped by factor(s) applied. Font color of each study denotes
species: black numbers = juvenile bovine, red numbers = adult canine, and green
numbers = adult human.
Hypothesis 2: Culturing constructs in a hypertonic, more physiologic (400
mOsM) environment (created by adding NaCl and KCl to 3D culture media)
improves the biochemical composition and mechanical properties of SDSC-
and chondrocyte-seeded constructs, compared to hypotonic (300 mOsM) or
isotonic media (330 mOsM).
 Specific Aim 2a: Investigate the effect of extracellular osmolarity on the mechan-
ical and biochemical properties of SDSCs and chondrocytes in 3D culture.
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 Specific Aim 2b: Investigate whether unprimed cells in 2D respond similarly to
static osmotic loading in order to assess whether osmotic loading and cell priming
are synergistic.
 Specific Aim 2c: Evaluate the effect of varying the extracellular osmolarity to cell
size changes of suspended chondrocytes and SDSCs and assess these in relation
to the Boyle-van’t Hoff (BVH) law. It has been established that chondrocytes
behave as perfect osmometers consistent with the BVH relationship; however, the
adherence of SDSCs to the BVH law has not been studied.
 Specific Aim 2d: Characterize our engineered tissue by investigating the hypo-
tonic loading response of engineered tissues as a biological assay to determine the
similarity of our neocartilage tissues to that of native cartilage. Assess the re-
sponse of SDSC-seeded constructs in response to both hypoosmotic challenge, as
well as blocking of the osmotically sensitive TRPV4 channel through the selective
antagonist RN1734.
 Specific Aim 2e: Apply dynamic deformational loading in conjunction with static
osmotic loading during long-term culture in order to determine if there is a syn-
ergistic response of mechanical and physico-chemical factors. In addition, further
investigate the role of TRPV4 in modulating the osmotic response. Measure bulk
mechanical properties and biochemical content of cartilage constructs.
The typical in vivo osmolarity of human articular cartilage is within 350–450 mOsM
depending on the zone [Urban et al., 1993, Koo et al., 2010]. The loss of proteogly-
cans during osteoarthritis reduces the osmotic environment of cartilage. Relative to
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native osmolarity, standard chondrogenic culture media is hypotonic and typically 330
mOsM. Theoretical predictions of in situ chondrocyte osmolarity indicates that extra-
cellular osmolarity does not vary significantly with physiologic loading [Oswald et al.,
2008]. Therefore, in an effort to optimize production of tissue-engineered cartilage,
we assessed the properties of cells in 3D tissue engineered constructs, as a function of
baseline osmolarity during long-term culture. Hypothesis 2 is motivated by the discrep-
ancy in osmolarities between native and in vitro conditions. Therefore, we hypothesize
that creating a more physiologic culture environment will promote tissue growth. In
addition, we aimed to determine and potentially manipulate some of the pathways
involved in the physico-chemical response by using chemical and physical factors to
further optimize and characterize our tissue-engineered cartilage constructs.
Hypothesis 3: Trimethylamine N-Oxide (TMAO) supplementation of cul-
ture media will result in increased mechanical and biochemical content of
SDSC-seeded constructs relative to control constructs, similarly to chondro-
cytes (previously published) [O’Connell et al., 2012].
 Specific Aim 3a: Assess the response of SDSC-seeded constructs to TMAO media
supplementation, which has not yet been characterized. Investigate the effect of
varying concentrations of TMAO (5 mM and 50 mM) on the mechanical and
biochemical properties of SDSCs in 3D culture.
The similarity in skeletal matrix constituents between shark and human cartilage has
prompted curiosity for tissue engineering applications [Porter et al., 2006]. In particular,
the function of TMAO as a protein stabilizer within shark tissue has been of particular
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interest [Yancey, 2005]. Previous studies in the lab have shown the pronounced effects of
exogenous supplementation of this chemical factor on tissue properties of chondrocyte-
seeded agarose hydrogels [O’Connell et al., 2012]. We were motivated by these findings
to investigate the influence of TMAO supplementation on SDSC-seeded engineered
constructs in Hypothesis 3.
Hypothesis 4: Human adult SDSCs and chondrocytes from normal, non-
diseased tissue will have an increased chondrogenic potential as compared
to tissue harvested from patients with osteoarthritis.
 Specific Aim 4a: Utilize previously established 2D and 3D culture techniques to
assess the chondrogenic potential through biochemical and histological analysis
of human SDSCs from normal and osteoarthritic synovium using 3D micropellet
culture. In addition, assess the chondrogenic potential of normal SDSCs in 3D
agarose hydrogel culture. Investigate the effect of osmolarity in both culture
systems.
 Specific Aim 4b: Utilize previously established 2D and 3D culture techniques to
assess the chondrogenic potential through biochemical and histological analysis of
human chondrocytes from normal and osteoarthritic cartilage using 3D micropel-
let culture. In addition, assess the chondrogenic potential of normal chondrocytes
in 3D agarose hydrogel culture. Investigate the effect of osmolarity in both culture
systems.
Through the preliminary data presented here, while we have been able to successfully
culture grafts with juvenile SDSCs to native mechanical and GAG content of juvenile
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bovine cartilage tissue, these tissues are not clinically relevant. Therefore, for the final
aim, we propose to investigate the potential of clinically relevant human synovium and
cartilage for growing tissue engineered cartilage grafts. Robust de novo tissue growth
from human cells has yet to be achieved. While it has been previously shown that SDSCs
from diseased joints retain their chondrogenic capacity [Nagase et al., 2008, Fickert
et al., 2003], the levels of chondrogenic markers produced by normal (non-diseased)
and diseased (OA or RA) synovium may differ in 3D culture. In order to “prime” the
donor cells we receive for enhanced tissue production in 3D culture, we employed the
same cocktail of growth factors initially assessed in Specific Aim 1a, previously shown to
increase the proliferation rates and retain the chondrogenic potential of human articular
chondrocytes and adult canine chondrocytes [Ng et al., 2009b,Barbero et al., 2003]. In
addition, to further compare across species, the impact of static osmotic loading was
assessed.
1.2 Significance
Osteoarthritis (OA) is the most common joint disease and the leading cause of disability
among Americans. It afflicts 20 million Americans and costs $128 billion in direct
medical and work-related losses in the U.S. each year. As a result, patients, health
care systems, and employers are all substantially affected by its prevalence [Lawrence
et al., 2008,Leigh et al., 2001,Reginster, 2002,Elders, 2000,Gabriel et al., 1995]. Nearly
1/3 of OA patients in the United States are over 65 years of age and given the aging
population of the “baby boomer” generation, the prevalence of this disease is predicted
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to increase dramatically in the coming decades (CDC 2010). In fact, it is predicted
that 1 in 2 Americans will develop OA symptoms in their knee joint at some point in
their lives [Murphy et al., 2008]. The disease is characterized by the degeneration of
cartilage and progressive loss of normal structure and function, without the capacity
for self-repair [Buckwalter et al., 1997].
OA can be either primary or secondary, where primary joint degeneration develops
without a known cause while secondary OA develops following joint injury [Buckwalter
et al., 1997]. Currently there is no cure for OA and as the disease progresses into later
stages, surgical intervention is often needed to ease patient suffering. Current treatment
techniques include lavage, subchondral bone drilling, and mosaicplasty. While these
treatments offer some relief for patients they have several limitations including donor
site morbidity, poor graft-to-bone integration, and the formation of fibrocartilage-like
tissue [Hunziker et al., 2001]. When cartilage lesions are large and cannot be repaired
using the aforementioned methods, joint replacement procedures are used.
As a result of the inability of cartilage to heal following injury or disease, cell-based
therapies, including tissue engineering strategies for growing clinically relevant grafts,
are being intensely researched [Ronziere et al., 2010, Moutos et al., 2010, Lima et al.,
2007,Huang et al., 2010,Gong et al., 2010,Buxton et al., 2010]. Autologous and juvenile
allogeneic chondrocytes (permitted due to the immunoprivileged nature of the joint) are
currently used in clinical strategies for cartilage repair by companies such as Genzyme
(Carticel®) and Isto (RevaFlex®), respectively. An autologous cell source would be
ideal for growing clinically relevant engineered cartilage; however, using cells from an
osteoarthritic or injured tissue to grow engineered cartilage with mechanical and bio-
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chemical properties similar to healthy native tissue poses several challenges, including
lack of healthy donor tissues and donor site morbidity [Ahmed et al., 2010, Gavénis
et al., 2006]. As a result, the clinical potential of stem cells has driven forward efforts
toward their optimization for tissue engineering applications. In the work presented in
this dissertation, we investigate the potential for MSCs derived from the synovium for
use in tissue engineered grafts aimed at cartilage repair or regeneration [Lima et al.,
2007, Pei et al., 2008b, Han et al., 2010]. Synovium-derived stem cells (SDSCs) are an
autologous, minimally invasive surgical MSC cell source with high regenerative capacity
and chondrogenic potency [Theoret et al., 1996, Sakaguchi et al., 2005, De Bari et al.,
2001]. While many studies have demonstrated the high chondrogenic potential of SD-
SCs [Sakaguchi et al., 2005,Theoret et al., 1996,De Bari et al., 2001], few studies in the
literature have utilized SDSCs to create functionally relevant tissue engineered cartilage
grafts [Pei et al., 2008b,Pei et al., 2008a]. In order to promote the production of func-
tionally relevant cartilage-like tissue using SDSCs, the work contained in this thesis
assesses the in vitro potential of several culture techniques, including, but not lim-
ited to, cell priming with chemical factors, physico-chemical supplementation through
static osmotic loading, and mechanical loading through dynamic deformational loading
bioreactors.
The studies presented in Chapter 3 provide the initial support for the clinical po-
tential of SDSCs for tissue engineering applications. More specifically, the potential of
using physiologically relevant chemical factors during both 2D expansion and 3D cul-
ture conditions was investigated and a baseline culture protocol was established. After
a baseline culture model was established, we sought to apply additional techniques to
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further optimize tissue growth. Motivated by the discrepancy in osmolarities between
native and in vitro culture conditions, we first assessed the influence of adjusting the
osmolarity of the baseline culture media (Chapter 4A). We then sought to determine
and potentially manipulate some of the pathways involved in the osmotic response
using a combination of stimuli in an effort to better optimize and characterize our
tissue-engineered cartilage constructs. Our results supported the role of the TRPV4
ion chnnel in our SDSC-seeded constructs as a key mechano-osmosensing mechanism
(Chapter 4D and 4E). Through the techniques evaluated in Chapter 4, we were able to
achieve native mechanical and biochemical measures of juvenile bovine cartilage using
SDSCs.
Our successful implementation of osmotic culture conditions led us to investigate the
potential of another chemical osmolyte, TMAO, for boosting tissue growth (Chapter
5). We found that TMAO supplementation was beneficial for tissue production.
In Chapter 6, we utilized the optimized 2D and 3D culture techniques established
in Chapters 3 and 4 to assess the translation of these to clinically relevant human cells
from both synovium and cartilage. We were able to promote matrix production in both
normal and OA cells and create a complete set of micropellet data for both SDSCs and
chondrocytes to allow for comparisons.
From a basic science perspective, the research findings presented may help to in-
crease our understanding of the role of cell membrane transport channels during osmotic
loading. By identifying mediators that are altered during osmotic loading it may help
to elucidate potential therapeutic targets. The data presented in this thesis strongly
supports SDSCs as a relevant tissue source for cartilage tissue engineering applications.
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We present the first studies to grow SDSC-seeded constructs to native mechanical and
biochemical properties of juvenile bovine chondrocytes. In addition, our group is the
first to grow human SDSCs with any sort of mechanical integrity. Therefore, utiliza-
tion of the culture techniques presented here and other optimization methods may hold
key insights to developing a tissue using autologous/allogeneic SDSCs that can fully
recreate native cartilage.
1.3 Background Literature
1.3.1 Diarthrodial Joint Structure and Function
1.3.1.1 Articular Cartilage and Osteoarthritis
Articular cartilage functions as the load-bearing soft tissue that covers the ends of
articular joints (2-4 mm thick) and is composed primarily of water (60-87%), an extra-
cellular matrix network composed largely of proteoglycans (PGs) (3-10%) and collagen
(primary collagen type II) (10-30%), which is synthesized and maintained by chondro-
cytes [Buckwalter et al., 1997, Stockwell, 1979, Mow et al., 1994, Guilak et al., 1997].
Chondrocytes differentiate from mesenchymal stem cells and comprise less than 10%
of adult tissue [Fox et al., 2009]. The interaction and organization of these matrix
components gives rise to the mechanical properties of the cartilage. In addition to the
primary solid and fluid phases, cartilage is also comprised of several ionic species, in-
cluding Na+, Ca2+, and Cl-(<1%). The pH of cartilage tissue in vivo is 6.8-7.1 with an
oxygen concentration of between 1-6% [Wilkins and Hall, 1995,Otte, 1990].
PGs consist of a protein core to which one or more negatively charged GAG chains
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are covalently attached. The major GAGs found in cartilage include hyaluronic acid,
keratan sulfate, chondroitin sulfate, and dermatan sulfate. The two classes of PGs found
in articular cartilage are aggrecans, which comprise the majority of the interfibrillar
space, and smaller PGs like decorin, biglycan, and fibromodulin. Aggrecans give carti-
lage its compressive stiffness [Buschmann et al., 1992,Buschmann et al., 1995,Maroudas,
1979]. Large PG aggregates are formed within cartilage through the association of ag-
grecans with hyaluronan and link proteins which help to secure and stabilize the network
during joint loading [Fox et al., 2009,Buckwalter et al., 1997,Roughley and Lee, 1994].
Positive ions concentrate around the negatively charged GAGs, which attract water
into the tissue causing it to swell.
Collagen fibrils are the other major component of the cartilage extracellular matrix.
Type II collagen is the primary collagen constituent in the ECM and comprises 90-95%
of the total collagen content. In addition to type II collagen, collagens I, VI, IX, X, and
XI are also present in minor quantity. These function to form and stabilize the type
II fibril framework [Buckwalter et al., 1997,Fox et al., 2009]. The collagen architecture
resists the swelling imposed by water uptake into the tissue and gives cartilage its tensile
stiffness [Maroudas, 1976].
Cartilage is composed of three zones, the superficial (10-20% of cartilage thickness),
middle (40-60% of cartilage thickness), and deep (30-40% of cartilage thickness) zones.
Collagen content is highest in the superficial zone and decreases by 20% in the middle
and deep zones. In contrast, proteoglycan content is lowest at the surface and increases
by as much as 50% in the middle and deep zones [Mow and Wang, 1999, Buckwalter
et al., 1997, McDevitt, 1973]. Collagen alignment is parallel to the surface in the su-
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perficial zone, more randomly oriented in the middle zone, and perpendicular to the
surface in the deep zone [Fox et al., 2009].
Osteoarthritis (OA) is a debilitating disease characterized by the degeneration of
cartilage and progressive loss of normal structure and function, without the capacity for
self-repair [Buckwalter et al., 1997] due to the avascular environment and low cellularity.
OA can be either primary or secondary, where primary joint degeneration develops
without a known cause while secondary OA develops following joint injury [Buckwalter
et al., 1997]. An early indicator of OA is an increase in water content due to a damaged
collagen network [Maroudas, 1976], while later stage OA is characterized by PG loss
[Stockwell, 1991]. OA can lead to pain and reduced joint motion, even to the point of
loss of joint function. On a molecular level, the decreasing PG content leads to decreased
mechanical stiffness [Buckwalter et al., 1997]. Loss of PGs also leads to loss of fixed
charges which maintain tissue hydration and determine the osmotic environment of the
tissue.
Currently there is no cure for OA and as the disease progresses into later stages,
surgical intervention is often needed to ease patient suffering. Treatment options include
lavage, subchondral bone drilling, and mosaicplasty. While these treatments offer some
relief for patients they have several limitations including donor site morbidity, poor
graft-to-bone integration, and the formation of fibrocartilage-like tissue [Hunziker et al.,
2001]. When cartilage lesions are large and cannot be repaired using the aforementioned
methods, joint replacement procedures are used. Joint replacement in the United States
is estimated to reach two million knees and hips per year by 2015 [Kim, 2008].
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1.3.1.2 Synovium: Structure and Function
Promising cell sources from tissues adjacent to defect sites are being considered for
repair and regeneration purposes [Fan et al., 2010b]. It has been established that
cartilage and synovium develop from a common precursor pool [Archer et al., 2003].
The synovium is a thin layer of tissue (2-3 cell layers) that lines the noncartilaginous
surfaces and maintains a fluid-filled capsule around the articulating joint [Edwards,
1994]. Synoviocytes lie on top of connective tissue consisting of fat, collagen, and
blood vessels. This environment makes the boundaries of the synovium sometimes
difficult to identify [Edwards, 1994]. The synovium is involved in the production and
maintenance of synovial fluid resulting in lubrication and oxygenation of cartilage, as
well as chondrocyte nutrition [OConnell, 2000, Smith, 2011, Blom and van den Berg,
2008]. Chondrocytes receive nutrients from the synovial fluid after first passing through
the synovium, synovial fluid, and finally the cartilage matrix [Buckwalter et al., 1997,
Schumacher et al., 1999].
The intimal cells of the synovium are comprised of Type A macrophages and Type B
fibroblast-like cells, from which synovium-derived stem cells are derived [Jones and Pei,
2012, Edwards, 1994]. Type A cells function to remove waste and potential pathogens
from the joint, while type B cells produce the primary component of synovial fluid,
hyaluronan [Edwards, 1994, Blom and van den Berg, 2008]. The synovium membrane
acts to maintain homeostasis within the joint environment by removing waste products
while maintaining lubrication and nutrient delivery.
The chondrogenic potential of synovial cells for creating tissue engineered cartilage
substitutes is supported by the disease condition synovial chondromatosis, in which
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abundant blue-gray nodules of hyaline cartilage develop in the synovial tissue [OConnell,
2000].
1.3.2 Functional Tissue Engineering of Articular Cartilage
The debilitating nature of cartilage damage and limitations of current treatments result
in the need for clinically relevant repair/regeneration strategies. As a result of today’s
population leading a more active lifestyle than ever before, there is a rising need for
total joint replacement earlier in life. Therefore, treatment strategies currently aim to
create grafts to delay the need for arthroplasty [Butler et al., 2000]. To address this
need, functional tissue engineering aims to restore cartilage function by culturing grafts
in vitro that recapitulate the mechanical, biochemical, and structural framework of the
tissue in order to have an increased chance of integration and survival upon in vivo
implantation [Butler et al., 2000]. In order to accomplish this, the general features of
tissue engineered cartilage include isolated cells embedded within a scaffold to allow
for matrix entrapment, with the application of extrinsic factors that induce matrix
development [Butler et al., 2000, Langer and Vacanti, 1993, Lum and Elisseeff, 2003].
An overview of each of these features as it relates to the current strategies in the field,
and particulary in this dissertation, is presented.
1.3.2.1 Scaffold Material: Agarose Hydrogel
The high water content and hydrophilic properties of hydrogels have made them a
widely used scaffold material for cartilage tissue engineering applications [Elisseeff et al.,
2002, Lewandrowski et al., 2002, Smetana Jr, 1993]. In particular, agarose hydrogels
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have been used widely in tissue engineering applications for growth of cartilage tissue
for clinical implantation [Huang et al., 2010,Kock et al., 2009,Selmi et al., 2008,Benya
and Shaffer, 1982,Mauck et al., 2000,Buschmann et al., 1992,Buschmann et al., 1995,
Mauck et al., 2002]. Agarose is a clear, inert, thermo-reversible hydrogel composed of
polysaccharides extracted from algae [Aymard et al., 2001, Benya and Shaffer, 1982].
This 3D scaffold acts to prevent cell and elaborated extracellular matrix leakage from
the implantation site, as well as stabilize the chondrocyte phenotype and promote a
homogeneous distribution of cells within the defect [Lee and Bader, 1995, Selmi et al.,
2008]. In addition, agarose allows for the influx of nutrients and chemical factors and
the removal of waste products [Lum and Elisseeff, 2003].
Agarose hydrogels been used extensively for long-term growth of tissue constructs
seeded with chondrocytes harvested from immature bovine or canine articular cartilage
[Ng et al., 2009b, Ng et al., 2009a, Mauck et al., 2000]. These studies were able to
achieve native compressive mechanical properties and glycosaminoglycan content over
4-6 weeks of in vitro culture. In addition, agarose hydrogels are currently employed
for autologous cartilage repair strategies clinically (Cartipatch®) [Selmi et al., 2008].
In addition, cartilage tissue engineered constructs created with agarose hydrogels have
been shown to allow for early application of mechanical load, which is vital for functional




Chondrocytes comprise less than 10% of articular cartilage and are responsible for the
synthesis and maintenance of the extracellular matrix, thus regulating the environment
within the tissue [Buckwalter et al., 1997]. Chondrocytes in situ are surrounded by
a pericellular matrix, characterized by a high concentration of type VI collagen and
keratin sulfate. The pericellular matrix and the encapsulated cell(s) are collectively
known as the chondron, which function to transduce biomechanical and biochemical
signals to the cells [Buckwalter et al., 1997,Guilak et al., 2006,Poole, 1997].
Chondrocytes are the clinical gold standard cell source for cartilage repair, as au-
tologous chondrocyte implantation involves expansion of patient chondrocytes that are
reintroduced into the patient’s joint (e.g., Carticel®, Genzyme Corporation). For this
reason, and better supported by the numerous reports in the literature that report
that chondrocytes are capable of making more mechanically functional cartilage in cul-
ture than mesenchymal stem cells [Vinardell et al., 2011, Erickson et al., 2008], we
chose to examine chondrocytes in multiple studies in this dissertation, thus providing
a clinically-relevant reference of comparison for SDSCs.
While differentiated chondrocytes may be obtained from a patient’s own healthy,
non-load-bearing cartilage, this may introduce donor site morbidity accompanied by
further tissue degeneration [Gilbert, 1997]. Chondrocytes may also be harvested from
the diseased knee during debridement procedures; however, cells from OA tissue may
present limitations with regards to reduced capacity to produce robust ECM compo-
nents [Günther, 2001, Wang et al., 2003]. In addition, due to the immunoprivileged
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nature of diarthrodial joints, the implantation of allogeneic cells from other patients
cells may be expanded for use [Glenn et al., 2006]. However, cell passaging is often
necessary to obtain sufficient cell number, particularly with adult cell sources. Most
in vitro studies utilize chondrocytes from juvenile tissue due to increased biosynthetic
activity, including much of the work in our lab with juvenile bovine chondrocytes.
The greater biosynthetic activity of juvenile chondrocytes has led to their investigation
clinically (Isto Technologies, Inc.-RevaFlexTM).
Synovium-Derived Stem Cells:
The limitations of chondrocytes for creating tissue-engineered substitutes has led to
the investigation of mesenchymal stem cells for creating functionally relevant grafts
[Ronziere et al., 2010, Moutos et al., 2010, Lima et al., 2007, Huang et al., 2010, Gong
et al., 2010, Buxton et al., 2010, Schulz et al., 2008, Fan et al., 2006]. MSCs have
the ability to differentiate in vitro into multiple cell types, including chondrocytes,
adipocytes, and osteocytes [Caplan, 1991, De Bari et al., 2001]. MSCs are positive for
some surface markers: CD73, CD90, and CD105, and negative for most hematopoietic
lineage markers [Dominici et al., 2006].
MSCs can be isolated from several sources, including bone marrow, adipose tis-
sue, periosteum, and synovium [De Bari et al., 2001, Pittenger et al., 1999, Zuk et al.,
2001, O’Driscoll et al., 1994]. Of these MSC sources, the synovium tissue is clinically
attractive since it can be harvested with minimal invasiveness by clinicians during
arthroscopy and thereby provides a source for autologous cells, without causing compli-
cations at the donor site due to its high regenerative capacity [Pei et al., 2008a,Theoret
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et al., 1996]. A pure population of SDSCs (type B-synovial fibroblasts) can be isolated
through multiple passages or by negative isolation, to remove cells that are positive for
CD14 (type A-synovial macrophages) [Pei et al., 2008b].
Because SDSCs are found in the intra-articular environment (as opposed to bone
marrow or adipose-derived stem cells), they may represent a local cell population of
tissue-specific stem cells found in a well-situated stem cell niche that can support car-
tilage repair. Several groups have shown the multi-differentiation potential of SDSCs,
thus confirming the mesenchymal potential of SDSCs [De Bari et al., 2001, Shirasawa
et al., 2006, Sampat et al., 2013]. With the reported findings that SDSCs exhibit
the greatest chondrogenic potential and a lower osteogenic potential (i.e., least hyper-
trophic) [Shirasawa et al., 2006, Jones and Pei, 2012, Dickhut et al., 2009] than their
counterparts from bone marrow or fat, there is growing interest in SDSCs as an at-
tractive and clinically-relevant cell source for cartilage repair strategies [Theoret et al.,
1996,Sakaguchi et al., 2005,Nagase et al., 2008]. SDSCs have shown potential for both
in vitro cartilage tissue engineering [Pei et al., 2008b, Pei et al., 2008a, Sampat et al.,
2013,Han et al., 2010,Bilgen et al., 2007] and in vivo cartilage regeneration [Koga et al.,
2007, Pei et al., 2009]. Tissues created from SDSCs have been shown to express and
accumulate collagen II but not collagen X [Pei et al., 2008b,Pei et al., 2008a]. Due to
the immunoprivileged nature of the joint that permits the use of allografts in cartilage
repair, in addition to autologous cells, allogeneic SDSC cells could also be used, similar
to current chondrocyte strategies clinically.
With appropriate stimulation, SDSCs are capable of migrating into articular car-
tilage defects and differentiating toward chondrocytes [Hunziker, 2001]. In addition,
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SDSCs are unique in that they maintain their chondrogenic capacity regardless of donor
age or disease condition [De Bari et al., 2001,Nagase et al., 2008]. They have been shown
to secrete lubricin, similar to the superficial layer of cartilage [Lee et al., 2009, Schu-
macher et al., 1999]. The chondrogenic potential of synovium-derived cells is further
demonstrated by the disease condition synovial chondromatosis, in which cartilaginous
nodules form within the synovium, further suggesting a high chondrogenic potency of
synovium [Maurice et al., 1988].
Synoviocytes have similar expression profiles to chondrocytes, which is particularly
induced with BMP-2 [Sakaguchi et al., 2005, De Bari et al., 2001]. Furthermore, they
produce similar proteins, including cartilage oligomeric matrix protein (COMP), link
proteins, and sulfated GAGs [Pei et al., 2008b]. Some recent studies are focusing on
utilizing an SDSC-derived extracellular matrix to serve as an in vitro 3D microenvi-
ronment to promote SDSC proliferation and eventual chondrogenesis. Initial results
indicate that this 3D environment coupled with growth factor application and hypoxia
may play a key role in recreating an in vitro tissue-specific microenvironment in order
to improve cartilage repair strategies [Ng et al., 2009b,He et al., 2009].
SDSCs, in contrast to chondrocytes, have shown resistance to cytokines that are
present in the synovial fluid during injury [Nagase et al., 2008, Zimmermann et al.,
2001]. In addition, these cells also produce antioxidants to resist damage in areas in
which injury or OA has produced oxidative damage [Pei et al., 2012].
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1.3.2.3 Applied Factors to Promote Development
Chemical Factors:
Growth Factors
Cell passaging and concurrent priming with chemical factors, such as growth factors,
are often necessary steps in cell-based strategies for regenerative medicine [Ng et al.,
2009b, Bilgen et al., 2007, Estes et al., 2008]. Growth factors have been particularly
useful for in vitro applications of adult human and canine chondrocytes that have a
lower cell yield when digested and are less biosynthetically active than cells from juvenile
sources [Ng et al., 2009b,Francioli et al., 2007,Barbero et al., 2003]. Passaging cells in
a physiologically appropriate cocktail of growth factors allows for cell proliferation, as
well as priming the cells to synthesize matrix components when reintroduced into a 3D
environment [Benya and Shaffer, 1982,Francioli et al., 2007,Ng et al., 2009b].
The fact that physiological formation of articular cartilage occurs through the com-
bination of several growth factors, and that both cartilage and synovium originate
from a common group of mesenchymal precursor cells, suggests that cartilage forma-
tion utilizing SDSCs may occur similarly [Archer et al., 2003, Shintani and Hunziker,
2007, Wagner and Karsenty, 2001]. Previous studies have induced chondrogenesis of
SDSCs in vitro using a growth factor cocktail including basic fibroblast growth factor
(bFGF), insulin-like growth factor I (IGF-I), and transforming growth factor-β1 (TGF-
β1), with limited clinical success [Pei et al., 2008b, Fox et al., 2010, Phan et al., 2009].
Therefore, the growth factor cocktail used to prime both chondrocytes and SDSCs in
the studies in this dissertation consisted of TGF-β1, bFGF, and platelet-derived growth
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factor-BB (PDGF-BB) [Francioli et al., 2007]. Previously, this growth factor cocktail
was shown to increase the proliferation rates and maintain the chondrogenic potential
of human articular chondrocytes [Francioli et al., 2007,Barbero et al., 2003].
In addition to their use in priming cells in monolayer expansion, growth factors are
also supplemented in 3D culture to enhance matrix synthesis, including those of the
TGF-β family, IGF, bone morphogenetic protein (BMP)-2, and bFGF [Mauck et al.,
2003b, Byers et al., 2008]. TGF-β3 was primarily used in the studies presented within
this dissertation.
Trimethylamine N-Oxide (TMAO)
The skeletal matrix of shark cartilage is comprised of similar proportions of constituents
as human articular cartilage [Porter et al., 2006]. Trimethylamine N-Oxide (TMAO) is
an organic osmolyte found in shark tissues which counteracts the protein perturbations
caused by urea by inducing protein folding and stabilization [Yancey, 2005]. The urea
allows for the sharks to maintain an osmotic balance with the external water. Previous
studies in the lab have shown the pronounced effects of 5 mM and 50 mM TMAO
concentrations on the mechanical and biochemical properties of chondrocyte-seeded
agarose hydrogels [O’Connell et al., 2012]. While TMAO is an osmolyte, at such low
concentrations it has negligible effects on the media osmolarity [O’Connell et al., 2012].
Physico-Chemical Factors: Osmotic Regulation
Towards creating more functionally relevant tissue engineered cartilage, in addition to
the supplementation of chemical factors in vitro, another potential factor to consider
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is creating a more physiologic extracellular osmotic environment, which can have a
significant effect on tissue development [Urban et al., 1993].
The in situ osmotic environment of chondrocytes varies with proteoglycan content
and tissue deformation [Urban et al., 1993,Urban, 1994]. Negatively charged sulfate and
carboxyl groups attached to the chondroitin and keratin sulfate chains of GAG lead to
high fixed charge density (FCD) within the cartilage tissue, normally ranging between
0.05 to 0.3 mEq/g [Maroudas, 1979,Maroudas et al., 1969]. The high concentration of
interstitial ions results in a higher fluid pressure inside of the tissue than the outside,
known as Donnan osmotic pressure [Maroudas et al., 1969]. Depth-dependent variation
in negatively charged proteoglycan content leads to zonal differences in FCD, which by
Donnan equilibrium leads to an increasing gradient in osmolarity through the depth of
the tissue [Urban et al., 1993].
The typical in vivo osmolarity of human articular cartilage ranges from 350–450
mOsM depending on the cartilage zone [Urban et al., 1993, Koo et al., 2010, Hopewell
and Urban, 2003,Maroudas and Evans, 1972]. Similarly, human synovium averages 400
mOsM [Shanfield et al., 1988].
OA is characterized by increased water content resulting in a lower tissue osmolarity
as well as loss of extracellular matrix components and decreased matrix synthesis as the
cells swell [Buckwalter et al., 1997]. The loss of proteoglycans during OA reduces the os-
motic environment of cartilage. Under loading conditions, OA chondrocytes experience
greater fluctuations in osmolarity than normal, due to an increased water loss [Hopewell
and Urban, 2003].
Relative to native osmolarity, standard chondrogenic culture media is hypotonic and
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typically 330 mOsM. The transient response of chondrocytes to osmotic loading has
been studied [Bush and Hall, 2001,Chao et al., 2006,Palmer et al., 2001]; results have
quantified osmolarity-induced effects on the biological response of chondrocytes in 2D
and 3D culture [Urban et al., 1993,Koo et al., 2010,Oswald et al., 2011a]. Chondrocytes
rapidly detect and adapt in response to changes in osmolarity by swelling (hypoosmotic
stimulus) or shrinking (hyperosmotic stimulus) [Urban et al., 1993].Theoretical predic-
tions of in situ chondrocyte osmolarity indicates that extracellular osmolarity does
not vary significantly with physiologic loading [Oswald et al., 2008]. Several studies
in this dissertation are motivated by the discrepancy between standard culture media
osmolarity relative to the native environment.
Transient Receptor Potential Vanilloid 4 (TRPV4):
Most cells rapidly respond to osmotic shrinkage by some regulatory volume control
mechanism initially involving ion transport [Hopewell and Urban, 2003]. However,
the complete mechanisms that may be responsible for the response of both SDSCs
and chondrocytes to long-term culture in varying osmolarities remain to be elucidated.
Based upon previous studies that evaluated the morphological response of cells to short-
term changes in osmolarity, the transient receptor potential vanilloid 4 (TRPV4) ion
channel has emerged as a candidate player in this response [Phan et al., 2009,Strotmann
et al., 2003,Kerrigan et al., 2006,Lewis et al., 2011].
The Transient Receptor Potential (TRP) family of ion channels is composed of 28
mammalian members divided into 7 subfamilies, including TRPV [Venkatachalam and
Montell, 2007]. TRPV4 expression has been previously confirmed in several tissues,
including epithelium, central nervous system, lungs, and kidney [Nilius et al., 2004,
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Clark et al., 2010], as well as more recently in both chondrocytes and SDSCs [Phan
et al., 2009,Sampat et al., 2013,Sanchez et al., 2003].
The TRPV4 ion channel is localized to the outer cell membrane and is activated by
hypoosmolarity, warmth, and chemical agents [Vriens et al., 2009,Clark et al., 2010,Nil-
ius et al., 2003]. As a result, it is involved in the regulatory volume decrease (RVD)
response [Phan et al., 2009]. Calcium is the primary ion traversing the channel [Strot-
mann et al., 2003]. Calcium influx following hypoosmotic shock can occur through both
opening of stretch activated cation channels and opening of TRPV4 channels [Sanchez
et al., 2003, Liedtke et al., 2000, Strotmann et al., 2003, Wissenbach et al., 2000, Nilius
et al., 2003].
Mechanical Factors: Dynamic Deformational Loading
Mechanical loading is important for the healthy maintenance of articular cartilage [Gray
et al., 1988]. Diurnal loading of the knee involves initial pressurization of the water
within the tissue before being expelled into the surrounding space. During this phase,
the cartilage volume decreases and the ECM and encapsulated chondrocytes deform
under the load, resulting in hypertonic changes to the osmotic environment. Upon
joint unloading, water is reabsorbed and the cells and matrix return to their original
state [Hopewell and Urban, 2003,Urban, 1994]. In addition to physical deformation of
cells, dynamic compression of cartilage also results in streaming potentials, hydrostatic
pressure, and increased nutrient transport, all of which can affect matrix synthesis
through mechanotransduction pathways [Albro et al., 2008,Chahine et al., 2009,Mauck
et al., 2003a,Mauck et al., 2003b,Mow et al., 1999,Kim et al., 1995].
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Previous studies have shown that dynamic deformational loading significantly im-
proves the properties of chondrocyte-seeded agarose hydrogels and encourages develop-
ment of physiologically relevant tissue [Mauck et al., 2000, Mauck et al., 2002, Mauck
et al., 2003b]. To this end, our lab has incorporated dynamic deformational bioreactors
that create a biomimetic joint loading environment for growing engineered cartilage
in culture. Adopting a functional tissue engineering strategy, engineered cartilage with
mechanical properties similar to native cartilage can be grown in eight weeks using chon-
drocytes, a process that is expedited with the application of dynamic deformational
loading bioreactors that simulate aspects of physiologic joint loading [Mauck et al.,
2000, Lima et al., 2007, Bian et al., 2010, Kelly et al., 2006]. In addition, the benefits
of dynamic loading, including ennhanced nutrient transport [Albro et al., 2008,Mauck
et al., 2003b], in conjunction with chemical and physico-chemical factors may be used




2.1 Overarching Experimental Methods
The proposed experiments will share common methodologies with regard to cell source
and scaffold material, culture media, and measurement of mechanical properties and
biochemical composition.
2.1.1 Rationale for Experimental Methods
2.1.1.1 Cell Sources, Construct Fabrication, and Cell Expansion
The juvenile bovine tissue model was chosen for Chapters 3-5 to permit comparisons
with previous experiments in our laboratory and in the literature. Chondrocytes were
employed in several of the aims as both a control condition as well as to evaluate the
effects of certain culture conditions on both chondrocyte and SDSC cell types. The
clinical potential of SDSCs overcomes the limitation of donor-site morbidity and lack
of donor cartilage tissues. Synovium tissue can be harvested with minimal invasive-
ness by clinicians during arthroscopy and SDSCs maintain their chondrogenic capacity
regardless of donor age or disease condition [De Bari et al., 2001,Nagase et al., 2008].
Juvenile cells exhibit significantly greater biosynthetic capacity relative to adult
cells [Tran-Khanh et al., 2005], however their use is limited due to the incompatibility
between cell donor and recipient. To investigate the clinical relevance of the proposed
studies, therefore, adult canine tissue, a widely used pre-clinical model, was used for the
proteomics study in Chapter 3.2. Furthermore, Chapter 6 is the most clinically relevant
with the investigation of chondrocytes and SDSCs from both normal and diseased
human donors.
2.1.1.2 Rationale for Osmotic Loading
Relative to native osmolarity, standard chondrogenic culture media is hypotonic and
typically 330 mOsM while physiologic osmolarity is closer to 400 mOsM [Koo et al.,
2010,Urban et al., 1993]. Theoretical predictions of in situ chondrocyte osmolarity in-
dicates that extracellular osmolarity does not vary significantly with physiologic load-
ing [Oswald et al., 2008]. Therefore, we utilized a straightforward manipulation of
culture media in 3D culture to a more physiologic osmolarity and investigated the
resultant tissue properties.
2.1.1.3 Rationale for Mechanical Testing Methodology
Young’s modulus (EY) and dynamic modulus (G*) are important determinants of func-
tion in tissue engineered constructs. While EY is a general indicator of construct stiff-
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ness, G* is a more accurate indicator of tissue functionality and ability to sustain the
physiological loading environment [Park et al., 2004].
2.1.1.4 Rationale for Biochemical Analyses
In order to quantify the major extracellular matrix constituents, GAG and collagen
assays were performed. In addition, DNA was measured to determine cell content
and viability. Histology and immunohistochemistry were used to assess qualitative
distribution of these matrix components.
2.1.2 Experimental Methods
2.1.2.1 Cell Culture for 3D Encapsulation
Articular cartilage and the intimal layer of synovium were harvested from juvenile
bovine knee joints (2-4 weeks old). Cartilage was digested in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% (v/v) fetal bovine serum (FBS) with colla-
genase type IV (Worthington Biochemical Corporation) for 11 hours at 37oC on an
orbital shaker (Figure 2.1). Synovial tissue was digested in alpha-minimum essential
medium (αMEM) containing 10% (v/v) FBS with collagenase type IV (Worthington
Biochemical Corporation) for 4 hours at 37oC on an orbital shaker. Digested cells were
filtered through a 70 μm porous mesh and remaining tissue was discarded. Following
digestion, SDSCs were seeded at a density of 1.76 x 103 cells/cm2 and expanded for 2
passages (unless otherwise noted) with media containing αMEM, 10% FBS, antibiotics
(100 U/mL penicillin, 100 μg/mL streptomycin, and amphotericin B), and a growth
factor cocktail of 1 ng/ml TGF-β1, 10 ng/mL PDGF-BB, and 5 ng/mL bFGF-2 [Bar-
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bero et al., 2003, Sampat et al., 2011, Sampat et al., 2013] (Figure 2.1). Medium was
changed three times per week.
Figure 2.1: Overall methods for juvenile bovine SDSC and chondrocyte encapsulation.
Articular cartilage and synovium were harvested from juvenile bovine knee joints. Syn-
ovium tissue was digested and cells were expanded for two passages with a growth
factor priming cocktail before trypsinization and encapsulation in a 3D agarose hydro-
gel. Cartilage tissue was digested and chondrocytes were encapsulated in a 3D agarose
hydrogel.
2.1.2.2 CD14 Negative Isolation
To obtain a pure population of SDSCs, a negative isolation procedure was performed
following the first passage (P1) using CD14 Dynabeads (Invitrogen Dynal) [Pei et al.,
2008a,Bilgen et al., 2009]. Cells were detached by trypsinization for 12 minutes (Trypsin
EDTA; Cellgro Mediatech, Inc.), and suspended in phosphate buffered saline (PBS)
with 0.1% bovine serum albumin and 2 mM EDTA at a concentration of 10 x 106
cells/mL. The Dynabeads were suspended in PBS with 0.1% bovine serum albumin,
and then mixed with the synoviocytes (50 μL of beads per 1 x 109 cells) for 30 min at
4oC on a rotational shaker. The synovial fibroblasts and the CD14 cells bound to the
Dynabeads were separated using the DynaMag-15 magnet (Invitrogen Dynal) (Figure
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2.1).
2.1.2.3 3-Dimensional Agarose Cell Encapsulation
Following digestion, primary chondrocytes were encapsulated in 2% w/v agarose (Sigma-
Aldrich) at a concentration of 30 x 106 cells/mL (Figure 2.1) [Bian et al., 2009, Lima
et al., 2007]. After passaging, SDSCs were encapsulated in 2% w/v agarose at a con-
centration of 60 x 106 cells/mL (Figure 2.1) [Sampat et al., 2011,Sampat et al., 2013].
The gels were maintained individually in serum-free chondrogenic media (DMEM, 1%
ITS+ Premix, 50 μg/ml L-proline, 0.1 μM dexamethasone, 0.9 mM sodium pyruvate,
and antibiotics) plus 50 μg/mL ascorbate and 10 ng/mL TGF-β3 at an osmolarity of
330 mOsM overnight and then discs were cored to final dimensions (4 mm diameter,
2.34 mm thickness unless otherwise noted). Constructs were cultured with serum-free
chondrogenic media with ascorbate (50 µg/mL) and TGF-β3 (10 ng/mL) added fresh
during each media change. Culture media was changed every other day. For juvenile
cells, TGF-β3 was removed at day 21 for SDSCs and day 14 for chondrocytes, as previ-
ously established. For adult human cells, TGF-β3 was applied continuously throughout
the culture, as previously established.
2.1.2.4 Osmotic Media Preparation
For osmotic culture specific studies, medium of 300 mOsM was made by diluting DMEM
(337 mOsM) to 300 mOsM with deionized water. Next, hyperosmotic media was pre-
pared at 400 mOsM by the addition of NaCl and KCl at a ratio of 20.7 moles NaCl to
1 mole KCl, the same concentration as in DMEM. Standard chondrogenic media of 330
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mOsM was kept as the isotonic control condition.
2.1.2.5 Mechanical Testing
The equilibrium Young’s modulus (EY) was determined under unconfined compression
following stress relaxation of the sample after 10% strain was applied, at a strain rate of
0.05%s-1. The dynamic modulus (G*) was determined by superimposing an additional
±1% strain at specified frequencies ranging from 0.01 to 1.0 Hz. All testing was done
using a custom computer-controlled testing device [Soltz and Ateshian, 1998].
2.1.2.6 Biochemical Composition
Samples were lyophilized and digested in proteinase K solution overnight (16 hours) at
56oC, as previously described [Kelly et al., 2006]. Biochemical analysis was performed to
determine the collagen and glycosaminoglycan (GAG) content using the orthohydrox-
yproline (OHP) and 1,9-dimethylmethylene blue assay (DMMB), respectively [Farndale
et al., 1982, Stegemann and Stalder, 1967]. The DNA content was determined using
the PicoGreen kit (Invitrogen Co., Carlsbad, CA).
2.1.2.7 Histological Analyses
Samples were fixed in acid-ethanol-formalin overnight at 4oC, dehydrated in a graded
series of ethanol, cleared, and embedded in paraffin wax. Samples were then sectioned
at 8 μm thick using a microtome. Sections were then stained with 0.1% Picrosirius Red
for collagen distribution and 1% Alcian Blue for GAG distribution and visualized under
a stereoscope.
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Immunohistochemistry was utilized to assess the structure and components of the
cultured constructs. Overall steps included digesting tissue sections in testicular hyaluronidase,
swelling in acetic acid, and blocking in normal goat serum prior to incubating with pri-
mary and secondary antibodies. Antibodies against type II collagen, type VI collagen,
COMP, and TRPV4 were assessed.
2.1.2.8 Flow Cytometry Analysis
(Performed by Dr. Elena Alegre-Aguarón, PhD)
The expression of surface markers on Dyna-ed synovial cells was studied by flow cytom-
etry. Cells were stained with fluorescein isothiocyanate (FITC)- or phycoerythrin (PE)-
conjugated monoclonal antibodies against various surface markers, including CD31
(Thermo Scientific), CD34 (Abcam), CD49c (Thermo Scientific), CD105 (Abcam),
CD151 (BD), and CD73 (BioLegend). Unstained cells were used as a negative fluo-
rescence control. Cells were incubated in the dark at room temperature for 15 min,
after which they were washed and resuspended in 0.5 mL of PBS containing 2 mM
EDTA for analysis. Immediately after incubation, cell fluorescence was evaluated using
a FACSCalibur flow cytometer (Becton Dickinson). The resulting data was analyzed
using FlowJo software (version 7.6.1).
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Chapter 3
Growth Factor Priming for
Cartilage Tissue Engineering
3.1 Study 3A-SDSC Priming
3.1.1 Introduction
The harsh loading environment and the avascular nature of mature cartilage lead to a
poor intrinsic healing capacity after injury. As a result, cell-based therapies, including
tissue engineering strategies for growing clinically relevant grafts, are being intensively
researched [Ronziere et al., 2010, Moutos et al., 2010, Lima et al., 2007, Huang et al.,
2010, Gong et al., 2010, Buxton et al., 2010]. An autologous cell source would be
ideal for growing clinically-relevant engineered cartilage; however, using cells from an
osteoarthritic or injured tissue to grow engineered cartilage with mechanical and bio-
chemical properties similar to healthy native tissue poses several challenges [Ahmed
et al., 2010,Gavénis et al., 2006]. Due to an insufficient supply of healthy chondrocytes
in damaged or osteoarthritic cartilage, donor site morbidity, and a lack of suitable donor
tissues, clinical application of cartilage tissue engineering may need to rely on other cell
sources. The clinical potential of stem cells has driven efforts toward their optimization
for tissue engineering applications.
Synovium-derived stem cells (SDSCs) have the potential for tissue-engineering appli-
cations aimed at cartilage repair or regeneration [Lima et al., 2007,Pei et al., 2008b,Han
et al., 2010]. A pure population of SDSCs (type B-synovial fibroblasts) can be isolated
through multiple passages or by negative isolation, to remove cells that are positive
for CD14 (type A-synovial macrophages) [Pei et al., 2008b]. The cells can then be
expanded in culture for three-dimensional (3D) encapsulation and the expansion me-
dia can be optimized to promote chondrogenesis [Pei et al., 2008b,Bilgen et al., 2007].
Previous studies have induced chondrogenesis of SDSCs in vitro using a growth factor
cocktail including basic fibroblast growth factor (bFGF), insulin-like growth factor I
(IGF-I), and transforming growth factor-β1 (TGF-β1), with TGF-β1 contributing to
chondrogenesis of the SDSCs [Pei et al., 2008b, Pei et al., 2008a]. While the SDSCs
in these studies showed potential to produce extracellular matrix components similar
to chondrocytes (i.e., collagen II and aggrecan), few studies have demonstrated that
SDSCs can be used to achieve a tissue-engineered material with mechanical properties
similar to native cartilage [Pei et al., 2008b,Pei et al., 2008a].
Therefore, our initial study explored the potential of using SDSCs as a tissue en-
gineering strategy for growing clinically relevant cartilage grafts. The two challenges
addressed were the priming of SDSCs towards a chondrogenic lineage in 2D culture,
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and the elaboration of construct tissue composition and material properties approach-
ing those of native cartilage. Accordingly, the first objective was to investigate the
influence of growth factor priming of SDSCs in 2D culture on the subsequent properties
of tissue formed by these cells after seeding in 3D hydrogel scaffolds. The second ob-
jective was to determine the impact of transient or continuous exposure of constructs
to TGF-β3 growth factor in 3D culture.
3.1.2 Materials and Methods
3.1.2.1 Cell Culture
Synovial tissue was harvested according to the methods outlined in 2.1.2.1. Synovio-
cytes were isolated, plated at a density of 180 cells/cm2, and cultured with medium
containing alpha-minimum essential medium (αMEM), 10% fetal bovine serum (FBS),
100 U/mL penicillin, 100 mg/mL streptomycin and amphotericin B (Invitrogen Co.).
SDSCs were negatively isolated following the first passage according to the method
outlined in 2.1.2.2. The isolated SDSCs were passaged until P3 before expanding for
3D culture.
To determine the effect of priming the cells towards a chondrogenic lineage in 2D
culture, the culture medium was supplemented with a cocktail of growth factors during
P4 expansion (1 ng/mL TGF-β1, 10 ng/mL PDGF-BB, and 5 ng/mL bFGF-2; primed
group; Figure 3.1) [Barbero et al., 2003]. Cells expanded without the cocktail of growth
factors served as the control (unprimed group). The synoviocytes were encapsulated in
2% w/v agarose (Type VII; Sigma-Aldrich) at a concentration of 60 x 106cells/mL and
discs were cored using a sterile disposable punch (Miltex) to final dimensions of 3 mm
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diameter and 2.34 mm thickness.
Constructs were cultured with serum-free chondrogenic media (Dulbecco’s modified
Eagle’s medium (DMEM), 1% ITS+ Premix, 50 µg/mL L-proline, 0.1 µM dexametha-
sone, 0.9 mM sodium pyruvate, antibiotics) with ascorbate (50 µg/mL) and TGF-β3
(10 ng/mL) added fresh during each media change. Culture media was changed every
other day. The effect of supplementing the culture media with TGF-β3 was evaluated
by removing the growth factor from half of the samples at day 21 (‘release’), while
the other half continued to receive the growth factor for the remainder of the study
(‘continuous’; Figure 3.1). This study was repeated with ‘primed’ cells (Study B) that
were not isolated with the Dynabeads procedure and were expanded for 3D culture at
P2. The Dynabeads were not used in the repeat study, since the first study (Study
A) observed that less than 5% of the cells were positive for CD14. Time points for
mechanical, biochemical, and histological analyses for Study A were days 0, 21, 35, and
56 (day 49 for Study B).
3.1.2.2 Flow Cytometry Analysis
The expression of surface markers on Dyna-ed synovial cells was studied by flow cy-
tometry. Cells were stained with fluorescein isothiocyanate (FITC)- or phycoerythrin
(PE)-conjugated monoclonal antibodies against CD31 (Thermo Scientific), CD34 (Ab-
cam), CD49c (Thermo Scientific), and CD73 (BioLegend). Unstained cells were used
as a negative fluorescence control. Cells were incubated in the dark at room temper-
ature for 15 min, after which they were washed and resuspended in 0.5 mL of PBS
containing 2 mM EDTA for analysis. Immediately after incubation, cell fluorescence
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was evaluated using a FACSCalibur flow cytometer (Becton Dickinson). The resulting
data was analyzed using FlowJo software (version 7.6.1).
Figure 3.1: Schematic of the study design. Synovium-derived stem cells were expanded
in 2D culture with (primed) or without (unprimed) growth factors. Once in 3D culture,
the culture medium was supplemented with transforming growth factor (TGF)-β3 for
the first 21 days (release) or throughout the study (continuous).
3.1.2.3 Mechanical Testing
The equilibrium Young’s modulus (EY) and dynamic modulus (G* at 0.5 Hz) was
determined according to the methods outlined in 2.1.2.5.
3.1.2.4 Biochemical Composition
Biochemistry was performed to determine the DNA, GAG, and collagen content using
the protocols outlined in 2.1.2.6. Samples for histological analysis were stained with
Picrosirius Red and Alcian Blue to visualize collagen and GAG distribution, respec-
tively, as outlined in 2.1.2.7. Immunohistochemical staining for type II and VI collagen
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(Abcam) was performed as outlined in 2.1.2.7.
3.1.2.5 Statistical Analyses
Statistics were conducted using a three-way ANOVA with α = 0.05, and Tukey’s HSD
post hoc test, with statistical significance achieved when p ≤ 0.05. The three factors
analyzed in the ANOVA were Factor 1 = growth factor priming treatment, Factor 2 =
TGF-β3 application, and Factor 3 = time. Factor 1 and Factor 2 each had two levels
while Factor 3 had four levels. All data is presented as mean ± standard deviation.
3.1.2.6 Multi-differentiation potential of SDSCs
Following passage 1, SDSCs were plated at 50 cells/cm2 and cultured in αMEM with
10% FBS and antibiotics, for 7 days. For adipogenic differentiation, the medium was
replaced with DMEM with 10% FBS and antibiotics, plus 10=6 M dexamethasone,
0.5 mM isobutyl-1-methyl xanthine, 100 μM indomethacin, and 10 μg/mL insulin, for
14 days. Following differentiation, cells were fixed in 10% formalin and stained with
Oil Red-O. For osteogenic differentiation, the medium was replaced with DMEM with
10% FBS and antibiotics, plus 10=7 M dexamethasone, 0.2 mM ascorbic acid, and 10
mM β-glycerolphosphate for an additional 14 days, followed by fixing with ethanol and
staining with Alizarin Red (pH 4.2) [Pei et al., 2008b]. As a negative control, SDSCs




3.1.3.1 Multi-differentiation potential of SDSCs in 2D
We tested the multi-differentiation potential of SDSCs by culturing in both adipogenic
and osteogenic media. Figures 3.2B and 3.2E show evidence of lipid vacuoles and
calcified nodules, confirming the mesenchymal potential of SDSCs. As expected, no
adipogenic and osteogenic phenotype were detectable in the negative controls (Figures
3.2C and 3.2F).
Figure 3.2: Multi-differentiation potential of juvenile bovine SDSCs in 2D monolayer
culture. (A) and (B): Adipogenesis of SDSCs. After 7 days of expansion in serum-
containing media, SDSCs were incubated in adipogenesis medium for an additional 14
days before staining with Oil Red-O. Lipid vacuoles are visible in (B). (C): SDSCs
were expanded in serum-containing media before staining with Oil Red-O as a negative
control. (D) and (E): Osteogenesis of SDSCs. After 7 days of expansion in serum-
containing media, SDSCs were incubated in osteogenic media for an additional 14 days
before staining with Alizarin Red. Calcified nodules are visible in (E). (F): SDSCs were
expanded in serum-containing media before staining with Alizarin Red as a negative
control. Bars: 50 μm. (A) and (D): Stereoscopic images; (B), (C), (E), and (F): 20x
magnification.
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3.1.3.2 Cell Characterization and Initial 3D Culture Observations
Flow cytometry analysis indicated the majority of synoviocytes showed low expression
(<5%) of CD31 (endothelial cell marker) and CD34 (hematopoietic cell marker). On
the other hand, the expression of CD49c (α3 integrin) was high (>95%) and CD73
(ecto- 5´nucleotidase, SH3, SH4) was above 60%.
Within the first 21 days of 3D culture, aggregated SDSCs (spherical balls) were
observed to emanate from and detach into the culture media. Their presence was
generally a precursor of 3D construct growth (Figure 3.3A). Cellular viability of the
aggregated SDSCs in the culture media, as assessed by the Live/Dead cytotoxicity
assay, indicated the presence of living cells throughout the mass (Figure 3.3B). Gross
morphology of the constructs after 7 weeks in culture revealed an increased volume and
tissue opacity of the primed release group as compared to the corresponding continuous
group (Figure 3.4).
Figure 3.3: (A) Representative image of aggregated SDSCs emanating from the con-
struct on the right half of the image (20x magnification). (B) Viability of the floating
cell mass in the culture media as indicated by pervasive green fluorescence of the cells
(40x magnification).
42
Figure 3.4: Representative gross morphology of constructs seeded with growth factor
primed synovium cells at day 49 (Study B). The continuous group (left panel) had final
average dimensions of  = 4.67 ± 0.23 mm, thickness = 2.91 ± 0.11 mm, and the
release group (right panel) had final dimensions of  = 4.81 ± 0.19 mm, thickness =
2.98 ± 0.11 mm (n = 5/group).
3.1.3.3 3D Culture: Effects of Cell Priming and TGF-β3 application
With continuous growth factor administration (from day 0 to day 56), both construct
groups (primed or unprimed with growth factor cocktail during 2D expansion) exhib-
ited significant increases in Young’s modulus relative to day 0 values (Figure 3.5A),
reaching as high as 96 ± 21 kPa on day 21 (primed). The primed and unprimed groups
exhibited generally similar mechanical properties, except for a transient increase in the
primed modulus relative to unprimed constructs observed for day 21. GAG levels of
primed constructs were significantly elevated for day 21-56 over corresponding unprimed
constructs (p < 0.001, Figure 3.5B).
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Figure 3.5: (A) Schematic of the experimental groups, (B) equilibrium Young’s mod-
ulus, and (C) glycosaminoglycan (GAG) (%ww) for constructs cultured over 8-week
study period. Solid line indicates release at day 21 time point (*p < 0.05).
At days 35 and 56, unprimed constructs that received only transient growth factor
administration (from day 0 to day 21) showed no improvement in mechanical properties
relative to day 0, despite a trend of increasing GAG. In contrast, primed constructs
exhibited significant temporal increases in Young’s modulus upon discontinuation (re-
lease) of growth factor (day 35 and day 56), with peak values of EY = 267 ± 96 kPa
and GAG levels of 5.19 ± 1.45 %ww attained on day 56 (Figure 3.5). The collagen
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content in the constructs at day 56 was 0.51 ± 0.03 %ww and was similar for release
and continuous groups (data not shown). The dynamic modulus (G*) followed a sim-
ilar trend to Young’s modulus across all four groups, and reached a maximum of 1.74
± 0.27 MPa for the primed-release group at day 56. These were the best mechanical
properties and biochemical content achieved in the study.
No significant changes in DNA content were observed over culture time or between
the four groups (data not shown). As a measure of cell metabolic activity, GAG was
normalized to DNA content, and demonstrated similar trends to the GAG content data
for the groups. The primed-release group reached a peak value (for the study) of 137.61
± 46.17 GAG/DNA on day 56. The corresponding peak collagen content achieved was
14.01 ± 1.68 collagen/DNA (pooled data, n = 5) and was similar for the release and
continuous groups (data not shown).
Histological analysis revealed strong GAG and collagen staining in the central re-
gion for the release groups at day 49, whereas the continuous groups showed more even
distribution throughout (Figure 3.6). Immunohistochemical staining indicated the pres-
ence of type II and type VI collagen in the primed release groups at day 49 (Figure 3.7).
At day 56, the mechanical properties of constructs that did not receive any TGF-β3
growth factor over the culture period had not increased from day 0 values (data not
shown).
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Figure 3.6: Representative GAG and collagen staining at days 0 and 49 (A) Alcian
Blue staining (GAG) and (B) Picrosirius Red staining (collagen) for constructs seeded
with growth factor primed SDSCs.
Figure 3.7: Representative immunohistochemical staining for (A) type II collagen
(green), (B) type VI collagen (green), and (C) negative control image (red for cell
nuclei) at day 49 (40x magnification).
The effect of continued or transient application of TGF-β3 to constructs seeded with
growth factor primed-SDSCs was repeated in a second study. In both studies, transient
application of TGF-β3 to the constructs led to significantly better tissue properties
compared to sustained growth factor application (Figure 3.8). While the growth of
constructs in the primed-release group was slightly delayed in the second study (day
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35), the relative values were comparable between the two studies by day 49.
Figure 3.8: Comparison of the Young’s modulus (EY) normalized to day 0 values for the
initial study (triangles) and the repeat study (circles). TGF-β3 was added to the culture
media either for a transient period of time (release: filled symbols) or continuously
throughout the 3D culture (continuous: open symbols). All groups were primed in 2D
culture with a growth factor cocktail.
3.1.4 Discussion
This study investigated the potential of SDSCs to grow engineered cartilage. SDSCs
have previously been shown to have potential for differentiating down a chondrogenic
lineage and are thought to aid in articular cartilage repair in vivo [Pei et al., 2008b].
Specifically, we examined the influence of supplementing the cell expansion and tis-
sue culture media with chemical growth factors on the mechanical and biochemical
properties of the engineered tissue constructs. Constructs that received application of
TGF-β3 for the first 21 days only (‘release’) exhibited significantly higher compressive
equilibrium modulus and GAG content compared to constructs that received continu-
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ous growth factor stimulation (Figure 3.5). This outcome with SDSCs replicates the
findings of previous studies that used juvenile chondrocytes or bone marrow-derived
mesenchymal stem cells (MSCs), suggesting that SDSCs may be just as effective as
these other cell sources [Lima et al., 2007, Huang et al., 2009]. Within seven weeks of
culture, constructs achieved a Young’s modulus approaching native immature bovine
cartilage levels (400-1000 kPa; Figure 3.5), with corresponding GAG content also simi-
lar to native values (approximately 6.0 - 8.0 %ww) [Lima et al., 2007,Bian et al., 2009].
In our previous work, we have reported a strong correlation between Young’s modulus
and GAG content in chondrocyte-seeded agarose constructs [Mauck et al., 2002]. These
initial findings were promising in terms of utilizing SDSCs as a source for cartilage tissue
engineering applications.
MSCs have been used to grow functional tissue engineered cartilage using bone
marrow-derived and synovium-derived stem cells [Pei et al., 2008a, Connelly et al.,
2008, Erickson et al., 2008, Huang and Mauck, 2010]. Juvenile bovine bone marrow
MSCs have been encapsulated in various hydrogels, including agarose and hyaluronan-
based hydrogels [Connelly et al., 2008, Erickson et al., 2008, Huang and Mauck, 2010].
The mechanical properties obtained with primed-SDSC seeded agarose gels reported in
this study are several fold greater than the properties achieved by engineered cartilage
with bone marrow MSCs [Connelly et al., 2008,Huang and Mauck, 2010]. More recently,
SDSCs were seeded in fibrin-PGA scaffolds and cultured in a bioreactor for four weeks
[Pei et al., 2008a]. The mechanical properties achieved with SDSCs seeded in the fibrin-
PGA scaffold are comparable to those observed in this study, demonstrating the general
utility of SDSCs as a cell source for cartilage repair strategies [Selmi et al., 2008].
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Growth factor priming in 2D was found to be essential for enhancing the mechan-
ical and biochemical properties of the engineered tissue constructs. Previously, this
growth factor cocktail has been used to rapidly expand cell number and prime the
cells to reactivate matrix synthesis when encapsulated and cultured in a 3D scaffold
environment [Ng et al., 2009b, Francioli et al., 2007, Benya and Shaffer, 1982]. A re-
cent study showed that priming chondrocytes with a growth factor cocktail including
TGF-β1, bFGF-2, and PDGF-BB significantly enhanced cell proliferation and aided in
maintaining a rounded chondrocyte-like morphology [Francioli et al., 2007]. Evaluation
of the individual growth factors have suggested that bFGF-2 increases the proliferation
rate of MSCs and TGF-β1 increases the expression of collagen type II and proteogly-
cans [Solchaga et al., 2005, Yamaguchi, 1995, Fortier et al., 2011]. Priming the SDSCs
during expansion resulted in a faster doubling rate (i.e. shorter time to reach conflu-
ence) and the engineered cartilage mechanical and biochemical properties were better
than the properties from constructs seeded with unprimed SDSCs (Figure 3.5). Further-
more, the extracellular matrix formed by the constructs seeded with primed SDSCs was
positive for collagen types II and VI (Figure 3.7). In articular cartilage, type II collagen
is the primary collagen constituent, and type VI collagen is thought to help facilitate
interactions between collagen type II and the cell surface in the pericellular matrix re-
gion [Loeser, 2010, Keene et al., 1988]. Therefore, this study supports the notion that
using a growth factor cocktail is important for promoting SDSC chondrogenesis and
cartilaginous extracellular matrix production.
Several studies comparing the cell-surface properties of MSCs isolated from bone
marrow, synovium, periosteum, skeletal muscle, and adipose tissue indicate the superior
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chondrogenic capacity of synovium-derived cells for tissue engineering applications [Sak-
aguchi et al., 2005]. Flow cytometry of the synoviocytes for common markers showed
that the cells were negative for endothelial (CD31) and hematopoietic (CD34) markers
and had notable expression of CD73, which is in agreement with previous studies with
MSCs [Dominici et al., 2006]. CD49c has been described by Grogan et al. as one of the
antigens highly expressed in monolayer-expanded chondrocyte populations with high
chondrogenic potential when used to form in vitro cartilaginous tissue [Grogan et al.,
2007]. In our laboratory we have observed that juvenile bovine chondrocytes and SD-
SCs have a high expression of CD49c. This suggests that MSCs, which can be easily
acquired from the synovium, can be cultured to differentiate towards a chondrogenic
lineage. In conclusion, the findings of this study showed that SDSCs provide a potential,
clinically relevant, source of cells for regenerative strategies for articular cartilage and
that priming these cells with growth factors in 2D culture promotes chondrogenesis.
3.2 Study 3B-Canine Proteomics
3.2.1 Introduction
In an effort to further understand the impact of the growth factor priming cocktail used
in Study 3A, comparative proteomics analysis was utilized to identify differentially reg-
ulated cartilage proteins in cells cultured with and without the growth factor priming
cocktail. Juvenile cells exhibit significantly greater biosynthetic capacity relative to
adult cells [Tran-Khanh et al., 2005], however their use is limited due to the incom-
patibility between cell donor and recipient. In the following study, adult canine cells
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were utilized since the dog represents an important large pre-clinical animal model for
musculoskeletal research [Ng et al., 2009b].
Cartilage tissues grown with chondrocytes have led to engineered cartilage with su-
perior mechanical properties, compared to tissues engineered using stem cells, providing
the primary motivation for the chondrocyte cell source adopted in this study [Vinardell
et al., 2011, Erickson et al., 2008]. Chondrocytes are the clinical gold standard cell
source for cartilage repair, as autologous chondrocyte implantation involves expansion
of patient chondrocytes that are reintroduced into the patient’s joint (e.g., Carticel®,
Genzyme Corporation). Our laboratory has shown that both chondrocytes and SDSCs
are promising cell sources for cartilage repair [Sampat et al., 2011,Mauck et al., 2000].
As a result, parallel studies were carried out using canine chondrocytes and SDSCs to
provide a clinically-relevant reference of comparison for SDSCs.
In order to create functional tissue, we used the growth factor expansion protocol
from Study 3A that we have observed to be efficacious for expanding bovine chondro-
cytes and SDSCs in producing subsequent functional tissue matrix. Cell passaging and
concurrent priming with chemical factors are often necessary steps in cell-based strate-
gies for regenerative medicine [Estes et al., 2008]. The fact that physiological formation
of articular cartilage occurs through the combination of several growth factors, and that
both cartilage and synovium originate from a common group of mesenchymal precursor
cells, suggests that cartilage formation utilizing SDSCs occurs similarly [Wagner and
Karsenty, 2001,Shintani and Hunziker, 2007]. The growth factor cocktail used to prime
both chondrocytes and SDSCs in this study consisted of TGF-β1, bFGF, and PDGF-
BB, the same utilized in Study 3A [Francioli et al., 2007]. Previously, this growth factor
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cocktail was shown to increase the proliferation rates and maintain the chondrogenic
potential of human articular chondrocytes [Barbero et al., 2003].
To understand the effects of using this growth factor cocktail on canine chondro-
cytes and SDSCs, we undertook comparative proteomics analysis. This technique is
potentially powerful for this effort, since it quantifies differences in expression of pro-
teins among different biological states. It also allows for the detection of proteins with
post-translational modifications; this information is not provided by genomic analy-
ses. Recently, proteomics approaches were applied to studies with MSCs [Wang et al.,
2004,Foster et al., 2005,Oswald et al., 2011b].
The first proteomic analysis of human bone marrow-derived MSCs used 2D gels to
identify differentially expressed proteins by mass spectrometry [Colter et al., 2001]. In
recent years several key technological developments have significantly advanced both
proteomic characterization and biomarker discovery [Wang et al., 2004]. Since the initial
report by Colter et al., proteomics has been used to identify biomarkers implicated in
cell migration in diverse tissues including bone marrow, umbilical cord blood, and
placenta [Li et al., 2009].
The objective of this study was to use comparative proteomics to investigate the
impact of growth factor priming on 2D canine chondrocyte and SDSC cultures, by
identifying differentially regulated cartilage proteins. Cells cultured without growth
factor supplementation served as the control. Based on our previous SDSC work [Sam-
pat et al., 2011], we hypothesized that primed cells in 2D culture would differentially
express some ECM proteins associated with cartilage.
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3.2.2 Materials and Methods
3.2.2.1 Tissue Harvesting and Cell Expansion
Cartilage and synovial tissue were harvested from adult knee joints from dogs eutha-
nized for other purposes. Typically, both hind limbs were harvested from each animal
and pooled together for the study. Cartilage and synovium were digested using type
IV collagenase (310 U/mg, Worthington) in medium containing 10% (v/v) FBS (At-
lanta Biologicals) at 37oC in a humidified 5% CO2 atmosphere. Digested cells were
filtered through a 70 μm porous mesh and remaining tissue was discarded. Chondro-
cytes were cultured in high-glucose DMEM at a density of 22 x 103 cells/cm2 and
SDSCs in αMEM at a density of 1.76 x 103 cells/cm2, both with 10% (v/v) FBS and
1% (v/v) antibiotic-antimycotic (100 U/mL penicillin, 100 mg/mL streptomycin and
amphotericin B), denoted as passage 1 (P1). To determine the effects of priming cells
towards a chondrogenic lineage in 2D culture, culture media was supplemented with a
cocktail of growth factors (1 ng/mL TGF-1, 5 ng/mL bFGF, and 10 ng/mL PDGF-BB
for the ‘primed’ group) [Sampat et al., 2011, Ng et al., 2009b, Bian et al., 2010]. Cells
expanded without the cocktail of growth factors served as the control or ‘unprimed’
group. When cells reached 80–90% confluence, they were detached from the flask and
replated at the same initial density (P2). When plated cells reached 80–90% conflu-
ence at P2, chondrocytes and SDSCs (unprimed and primed) were harvested for flow
cytometry and proteomics analyses (Figure 3.9). Cultures were fed three times per
week. Proliferation rate was calculated at each passage using the doubling time for-
mula: td = tc x
ln(2)
ln( finalinitial)
, where: td = doubling time (days), tc = time in culture (days),
final = number of cells harvested from trypsinization, initial = number of cells initially
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seeded.
Figure 3.9: Cells isolated from canine cartilage and synovium were cultured in 2D
with (primed, -P) or without (unprimed, -U) a growth factor cocktail (see Materials
and Methods). Surface marker expression by flow cytometry and label-free proteomic
profiling were assessed in chondrocytes and SDSCs at passage 2 (P2). Cells were sub-
sequently evaluated for chondrogenic capacity in 3D pellet culture at passage 2 (P2).
3.2.2.2 Flow Cytometry
At P2, chondrocytes and SDSCs were resuspended in PBS containing 2 mM EDTA
(GIBCO) and FITC- or PE-conjugated monoclonal antibodies. Unstained cells were
used as a fluorescence negative control. Antibodies against CD31 (Abcam), CD34
(Abcam), and CD45 (Invitrogen) were used as negative indicators. CD31 (PECAM-1)
is an endothelial cell marker; CD34 and CD45 (LCA) are hematopoietic cell markers.
Antibodies against MSC markers, CD105 (endoglin, Abcam), CD151 (PETA-3, BD
Pharmigen), and CD166 (ALCAM, BioLegend) were also used. Cells were incubated
in the dark at room temperature for 15 minutes, after which they were washed and
resuspended in 0.5 mL PBS containing 2 mM EDTA. Cell fluorescence was evaluated by
flow cytometry using a FACSCalibur flow cytometer (Becton Dickinson). The resulting
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data were analyzed by FlowJo software (version 9.3.2).
3.2.2.3 Proteomics Analyses
A label-free protein profiling technique for mass spectrometry based shotgun proteomics
was performed using a NanoAcquity liquid chromatograph and a Synapt G2 HDMS
QTOF mass spectrometer (Waters Corp.). Cells were washed with ice cold PBS,
lysed in 0.3% SDS, TRIS-buffered saline with 1% Protease Inhibitor Cocktail (Sigma-
Aldrich), precipitated using a methanol/chloroform extraction and then dissolved in
0.1% RapiGestTM SF detergent-containing (Waters Corp.) 50 mM ammonium bi-
carbonate. Dithiothreitol was added and the solution was sonicated and boiled for
5 minutes. Protein concentration was determined using the Bradford Protein Assay
(Bio-Rad). Cysteines were alkylated with iodoacetamide. Proteins were digested with
trypsin and 50 fmol of a digest of yeast alcohol dehydrogenase was added as an internal
detection control. The mass spectrometer was equipped for traveling wave ion mo-
bility spectrometry (TWIMS). Ion mobility provided separation on the basis of shape
and cross-sectional area, in addition to the conventional mass-to-charge ratio. The
use of ion mobility for shotgun proteomics has been demonstrated to be effective in
increasing proteome depth of coverage [Cyr et al., 2011, Ibrahim et al., 2011]. Three
independent biological replicates from three separate cultures were analyzed. For each
replicate, three 120 min liquid chromatography (LC)/mass spectrometry (MS) runs
were carried out, providing a total of 36 chromatograms (nine replicate analyses for
each group) in resolution/ion mobility mode. Spectra were recorded with a 0.6 second
scan time, analyzed with ProteinLynx Global Server V.2.5, RC9, (Waters Corp.) on a
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Lenovo D20 Workstation with Xeon Processor equipped with a NVIDIA Tesla C2050
graphics processing unit (GPU) processor with 448 CUDA cores. Data was searched
against an NCBI Refseq database of canine sequences derived from Release 47. This
database containing 33,335 canine sequences (18,873,091 residues). Accurate mass and
retention time matches of precursors were compared across all LC/MS runs for label-
free intensity based quantitation were performed with Rosetta Elucidator software Ver.
3.3.0.1.SP3 CRE52.21 (Ceiba Solutions, Inc.) as described previously [Oswald et al.,
2011b]. Statistical analyses were generated by Elucidator with p-values calculated from
an application of an error model developed for large-scale microarray data as adapted
for proteomics within the Elucidator program. Protein ratio p-values for differential
expression were calculated by the Elucidator program using the xdev parameter [Dai
et al., 2002,Weng et al., 2006].
The combination of label-free MSE data acquisition and post-processing with Elu-
cidator data mining software for accurate mass and retention time matching is vali-
dated independently by other groups [Cyr et al., 2011,Levin et al., 2011,Reidel et al.,
2011,Chien et al., 2012]. From one C-P sample, all three chromatograms were outliers
(derived from this one sample) and were excluded from the data set based on visual
inspection [Matzke et al., 2011] and principal component analysis (data not shown).
This individual sample may have had some aberrant culture problem or problem with
protein extraction. Such exclusions are a normal prerequisite for analysis of proteomics
data [Matzke et al., 2011].
In order to better understand the relevance of the resulting canine proteins and for
pathway analysis, canine Protein GI numbers were converted into official gene symbols
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using the DAVID conversion tool found at http://david.abcc.ncifcrf.gov/ conversion.jsp.
Following this, canine official gene symbols were converted to their human equivalent
(when available) using Homologene on NCBI. UniProt [Uni, 2012] was used to generate
all of the annotated protein data. Finally, the DAVID tool [Dennis Jr et al., 2003]
was used as an interface to the Kyoto Encyclopedia of Genes and Genomes (KEGG)
[Kanehisa and Goto, 2000] pathway repository at Kyoto University to generate pathway
diagrams that illustrate some possible relationships from the proteomics data.
3.2.2.4 In vitro Chondrogenic Differentiation
Chondrogenic differentiation of canine chondrocytes and SDSCs at P2 was evaluated
in a 28-day micropellet culture study [Pittenger et al., 1999]. Briefly, 0.5 x 106 cells
were centrifuged (300 x g for 7 min) in 15 mL conical polypropylene tubes (Becton
Dickinson) and the resulting pellets were cultured in 0.5 mL of CM with 50 μg/mL
ascorbate-2-phosphate and 10 ng/mL TGF-3 added fresh during each media change.
SDSC pellets were additionally treated with 500 ng/mL bone morphogenetic protein-2
(BMP-2, GenScript) [Fan et al., 2010a]. All chondrocyte and SDSC pellets were fed
twice per week.
3.2.2.5 Biochemical Analyses
Time points for biochemical analyses were conducted on days 0, 14, and 28. Pellets were
digested in proteinase K solution overnight at 56oC, as previously described [Kelly et al.,
2006]. Biochemical analysis was performed to determine the GAG content using the
dimethylene blue assay [Farndale et al., 1982]. In addition, the OHP assay [Stegemann
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and Stalder, 1967] was used to assess collagen content. Overall collagen content was
calculated by assuming a 1:7.64 orthohydroxyproline-to-collagen mass ratio [Hollander
et al., 1994]. The DNA content was determined using the PicoGreen kit (Invitrogen),
according to the manufacturer’s standard protocols. GAG and collagen content was
normalized to DNA content.
3.2.2.6 Statistical Analyses
Statistics were performed using a student’s t-test to compare groups (primed vs. un-
primed in both chondrocytes and SDSCs). Results were considered to be significant for
p ≤ 0.05. Data was analyzed using GraphPad Prism software (version 4.0c).
3.2.3 Results
3.2.3.1 Cell Proliferation
Treatment with the growth factor cocktail resulted in changes in morphology and pro-
liferation of cells. The doubling times from P1 to P4 for each cell line (unprimed
chondrocytes: C-U; primed chondrocytes: C-P; unprimed SDSCs: S-U; primed SDSCs:
S-P) are shown in Figure 3.10. For each cell type (chondrocytes and SDSCs), primed
cells clearly proliferated more rapidly than unprimed cells, as seen by the doubling rates
(chondrocytes: p < 0.001 at P1 and P4, p < 0.01 at P2; SDSCs: p < 0.01 at P2, P3,
and P4).
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Figure 3.10: Doubling times of canine (A) chondrocytes (unprimed (C-U), primed (C-
P)) and (B) SDSCs (unprimed (S-U), primed (S-P)) from P1 to P4 (n = 5). Statistically
significant differences relative to unprimed cells are represented as **p < 0.01 and
***p < 0.001.
3.2.3.2 Flow Cytometry
Cell surface marker expression was analyzed for canine chondrocytes and SDSCs at
P2 (Table 3.1). The expression of CD31 (endothelial cell marker), CD34, and CD45
(hematopoietic cell markers) was <5% for all groups and no differences were detected
between the groups. The highest expression of CD105 (a MSC marker) was seen in
S-P (79%, p < 0.001; S-P vs. S-U). Both primed SDSCs and chondrocytes showed
similar expression of CD151 (˜60%) (Table 3.1). Surprisingly, S-U showed the highest
expression (82%) of CD151 as compared to its expression in S-P (59%) (p < 0.05).
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However, the lowest expression of CD151 was found in C-U (27%), roughly half of
its expression in C-P (58%; p < 0.01). Another MSC marker, CD166, was positive
(mean ≥ 95%) in SDSCs, regardless of treatment. In chondrocytes, the percentage of
CD166-positive cells was higher in C-P (76%) (p < 0.01; C-P vs. C-U).
Expression (%) C-U C-P S-U S-P
CD31 0.02±0.02 0.04±0.03 0.06±0.07 0.00±0.01
CD34 0.13±0.14 0.12±0.14 0.48±0.46 0.14±0.19
CD45 0.63±0.31 1.20±0.9 4.25±3.09 1.14±0.89
CD105 45.78±9.65 35.18±5.23 61.90±5.46 78.82±3.31***
CD151 26.67±9.76 57.80±3.61** 81.57±9.61 59.00±6.53*
CD166 52.50±5.53 75.83±7.18** 95.00±3.49 96.28±1.29
Table 3.1: Phenotype of canine chondrocytes (C-U, C-P) and SDSCs (S-U, S-P) at
passage 2. Percentages of positive cells are shown as mean percentage ± SD (n =
5). Statistically significant differences relative to unprimed cells are represented as
∗p < 0.05, ∗ ∗ p < 0.01, and ∗ ∗ ∗p < 0.001.
3.2.3.3 Proteomics Analyses
Proteomic analysis focused on 1,766 proteins from which three or more peptides were
detected. Criteria for further protein selection were based on p-value, ratio between
–P and –U (considered of interest when the increase or decrease was >1.75- fold), and
peptide count, which allowed us to narrow our study to 357 proteins of interest. SDSCs
had a greater number of proteins of interest, in that 172 proteins were up-regulated
(the abundance of these proteins was higher in S-P than in S-U cells), while only 21
were up-regulated by priming in chondrocytes. To gain insight into the biological
significance of the altered proteins during the priming treatment, the differentially
expressed proteins were categorized according to their reported biological functions.
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Functional characterization of these 357 proteins of interest reveals that more than
50% are involved in cellular organization (including proteins whose primary function
is in the ECM, cytoskeleton, or membrane organization) and transcription, protein
synthesis, and turnover.
In primed chondrocytes, some ECM-related proteins were down-regulated (i.e.,
abundance of these proteins was higher in C-U than C-P). These included type I col-
lagen, type II collagen (4-fold decrease) (Figure 3.11A), type V procollagen, type V
collagen, type XII collagen, which interacts with type I collagen, and aggrecan (2.77-
fold decrease) (Table 3.2). Thrombospondin 1, a marker of articular cartilage, was less
abundant in both primed chondrocytes and SDSCs (1.82-fold decrease) (Table 3.3). In
addition, other proteins involved in synthesis and processing of ECM components were
also down-regulated: procollagen-lysine, 2-oxoglutarate 5- dioxygenase 2 isoform b pre-
cursor which forms hydroxylysine residues in Xaa-Lys-Gly- sequences in collagens, and
lysyl oxidase preproprotein isoform 1, which is responsible for the post-translational
oxidative deamination of peptidyl lysine residues in precursors to fibrous collagen and
elastin (Table 3.2). On the other hand, tenascin, another ECM protein expressed in
chondrocytes, was up-regulated with priming (1.92-fold increase). Transforming growth
factor-beta induced protein IG-H3 precursor, which binds to types I, II, and IV colla-
gens, was highly up-regulated (6.39-fold increase) in C-P too (Table 3.2). Additional
proteins associated with cell stress, rescue or defense, were more abundant in C-U, in-
cluding heat shock protein beta-1, alpha crystallin B chain, nucleoredoxin, and stress-70
protein (Table 3.2).
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Figure 3.11: A) Example of differential expression of collagen alpha-1(II) chain.
The plot represents one isotopic signal from the mass spectrum of peptide GFT-
GLQGLPGPPGPSGDQGASGPAGPSGPR at 1337.1 m/z and 45.6 min retention time.
Unprimed chondrocytes (C-U) cells exhibit strong accumulation of this protein, com-
pared to primed chondrocytes (C-P) samples or either S-U or S-P samples B) Example
of differential expression of aminopeptidase N (CD13). Plot represents one isotopic
signal from the mass spectrum of peptide ESALLYDPQSSSIGNK at 854.9 m/z and
46.3 min retention time. Primed SDSCs (S-P cells) exhibit strong accumulation of this
protein in response to growth factor priming; in comparison, neither C-P nor unprimed
SDSCs (S-U cells) show a significant signal.
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Table 3.2: Most prominent differentially expressed proteins found in the proteomics
analysis in chondrocytes. Most of the protein names are truncated from the full names
listed in the database for simplicity.
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Table 3.3: Most prominent differentially expressed proteins found in the proteomics
analysis in chondrocytes and SDSCs. Most of the protein names are truncated from
the full names listed in the database for simplicity.
In SDSCs, some transcription factors and protein products linked to chondrogenic
differentiation were down-regulated. Ybox transcription factor, known to be a regulator
of collagen translation, and collagen alpha 1(III) chain precursor isoform 2, present in
most soft connective tissues along with type I collagen, were down-regulated. In con-
trast, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 precursor (Lysyl hydroxylase
1) (LH1) isoform 3, which forms hydroxylysine residues in nascent collagen chains, and
type VI collagen, were both up-regulated in S-P cells. Meanwhile, other ECM proteins,
namely biglycan and lumican, were down-regulated in S-P (3.45- and 2.7-fold decrease,
respectively). Integrin beta 1, a receptor for collagen and fibronectin, and integrin
alpha-5 precursor, a receptor for fibronectin and fibrinogen, were both down-regulated
(Table 3.4).
In general, our data suggest that S-P were metabolically more active than S-U and
most of the proteins whose level increases metabolism and cellular energy were up-
regulated. For example, ATP synthases, in NAD, lipid, or carbohydrate biosynthetic
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enzymes, as well as oxidative tricarboxylic cycle enzymes, and mitochondrial respira-
tory chain components were all up-regulated. Moreover, some enzymes involved in
glycine biosynthesis and collagen synthesis (D-3-phosphoglycerate dehydrogenase, C-1-
tetrahydrofolate synthase), were also upregulated (Table 3.3, 3.4). Protein disulfide-
isomerase A4 precursor (Protein ERp-72) (ERp72) isoform 3, that catalyzes the rear-
rangement of -S-S- bonds in proteins and related to collagen biosynthesis and assem-
bly too, was also up-regulated (2.02-fold increase) (Table 3.4). A number of proteins
involved in proteasome dependent protein turnover, or amino acid turnover, were in-
creased in primed cells.
Proteomic data also documented the altered abundance of proteins whose function
it is to regulate the cell cycle or cell fate. Endothelial protein C receptor (stem cell
marker) was up-regulated in both C-P (6.04-fold increase) and S-P (2.69-fold increase)
(Table 3.3). A marker typically used to identify stem cells, aminopeptidase N (CD13),
was 4.5-fold up-regulated in S-P (Table 3.4) (Figure 3.11B). CD63, a tetraspanin, was
also up-regulated (2.34-fold increase) (Table 3.4). As stated previously, S-P cells showed
greater proliferation than S-U cells and proteins associated with cell cycle, cell division,
and DNA replication were mostly upregulated.
A variety of proteins known to regulate the cytoskeleton, subcellular organization,
or the mechanics of secretion, were regulated by priming. Therefore, the majority
of proteins associated with the cytoskeleton (actin, microtubules, actin binding pro-
teins (tropomyosin, drebrin, and stathmin that regulate microtubule remodeling), and
myosin and dynactin involved in cellular and organelle motility and secretion) were
down-regulated. Other actin-remodeling proteins were differentially expressed, includ-
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ing transgelin (down-regulated) or cofilin and gelsolin (up-regulated) (Table 3.4).
Table 3.4: Most prominent differentially expressed proteins found in the proteomics
analysis in SDSCs. Most of the protein names are truncated from the full names listed
in the database for simplicity.
3.2.3.4 Biochemical Analyses
After 28 days in culture, chondrocyte pellets showed significant differences in GAG
content (p < 0.001), with 62.95 ± 5.69 GAG/DNA in C-P pellets and 43.07 ± 5.19
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GAG/DNA in C-U pellets (Figure 3.12A). In contrast, C-P pellets showed a higher
collagen content than C-U pellets at day 14 (p < 0.05), but a similar level by day
28 for both C-P and C-U cells (Figure 3.12B). A significant increase in GAG and
collagen content was detected in S-P pellets (31.82 ± 4.39 GAG/DNA and 25.39±4.41
collagen/DNA) compared to S-U pellets (15.92 ± 2.24 GAG/DNA and 10.67 ± 2.82
collagen/DNA) (p < 0.001) at day 28 (Figure 3.12C, D), while no significant differences
in DNA content were found over culture time or between groups (data not shown).
Figure 3.12: (A, C) GAG content (g) normalized by DNA (g). After 28 days in cul-
ture, primed cells produced significantly more GAG/DNA. (B, D) Collagen content (g)
normalized by DNA (g). Primed SDSCs (S-P cells) produced more collagen after 14 or
28 days. Results are shown as mean ± SD (n = 5). Statistically significant differences
relative to unprimed cells are represented as *p < 0.05, **p < 0.01, and ***p < 0.001.
3.2.4 Discussion
The aim of this study was to prime canine chondrocytes and SDSCs with a cocktail
of growth factors that maintains their potential for chondrogenic differentiation, and
to identify differentially regulated cartilage proteins. The results from this study could
potentially be used to identify predictors of cells’ utility in cartilage tissue engineering
67
protocols. The current study demonstrated that growth factor priming had a much
greater effect on SDSCs than on chondrocytes, as seen by the number of proteins dif-
ferentially expressed in 2D between primed and unprimed cells, and the differences
in GAG and collagen content in 3D pellet culture. Primed SDSCs appear to retain
their stem cell potential, although some collagen-related proteins, indicative of differ-
entiation, were up-regulated, which could be significant in their future tendency for
chondrogenic differentiation. In contrast, chondrocytes, which start out in a differenti-
ated state, dedifferentiated over the culture period in 2D. In addition to the transition of
chondrocyte morphology from spherical to more widespread over the surface, monolayer
culture has also been found to result in a reduced type II collagen expression [Qusous
and Kerrigan, 2012, Horton and Hassell, 1986, Benya and Shaffer, 1982]. Chondrocyte
dedifferentiation was recently investigated to determine quantifiable cellular changes in
monolayer culture, including changes in morphology and regulatory volume increase
(RVI) response [Qusous and Kerrigan, 2012].
Moreover, a dramatic increase in cell number (doubling time), especially in SDSCs,
was observed. After 4 weeks of incubation, cells in pellet cultures adopted a chondro-
cytic fate; GAG and collagen content increased in a time-dependent manner. Recent
studies have found that cultured chondrocytes show better chondrogenic differentiation
ability than human MSCs [Saha et al., 2010,Chiang et al., 2011]. These studies are con-
sistent with our results that chondrocytes produced more GAG than SDSCs in pellet
culture.
Although SDSCs are distinct from bone marrow-derived MSCs, they are similar in
their surface epitope expression [Shirasawa et al., 2006]. To date, no epitope unique to
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only SDSCs has been identified [Shirasawa et al., 2006]. However, since SDSCs have
been characterized as MSCs, surface epitopes specific to MSCs are used for analysis. Of
the surface markers expressed by SDSCs, CD105 binds TGF-β1 and TGF-β3 with high
affinity. Thus, CD105 may be a required mediator of TGF-β signaling during chon-
drogenic differentiation of MSCs [Cheifetz et al., 1992]. Further, it was found that the
CD105-positive subpopulation of MSCs from human synovial membrane differentiated
toward chondrocyte-like cells [Arufe et al., 2009]. In our study, this marker was more
highly expressed in S-P than S-U, and S-P cells differentiated towards chondrocytes
more fully than S-U cells, based on their increased GAG and collagen content in pellet
culture. CD166, another MSC marker [Delorme and Charbord, 2007], was positive in
both S-U and S-P cells, although its expression was significantly higher in C-P than
C-U, which may be attributable to the observed dedifferentiation of the chondrocytes.
In vitro culture conditions are important in determining the proteome of cells. For
example, culturing bone marrow-derived stem cells with bFGF prolonged the cells’
differentiation potential [Bianchi et al., 2003]. In agreement with Solchaga et al., who
showed that human bone marrow-derived MSCs expanded in the presence of bFGF were
smaller in size and faster growing than cells without bFGF supplementation [Solchaga
et al., 2005], both canine primed SDSCs and chondrocytes showed spindly morphology
and proliferated more rapidly.
In our study, identification of differentially expressed proteins was based on label-
free shotgun mass spectrometry and ion mobility spectrometry, which together enhance
peptide resolution, and provide orthogonal separation of peptides in the gas phase to
increase detection and sequence coverage of proteins. The label-free protein profiling
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approach has been utilized previously in our laboratory to characterize human adipose-
derived stem cells [Oswald et al., 2011b]. However, our current study presents the first
proteomic profile of SDSCs upon growth factor cocktail stimulation.
Park et al. summarized the proteome identified for human mesenchymal stem cells
[Park et al., 2007]. It is noteworthy that among the proteins Park et al. identified,
some were also found to be proteins of interest in our SDSC study, such as prohibitin,
type VI collagen, and CD63, which were all up-regulated in S-P cells. Senescent cells
down-regulate prohibitin expression [Park et al., 2007]. Thus, S-U cells showed a lower
abundance of this protein compared to S-P cells, which could be attributed to their
reduced proliferation. Moreover, another stem cell surface marker (CD63) we identified
in SDSCs is also expressed on human articular chondrocytes [Diaz-Romero et al., 2005]
and human marrow stromal cells [Stewart et al., 2003]. Another protein we identified
as being up-regulated in S-P has been reported to be a stem cell surface marker, CD13
[Delorme and Charbord, 2007]. However, we found that other proteins previously
identified in the MSC proteome, such as transgelin, integrin beta 1, LIM and SH3
domain protein 1, peptidylprolyl isomerase A and lumican [Park et al., 2007], were
downregulated in SDSCs.
The presence of smooth muscle proteins was previously demonstrated in bone marrow-
derived MSCs [Colter et al., 2001] and adipose-derived MSCs [DeLany et al., 2005].
However, several isoforms of tropomyosin and α–tubulin were down-regulated in S-P
cells. Small leucine-rich proteins, such as decorin, fibromodulin, lumican, and biglycan,
which interact with collagen fibrils and influence their fibrillar architecture and func-
tion [Geng et al., 2006], were mostly unchanged, but two of these, lumican and biglycan,
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were downregulated in S-P cells. Cartilage oligomeric matrix protein (COMP), a large
pentameric glycoprotein and a member of the thrombospondin group of extracellular
proteins, also binds collagen and is thought to mediate cell–matrix interactions [Rosen-
berg et al., 1998,Chen et al., 2005]. Although we did not identify COMP in this study,
we did identify a COMP-related protein, protein disulfide isomerase, which functions in
the processing and transport of wild-type COMP, in chondrocytes [Juang et al., 2010].
In addition, protein disulfide isomerase helps in the folding of many other extracellular
proteins; thus it was more abundant in S-P cells, where it acts as a subunit for prolyl
4-hydroxylase in collagen biosynthesis, and as a molecular chaperone for assembly of
procollagen [Wilson et al., 1998].
In situ, articular chondrocytes reside in a hypoxic environment and therefore rely
primarily on anaerobic glycolysis to generate ATP [Blanco et al., 2004]. Our study found
few differences in proteins involved in energy production between C-P and C-U samples,
potentially due to the fact that the culture environment we used was not hypoxic.
However, one exception was dihydrolipoamide S-acetyl transferase, a component of the
pyruvate dehydrogenase complex (one of the links between glycolysis and the Krebs
cycle) [Sümegi et al., 1980]. This enzyme was up-regulated in both C-P and S-P cells.
In fact, most of the differentially expressed proteins involved in cellular metabolism and
energy production were up-regulated in S-P cells.
αβ-crystallin (heat-shock protein b5) is a member of the small heat-shock protein
family and it functions to protect cells against stress factors, such as heat shock, ox-
idative stress, osmotic shock, and chemical stress. A decrease of αβ-crystallin was
associated with a decrease in collagen type II and aggrecan; a decrease in both of the
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latter typifies dedifferentiation of chondrocytes [Lambrecht et al., 2009]. Our results
appear similar: we found αβ-crystallin, type II collagen, and aggrecan were all down-
regulated in C-P. Another small heat shock protein, heat shock protein beta 1, was
downregulated in C-P cells, similar to decreases that had been reported for this protein
after stimulation with TGF-β in human bone marrow-derived MSCs [Wang et al., 2004].
As observed with other MSC types [Park et al., 2007], the global proteome of SD-
SCs would be a more reliable predictor of chondrogenic potential than focusing only
on specific markers. Thus, it was shown by proteomic profiling that the use of TGF-
β1, bFGF, and PDGF-BB to stimulate canine chondrocytes and SDSCs in 2D cul-
ture is accompanied by remodeling of the cytoskeleton and other proteins associated
with the ECM, and led to better chondrogenic differentiation in 3D culture. Conse-
quently, understanding the importance of multiple proteins within the protein profile
obtained by priming may elucidate the underlying mechanism by which this growth fac-
tor cocktail mediates better chondrogenesis. Specifically, most proteins associated with
cartilage were down-regulated in chondrocytes including collagens, aggrecan, throm-
bospondin 1, D-3-phosphoglycerate dehydrogenase, procollagen-lysine, 2-oxoglutarate
5-dioxygenase 2 isoform b precursor, and lysyl oxidase preproprotein isoform 1. How-
ever, some collagen-related proteins were up-regulated in SDSCs, including type VI
collagen, protein disulfide isomerase, D-3- phosphoglycerate dehydrogenase, and C-1
tetrahydrofolate synthase. These results argue that priming mediated a partial ded-
ifferentiation of chondrocytes and a partial differentiation of SDSCs as seen by the
regulation of a series of ECM related proteins, both of which allowed expansion of cells
that have great chondrogenic potential once placed in 3D culture. That is, ECM com-
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ponents of the priming-induced protein profile may be directly linked with the higher
GAG and collagen production demonstrated in pellet culture, both in this study and
in constructs seeded with primed SDSCs in previous work [Sampat et al., 2011]. The
results of the present study also verify that the label-free profiling proteomics technique
is a robust, consistent, and automated technology that is suitable for high throughput
quantitative proteomics studies. Future work includes confirming the proteomics results
with ELISAs and Western blots because we agree that it is important to understand
the mechanisms responsible for enhanced chondrogenic potential. Future insights in
this field will allow for the identification of biomarkers that could produce better tissue
engineered cartilage.
3.3 Conclusions
In order to overcome the limitations of using chondrocytes for creating functionally rel-
evant cartilage, juvenile bovine synovium-derived stem cells were investigated for their
chondrogenic potential and use in repairing or replacing damaged cartilage. To guide
this effort, we first assessed the resultant response of SDSCs in 3D to initial growth
factor priming in 2D culture. We found that growth factor priming in 2D was essential
for enhancing chondrogenesis and matrix production of the encapsulated cells [Sampat
et al., 2011], similarly to previous work utilizing adult canine chondrocytes [Ng et al.,
2009b]. We also determined that transient application of TGF-β3 during 3D culture
developed the tissue with the most robust properties, similarly to previous work with ju-
venile bovine chondrocytes [Byers et al., 2008,Lima et al., 2007]. Within seven weeks of
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culture, constructs achieved mechanical and biochemical properties approaching native
immature bovine cartilage levels. In the second study, we wanted to further understand
the impact of adding the growth factors by finding differences in the extracellular ma-
trix proteome in chondrocytes and SDSCs in absence or presence of the cocktail. This
study was done in a more clinically relevant canine animal model. In particular, growth
factor priming modulated the proteins associated with the extracellular matrix in two-
dimensional cultures of chondrocytes and SDSCs, inducing a partial dedifferentiation of
chondrocytes (most proteins associated with cartilage were down-regulated in primed
chondrocytes) and a partial differentiation of SDSCs (some collagen-related proteins
were up-regulated in primed SDSCs). However, when chondrocytes and SDSCs were
grown in pellet culture, growth factor-primed cells maintained their chondrogenic po-
tential with respect to glycosaminoglycan and collagen production. In conclusion, the
strength of the label-free proteomics technique is that it allows for the determination of
changes in components of the extracellular matrix proteome in chondrocytes and SD-




Osmotic Regulation for Promoting
Development of Engineered
Cartilage
4.1 Study 4A-Applied osmotic loading for promot-
ing development of engineered cartilage
4.1.1 Introduction
We previously cultured juvenile bovine chondrocytes in 3D agarose hydrogels that
achieved physiologic cartilage tissue properties [Bian et al., 2009,Lima et al., 2007,Lima
et al., 2008a,Mauck et al., 2003b]. Recently, the clinical potential of mesenchymal stem
cells (MSCs) has motivated efforts toward their optimization for tissue engineering
applications [Buxton et al., 2010, Gong et al., 2010, Huang et al., 2010, Lima et al.,
2007,Moutos et al., 2010,Ronziere et al., 2010,De Bari et al., 2001]. In Chapter 3, we
cultured SDSCs in a 3D hydrogel which achieved properties approaching those of native
juvenile bovine cartilage. We also found that supplementation of 2D cultures with a
growth factor cocktail was essential to SDSCs’ production of cartilage-like tissue when
encapsulated in 3D (Chapter 3) [Francioli et al., 2007,Sampat et al., 2011].
Our success in utilizing biomimetic chemical factors for priming SDSCs to grow
functionally relevant cartilage grafts prompted us to manipulate another factor endemic
to in situ cartilage, namely altered extracellular osmolarity, as an additional growth
strategy [Sampat et al., 2011]. The in situ osmotic environment of chondrocytes varies
with proteoglycan content and tissue deformation [Urban et al., 1993,Urban, 1994].
The typical in vivo osmolarity of human articular cartilage ranges from 350-450
mOsM depending on the zone [Koo et al., 2010,Urban et al., 1993]. The loss of proteo-
glycans during osteoarthritis reduces the osmotic environment of cartilage. Similarly,
human synovium averages 400 mOsM [Shanfield et al., 1988]. Relative to native osmo-
larity, standard chondrogenic culture media is hypotonic and typically 330 mOsM.
The transient response of chondrocytes to osmotic loading has been studied [Bush
and Hall, 2001,Chao et al., 2006,Palmer et al., 2001]; results have quantified osmolarity-
induced effects on the biological response of chondrocytes in 2D and 3D culture [Koo
et al., 2010,Oswald et al., 2011a,Urban et al., 1993]. Theoretical predictions of in situ
chondrocyte osmolarity indicates that extracellular osmolarity does not vary signifi-
cantly with physiologic loading [Oswald et al., 2008]. Therefore, in the following study,
we assessed the properties of cells in 3D tissue engineered constructs, as a function of
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baseline osmolarity during long-term culture.
Our experimental approach assessed the effects of static osmotic loading, as a
physico-chemical stimulus, on the mechanical and biochemical properties of 3D tissue-
engineered constructs prepared from SDSCs and chondrocytes. We utilized culture
techniques, specific to each cell type, previously demonstrated to create functionally
relevant tissue. We tested the hypothesis that application of a hypertonic, more physio-
logic environment (created by adding NaCl and KCl to 3D culture media) (400 mOsM)
improves the biochemical composition and mechanical properties of the constructs,
compared to culturing under hypotonic (300 mOsM) or isotonic media (330 mOsM)
conditions.
4.1.2 Materials and Methods
4.1.2.1 Cell Culture
Articular cartilage and synovium were harvested and encapsulated according to the
methods outlined in 2.1.2.1 and 2.1.2.3. SDSCs were negatively isolated following the
first passage according to the method outlined in 2.1.2.2 (Figure 4.1).
The gels were maintained individually in serum-free chondrogenic media (2.1.2.3)
plus 50 μg/mL ascorbate and 10 ng/mL TGF-β3 at an osmolarity of 330 mOsM
overnight and then discs were cored to final dimensions (4 mm diameter, 2.34 mm
thickness). Constructs were divided into chondrogenic media of osmolarities 300, 330,
and 400 mOsM plus 50 μg/mL ascorbate and 10 ng/mL TGF-β3. Mechanical testing
was performed and biochemical composition was assessed for DNA, glycosaminoglycan
(GAG), and collagen content. Time points for analyses occurred at days 0, 21, 35 and
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49 for SDSC constructs and days 0, 14, 28, and 42 for chondrocyte constructs, based
on removal of TGF-β3. TGF-β3 was removed at day 21 for SDSCs and day 14 for
chondrocytes, as previously established.
Figure 4.1: Schematic of the experimental groups. After 3D encapsulation in agarose,
SDSC- and chondrocyte-seeded constructs were cultured with serum-free chondrogenic
media of osmolarities 300, 330, and 400 mOsM. TGF-β3 was removed at Day 14 for
chondrocytes and Day 21 for SDSCs, which were previously demonstrated to create
functionally relevant tissue.
4.1.2.2 Micropellet Culture
In addition to hydrogel encapsulation, following passaging, SDSCs were trypsinized
and micropellets were formed from each. Briefly, 0.25 x 106 cells were centrifuged in
screw-top microcentrifuge tubes with 0.5 mL of chondrogenic media (DMEM, 1% ITS
+ Premix, 50 μg/mL L-proline, 0.1 mM dexamethasone, 0.9 mM sodium pyruvate, and
antibiotics) with ascorbate (50 μg/mL) and TGF-β3 (10 ng/mL) added fresh during
each media change. Micropellets were cultured in normal 330 or 400 mOsM media.
TGF-β3 was removed at day 21. Pellets were fed three times per week. Time points for
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biochemical and histological analyses were days 0, 21, and 49. Biochemical composition
of micropellets was assessed for DNA, GAG, and collagen content, as described below.
GAG and collagen content were normalized to pellet dry weight (%) and DNA content
(g/g).
4.1.2.3 Osmotic Media Preparation
Osmotic medium was prepared according to the protocol outlined in 2.1.2.4. Standard
chondrogenic media of 330 mOsM was kept as the isotonic control condition.
4.1.2.4 Mechanical Testing
The equilibrium Young’s modulus (EY) and dynamic modulus (G*) were determined
according to the methods outlined in 2.1.2.5.
4.1.2.5 Biochemical Composition and Histological Analyses
DNA, GAG, and collagen content were determined using the protocols outlined in
2.1.2.6. Samples for histological analyses were stained with Picrosirius Red and Alcian
Blue to visualize collagen and GAG distribution, respectively, as outlined in 2.1.2.7. Im-
munohistochemical staining for types II and VI collagen (Abcam), cartilage oligomeric
matrix protein (COMP) (Abcam), and transient receptor potential vanilloid 4 (TRPV4)
(Aviva Systems Biology) was performed as outlined in 2.1.2.7.
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4.1.2.6 Statistical Analyses
Statistical analysis was performed with Statistica software using a two-way ANOVA
with α < 0.05 and Tukey’s HSD post hoc test, with statistical significance achieved
when p ≤ 0.05. The two factors analyzed in the ANOVA were Factor 1 = osmotic
media condition and Factor 2 = time. For 3D constructs, Factor 1 had three levels
while Factor 2 had four levels. For SDSC pellets, Factor 1 had two levels while Factor
2 had three levels. All data is presented as mean ± standard deviation.
4.1.3 Results
4.1.3.1 Effects of Static Osmotic Loading in 3D Hydrogel Culture
We revisited chondrogenic differentiation of SDSCs and chondrocytes, to test the hy-
pothesis that hypertonic loading during culture enhances tissue properties. Representa-
tive gross morphology of the constructs revealed the greatest volume and tissue opacity
for the 400 mOsM group for both SDSCs (Figure 4.2) and chondrocytes, as compared to
the 300 mOsM group (p < 0.05 for volume difference). At day 49, the SDSC constructs
had the following average dimensions: 300 mOsM:  = 3.85 ± 0.07 mm, thickness =
2.49 ± 0.02 mm, 330 mOsM:  = 3.84 ± 0.06 mm, thickness = 2.52 ± 0.12 mm, and
400 mOsM:  = 4.40 ± 0.13 mm, thickness = 3.02 ± 0.08 mm (Figure 4.2). At day
42, the 400 mOsM chondrocyte group had a larger average thickness than the other
conditions (p < 0.05). The chondrocyte constructs had the following average dimen-
sions: 300 mOsM:  = 4.12 ± 0.03 mm, thickness = 2.49 ± 0.03 mm, 330 mOsM:  =
4.01 ± 0.10 mm, thickness = 2.49 ± 0.02 mm, and 400 mOsM:  = 4.13 ± 0.06 mm,
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thickness = 2.58 ± 0.07 mm (gross morphology images not shown).
Figure 4.2: Representative gross morphology of SDSC-seeded constructs at day 49. The
300 mOsM group (left) had final average dimensions of  = 3.85 ± 0.07 mm, thickness
= 2.49 ± 0.02 mm, the 330 mOsM group (middle) had final average dimensions of 
= 3.84 ± 0.06 mm, thickness = 2.52 ± 0.12 mm, and the 400 mOsM group (right) had
final average dimensions of  = 4.40 ± 0.13 mm, thickness = 3.02 ± 0.08 mm.
With the application of static osmotic loading, constructs seeded with either primary
chondrocytes or passaged SDSCs responded most favorably to culturing under the most
physiologic osmolarity (p < 0.05). With 400 mOsM static exposure, SDSC constructs
exhibited significant increases in Young’s modulus (Figure 4.3A), reaching 513 ± 89
kPa on day 49, well within native values of immature bovine cartilage (400-1000 kPa).
At day 49, the 400 mOsM group of SDSC constructs exhibited a 15-fold higher Young’s
modulus when normalized to the isotonic condition. Chondrocyte constructs followed a
similar trend; the hypertonic condition led to the most favorable mechanical properties,
reaching 487 ± 187 kPa (day 42). This value was significantly higher than the other
two conditions (p < 0.05) (Figure 4.3E), and was within native levels. The overall
trends for equilibrium modulus were paralleled in dynamic modulus (G* 1 Hz) values,
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although these were not within native levels (Figures 4.3B,F). The results of each study
were repeated and consistent.
The increased stiffness in response to hypertonic loading was accompanied by cor-
responding increases in GAG (Figures 4.3C,G) and DNA content (Figures 4.3D,H) for
both studies. GAG content for both physiologically loaded SDSCs and chondrocytes
were within native levels, ranging from 7-8% as a function of tissue wet weight (Fig-
ures 4.3C,G). At day 49, a significant ˜6-fold higher GAG (%ww) was observed in the
400 mOsM SDSC constructs (7.39 ± 0.52 %ww) as compared to the 300 mOsM con-
structs (1.28 ± 0.13 %ww) (p < 0.05). Chondrocyte constructs exposed to hypertonic
conditions had significantly higher levels of GAG (6.77 ± 0.54 %ww) than the other
conditions at day 42 (p < 0.05).
Collagen levels in SDSC constructs failed to reach native levels, unlike the mechan-
ical properties and GAG content. In the 400 mOsM SDSC constructs at day 49, the
collagen content was 1.32 ± 0.27 %ww and was not significantly different from the 300
and 330 mOsM groups (Table 4.1). The collagen content in the 400 mOsM chondrocyte
constructs at day 42 was 1.53 ± 0.57 %ww and was similar across groups (Table 4.1).
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Figure 4.3: (A) Equilibrium Young’s modulus (EY), (B) dynamic modulus (G*), (C)
glycosaminoglycan (GAG) (%ww), and (D) DNA content (μg) for SDSC-seeded con-
structs cultured over the 7-week study period. (E) Equilibrium Young’s modulus (EY),
(F) dynamic modulus (G*), (G) glycosaminoglycan (GAG) (%ww), and (H) DNA con-
tent (μg) for primary chondrocyte-seeded constructs cultured over the 6-week study
period. Solid line indicates discontinuation of TGF-β3 (*p < 0.05). The results of each
study were subsequently repeated and consistent.
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Collagen content (%ww) 300 mOsM 330 mOsM 400 mOsM
SDSC constructs 0.87 ± 0.24 0.86 ± 0.22 1.32 ± 0.27
Chondrocyte constructs 1.39 ± 0.09 1.53 ± 0.147 1.53 ± 0.57
Table 4.1: Collagen content (%ww) of 300, 330, and 400 mOsM groups for SDSC
and chondrocyte constructs at day 49 and 42, respectively. No statistical significance
amongst conditions.
Because of the volume (and weight; see below) differences caused by culture in
hypertonic medium, the absolute amount of collagen (per construct at day 49) for
SDSCs was highest in the 400 mOsM constructs (297 ± 63 μg), with significantly less
collagen in the 300 (119 ± 26 μg) and 330 (131 ± 34 μg) mOsM constructs (p < 0.0005).
In contrast, the absolute collagen (per construct) for chondrocyte constructs at day 42
was more similar amongst the three treatments, with the 400 mOsM having only slightly
higher content (282 ± 104 μg) than the 300 (233 ± 22 μg) (p = 0.58) and 330 (273 ±
47 μg) (p = 0.98) mOsM groups. In addition to having the highest absolute collagen
content, the hypertonic-loaded SDSC constructs also exhibited linearly increasing (as
a function of time) (R2 > 0.99) total volume and wet weight when these values were
normalized to day 0 values at each time point (data not shown). The isotonic and
hypotonic conditions did not lead to temporal variation in volume and wet weight.
Histological staining for GAG and collagen distribution indicated stronger peripheral
staining for both 300 and 330 mOsM SDSC conditions. Staining of the hypertonic
media condition showed a different distribution pattern with stronger central GAG and
collagen staining (Figures 4.4A,B). In chondrocyte constructs at day 42, all three media
conditions showed similar uniform GAG and collagen distribution (Figures 4.4C,D).
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Figure 4.4: Representative GAG and collagen staining (A) Alcian Blue staining (GAG)
and (B) Picrosirius Red staining (collagen) for constructs seeded with SDSCs at days
0 and 49. (C) Alcian Blue staining (GAG) and (D) Picrosirius Red staining (collagen)
for constructs seeded with primary chondrocytes at days 0 and 42.
Immunohistochemical staining indicated the presence of COMP (Figures 4.5A,E),
type II (Figures 4.5B,F) and type VI collagen (Figures 4.5C,G), and TRPV4 (Figures
4.5D,H) in both the SDSC and chondrocyte constructs that were cultured in 400 mOsM
hypertonic media for the duration of the study (Figure 4.5).
Figure 4.5: Representative immunohistochemical staining for (A) COMP (green), (B)
type II collagen (green), (C) type VI collagen (green), and (D) TRPV4 (green) for
SDSC constructs and (E) COMP (green), (F) type II collagen (green), (G) type VI
collagen (green), and (H) TRPV4 (green) for chondrocyte constructs cultured in 400
mOsM media at final time point. (I) Negative control image. Cell nuclei (A-I) stained
with TOTO-3 (red).
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4.1.3.2 Effects of Static Osmotic Loading in 3D Pellet Culture
In order to determine the effect of static osmotic loading across varying 3D culture
systems (construct vs micropellet), SDSCs were subsequently cultured in micropellets
and exposed to 330 and 400 mOsM medias for 49 days. By day 49, pellets cultured in
400 mOsM media were significantly larger in gross appearance relative to those cultured
in 330 mOsM (images not shown). For simplicity, only day 49 data is presented in Table
4.2. At day 49, the micropellets cultured in 400 mOsM media had a significantly higher
dry weight, DNA, GAG (absolute, %dw, /DNA) and absolute collagen content relative
to the micropellets cultured in 330 mOsM media (Table 4.2) (p < 0.05), mirroring the
trends seen in 3D construct culture. Absolute collagen content was significantly higher
in hypertonic culture than isotonic (p < 0.05), but as a result of lower dry weight for
330 mOsM micropellets, when normalized to dry weight, collagen appeared to be higher
in the isotonic condition (Table 4.2).
Table 4.2: Dry weight, DNA, GAG (absolute and normalized by DNA), and collagen
(absolute and normalized by DNA) content of 330 and 400 mOsM groups for SDSC
micropellets at day 49 in culture (*p < 0.05 vs 330 mOsM group) (n=5 micropel-
lets/group).
4.1.4 Discussion
In the current study, we investigated the potential of utilizing static osmotic loading as
a 3D culturing technique for cartilage tissue engineering. The osmolarity of hypertonic
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medium (400 mOsM) was chosen to mimic the environment of native cartilage, while
the osmolarity of hypotonic medium (300 mOsM) was chosen to mimic an osteoarthritic
environment. The osmolarity of standard chondrogenic medium (330 mOsM) was used
as the isotonic control. The 400 mOsM condition was chosen based on previous work
in the literature showing a maximum rate of PG-associated sulfate incorporation at os-
molarities closer to the in vivo environment (400 mOsM), and a proportional decrease
in response to both relative hypo- or hyperosmolarity [Urban et al., 1993, Hopewell
and Urban, 2003]. Our results support the hypothesis, that SDSCs and chondrocytes
cultured in individually encapsulated agarose hydrogels are improved in cartilaginous
properties by exposure to a hypertonic physiological osmolarity, compared to a hy-
potonic or isotonic environment. This was further supported by micropellet data for
SDSCs.
Oswald et al. showed that the baseline osmotic environment of cartilage, under
unloaded conditions, is ˜340 mOsM at the surface and increases to ˜410 mOsM at
the cartilage-bone interface [Oswald et al., 2008]. The Oswald study suggests that
changes in interstitial fluid osmolarity are negligible in the short-term tissue response
to physiologic loading [Oswald et al., 2008]. However, prolonged static compression may
result in an increase of ˜80 mOsM near the surface and ˜20 mOsM near the bone, as
a result of increased localized fixed charge density. The baseline osmotic environment
may be shifted or reset when loading persists for a longer duration than physiologically
normal. This was supported by Coleman et al., in that changes to normal joint loading
can disrupt homeostasis [Coleman et al., 2013].
In addition to the measured effects of extracellular osmolarity on tissue growth, we
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also found that, within 5-7 weeks of culture, SDSC constructs achieved a Young’s modu-
lus representative of native immature bovine cartilage, with corresponding GAG content
also within native values (Figure 4.3A-D) [Bian et al., 2009, Lima et al., 2007, Mauck
et al., 2002]. The equilibrium modulus, GAG content, and collagen levels achieved for
SDSCs cultured in 400 mOsM media were higher than previously obtained after 56
days (EY: 267 ± 96 kPa, GAG: 5.19 ± 1.45 %ww, collagen: 0.51 ± 0.03 %ww) (Study
3A) [Sampat et al., 2011]. The mechanical and biochemical data suggests that the
magnitude of the osmotic response may depend on cell type; nonetheless, growth of 3D
constructs in hypertonic media enhances their chondrogenesis significantly (p < 0.05).
Additionally, the results indicate that the 300 mOsM media may have a detrimental
effect on the SDSCs as demonstrated by the DNA, GAG, and mechanical properties
(Figure 4.3A-D), although this same effect was not seen for the chondrocytes (Figure
4.3E-H).
SDSCs and chondrocytes produce similar proteins, including COMP, link proteins,
and sulfated GAGs [Pei et al., 2008b]. The ECM formed by SDSC constructs that
were cultured in hypertonic media was determined by immunohistochemistry to con-
tain COMP (Figure 4.5A) and types II (Figure 4.5B) and VI collagen (Figure 4.5C).
This evidence supports the notion that a hypertonic environment promotes SDSC chon-
drogenesis and production of cartilaginous ECM.
Studies in multiple species have shown that static osmotic loading of chondrocytes
during 2D passaging influences cell proliferation rate and subsequent properties achieved
in 3D culture. Culturing human articular chondrocytes in 2D in serum-free media at a
hypotonic osmolarity was found to increase cellular proliferation rate [Koo et al., 2010].
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Recent work from our lab indicates that hypertonic loading of mature chondrocytes
in 2D culture leads to improved mechanical properties in 3D [Oswald et al., 2011a].
The current strategy demonstrates that, regardless of cell type, the osmolarity of the
media during 3D culture affects the construct properties of both juvenile SDSCs and
chondrocytes similarly.
To date, most studies have focused on evaluating aggrecan promoter activity and
gene expression, and sulfate incorporation, in response to osmotic loading [Hung et al.,
2003,Palmer et al., 2001,Urban et al., 1993]. In this study, we explored the impact of
hypertonic conditions created through the addition of the physiologic ionic osmolytes,
NaCl and KCl, on construct properties [Urban et al., 1993]. According to the litera-
ture, it is not definitive whether ionic and nonionic osmolytes lead to similar metabolic
activity in chondrocytes. Preliminary work in our lab indicates a detrimental effect of
hypertonic media created through a nonionic osmolyte, sucrose, on the culture of engi-
neered constructs. With respect to ionic osmolytes, results may depend upon which so-
lutes are used to increase osmolarity. The results of this study appear inconsistent with
the above-mentioned work with mature chondrocytes, which indicated that hypertonic
culture (prepared with NaCl) decreased cell number and per-cell GAG content in 3D
cell constructs, despite the benefit of increased osmolarity shown in 2D cell culture [Os-
wald et al., 2011a]. However, these studies may not be inconsistent; differences may
be due to variances in cell maturity and osmolytes used. The osmotic effects observed
here should be considered to be specific to the application of hypertonic NaCl/KCl
conditions on the two cell types used.
It should be noted that the 330 mOsM media was prepared from undiluted DMEM,
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whereas the 400 mOsM condition was made from diluted 300 mOsM hypotonic me-
dia. Therefore, the concentration of DMEM components and sodium bicarbonate were
higher in the 330 mOsM media. The differences observed may be not only a response
to the osmolarity but also to different concentrations of original media components.
For this study, however, it was important to compare our experimental groups to our
normal culture conditions used in the lab. In a separate study to assess the impact of
the higher DMEM component concentrations, two separate isotonic medias were evalu-
ated, one in which the 330 mOsM media was made from the diluted 300 mOsM media
with the addition of NaCl and KCl solutes and the other being standard undiluted 330
mOsM media. While the standard 330 mOsM media produced higher properties than
the modified 330 mOsM media, both formulations were inferior to the 400 mOsM media
condition, further corroborating the results of the present study.
SDSCs and chondrocytes may be differentially responding to the osmotic environ-
ment and therefore it is unknown whether the same mechanisms are responsible for
sensing and translating changes in osmolarity for both cell types. The SDSC constructs
exposed to hypertonic media exhibited increased volume, wet weight, stiffness, GAG
(%ww), and absolute collagen content. However, the volume, wet weight, and absolute
content of collagen stayed relatively similar for all groups in the chondrocyte study. For
chondrocytes, the increased tissue stiffness seen with the physiologic osmolarity could
be attributed to the increased GAG content (Figure 4.3G) whereas the increased GAG
and collagen could both play a role for SDSCs. The decreased collagen production by
the SDSCs may be due to a potentially mixed cell population despite the negative selec-
tion procedure or passaging [Edwards, 1994,Hallbeck, 2007,Smith, 2011,Vandenabeele
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et al., 2003].
In a separate study with juvenile canine chondrocytes, applied osmotic loading at
400 mOsM also produced the most favorable mechanical properties over the 330 mOsM
(349 ± 182 kPa) baseline, with constructs reaching 740 ± 148 kPa by Day 35 in culture
(p < 0.05) (data not shown). Therefore, age of the donor may play a determining role
in tissue growth.
The mechanisms that may be involved in the response of both SDSCs and chon-
drocytes to long-term culture in varying osmolarities remain to be elucidated. Chon-
drocytes exhibit a rise in intracellular calcium in response to changes in extracellular
osmolarity. Based on previous studies that have evaluated the morphological response of
cells to short-term changes in osmolarity, the Na+-K+-Cl2-- ion co-transporter (NKCC)
and the TRPV4 ion channel are potential mechanisms to consider [Kerrigan et al.,
2006,Lewis et al., 2011,Phan et al., 2009]. TRPV4 is involved in the regulatory volume
decrease response and is present in both chondrocytes and SDSCs (Figure 4.5D,H).
Recently, activation of TRPV4 was used to grow engineered cartilage with improved
tensile properties [Eleswarapu and Athanasiou, 2013]. The potential role of TRPV4
was investigated further in Studies 4D and 4E.
Our findings establish the potential of SDSCs as a clinically relevant cell source for
regenerative strategies for articular cartilage repair. Hypertonic loading is a straight-
forward 3D cultivation technique for both SDSCs and chondrocytes with significant
benefits for cartilage tissue engineering strategies.
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4.2 Study 4B-Growth Factor Priming Necessary for
Benefits of Static Osmotic Loading
4.2.1 Introduction
Based on our previous findings (Study 4A) noting the positive effect of static osmotic
loading to constructs that have been primed during 2D expansion culture with a growth
factor cocktail (Study 3A), we wanted to investigate whether SDSCs that were left
unprimed in 2D culture responded similarly to static osmotic loading when encapsulated
in 3D. We wanted to assess whether osmotic loading and cell priming are synergistic.
In addition, we wanted to investigate the impact of construct properties when cultured
in isoosmotic (330 mOsM) media made with the addition of NaCl and KCl from diluted
300 mOsM media versus isoosmotic media that had not been diluted from stock DMEM.
We hypothesized that cell priming is necessary to observe the same beneficial effects of
osmotic loading.
4.2.2 Materials and Methods
4.2.2.1 Cell Culture
Synovium was harvested from juvenile bovine knee joints (2–4 weeks old) and digested
using collagenase type IV (Worthington). Following digestion, SDSCs were seeded at
a density of 1.76 x 103 cells/cm2 and expanded for 2 passages with media containing
αMEM, 10% FBS, and antibiotics (100 U/mL penicillin, 100 μg/mL streptomycin, and
amphotericin B) [Sampat et al., 2011].
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A negative isolation procedure was performed following the first passage as outlined
in 2.1.2.2 [Sampat et al., 2011, Pei et al., 2008a]. After passaging, SDSCs were en-
capsulated in 2% w/v agarose at a concentration of 60 x 106 cells/mL [Sampat et al.,
2011]. The gel was maintained individually in serum-free CM (2.1.2.1) plus 50 μg/mL
ascorbate and 10 ng/mL TGF-β3 at an osmolarity of 330 mOsM overnight and then
discs were cored to final dimensions (4 mm diameter, 2.34 mm thickness). Constructs
were divided into CM of osmolarities 300, 330 (control), 330 (with the addition of NaCl
and KCl) and 400 (with the addition of NaCl and KCl) mOsM plus 50 μg/mL ascorbate
and 10 ng/mL TGF-β3. TGF-β3 was removed at day 21.
4.2.2.2 Osmotic Media Preparation
Osmotic medium was prepared according to the protocol outlined in 2.1.2.4. Media
was prepared at 330 mOsM and 400 mOsM by the addition of NaCl and KCl at a ratio
of 20.7 moles NaCl to 1 moles KCl, the same concentration as in DMEM. Standard
chondrogenic media of 330 mOsM was kept as the isotonic control condition.
4.2.2.3 Mechanical Testing and Biochemical Analysis
Mechanical testing was performed and biochemical composition was assessed for DNA
and GAG content (2.1.2.6) at days 0 and 42. The equilibrium Young’s modulus (EY)
was determined according to 2.1.2.5.
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4.2.2.4 Statistical Analysis
Statistical analysis was performed with Statistica software using a two-way ANOVA
with α < 0.05 and Tukey’s HSD post hoc test, with statistical significance achieved
when p ≤ 0.05. The two factors analyzed in the ANOVA were Factor 1 = osmotic
media condition and Factor 2 = time. Factor 1 had four levels while Factor 2 had two
levels. All data is presented as mean ± standard deviation.
4.2.3 Results
We tested the hypothesis that osmotic loading and cell priming are synergistic. With
the application of static osmotic loading, constructs seeded with unprimed passaged
SDSCs responded similarly to culturing with 330 control mOsM and 400 mOsM media.
While the equilibrium modulus and GAG content of the 330 control mOsM and 400
mOsM were statistically higher (˜25-30 kPa; ˜1.5 %ww) than the 300 and 330 NaK
mOsM groups (˜14 kPa; ˜0.9 %ww) (Figure 4.6), the values were not comparable to
those achieved when the cells were first primed in 2D culture and thus were not within
native levels (Figure 4.3). DNA content was similar amongst groups (data not shown).
4.2.4 Discussion
The results of this study further supported the necessity to prime cells in 2D culture in
order to produce mechanicaly and biochemically competent tissues in 3D. In addition,
it was again established that constructs cultured in isoosmotic media that was first
diluted to 300 mOsM and then raised to 330 mOsM with the addition of NaCl and KCl
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were mechanically inferior to isoosmotic media from undiluted DMEM. Growth factor
priming in 2D was further confirmed to be essential for enhancing the mechanical and
biochemical properties of the engineered tissue constructs.
(a) (b)
Figure 4.6: (A) Equilibrium Young’s modulus (EY) and (B) GAG (%ww) for SDSC-
seeded constructs cultured for 6 weeks (n=5 constructs/group) *p < 0.05.
4.3 Study 4C-Boyle van’t Hoff (BVH) Law
4.3.1 Introduction
In response to osmotic loading, chondrocytes exhibit passive volume changes consistent
with the Boyle van’t Hoff (BVH) relationship, which suggests that the chondrocyte
behaves as a perfect osmometer. Unlike chondrocytes, the adherence of SDSCs to the
BVH relationship has not been studied. SDSCs express the same aquaporin 1 water
channels as chondrocytes suggesting that they may behave similarly [Mobasheri et al.,
2010]. In order to extract intracellular water content, models have been used that fit
equilibrium volume response to changes in extracellular osmolarity (BVH relationship).
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Osmotically active intracellular water content has been determined experimentally to be
around 60% for chondrocytes [Guilak et al., 2002,McGann et al., 1988]. In the following
study, we identified potential mechanisms responsible for the osmotic responses observed
by evaluating cell volume changes in relation to the BVH law.
4.3.2 Materials and Methods
4.3.2.1 Cell Volume Measurements
In an effort to identify differences in the intrinsic osmotic behavior of chondrocytes and
SDSCs, the volume response of isolated cells to varying applied osmotic conditions was
monitored. At passage 2, cells were trypsinized and allowed to recover for at least 3
hours in FBS media. Cells were then independently suspended for 30 minutes in DMEM
of the following osmolarities: 200, 300, 330, 400*, 500*, and 600* mOsM (*created by
the addition of NaCl and KCl), at 4.0 x 104 cells/mL before measurements were taken at
room temperature (˜22oC). Only passive volume response was evaluated in this study.
Cell size was determined using the Beckman-Coulter MultisizerTM 4 particle counter
at each osmolarity (n=3 replicates from same initial cell population/osmotic condition;
˜200,000 cells/replicate). The isoosmotic condition, 330 mOsM, was established by
standard culture media. Cell volumes (μm3) were determined from measurements of cell
diameter (μm). To determine the applicability of the BVH relation to both cell types,
the following equations, taken from Katkov [Katkov, 2011], were utilized to calculate
the osmotically inactive volume, νb, and plot the true BVH line [Katkov, 2011]. The
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where Viso,j is the isoosmotic volume obtained at a particular j th replicate. The
osmotically inactive volume was found using Equation 4.2:
vb =
∑N
i=1 [(xi − 1) (xi − v̄i)]∑N
i=1 (xi − 1)
2
(4.2)
where xi is the ith normalized inverse osmolarity and v̄i is the average normalized
cell volume at a given ith osmolarity. Each value of anisoosmotic measurement was
normalized to the individual iso-volume obtained for each replicate j (j =1, 2, 3). The
values obtained from Equations 4.1 and 4.2 were entered into the following Equation
4.3:
vBVH = (1− vb)x+ vb (4.3)
from which the true BVH line was plotted. Deviation of the experimental data from
the true BVH line was used to assess whether the cells behaved as ideal osmometers
(i.e. within 5%) as determined using the following Equation 4.4:
α =
∣∣∣∑Ni=1 {v̄i − [(1− vb)x+ vb]}∣∣∣∑N
i=1 v̄i
(4.4)
In cases where α ≥5%, cellular behavior was not that of an ideal osmometer.
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4.3.3 Results
SDSCs exhibited a larger average cell diameter (14.39 ± 0.12 μm) than chondrocytes
(13.25 ± 0.02 μm) at the isoosmotic condition of 330 mOsM (p = 0.0001) (data not
shown). The normalized cell volumes for both SDSCs and chondrocytes (isoosmotic:
330 mOsM) were independently plotted against the inverse osmolarity (normalized to
330 mOsM) to evaluate agreement with the true BVH line for each cell type (Equations
4.1-4.3) (Figure 4.7A,B). We employed Equation 4.4 to assess deviation from the true
line and found that chondrocytes deviated by 4% from the true BVH line, while SDSCs
deviated by 8%. According to the customary 5% deviation criterion, therefore, it was
determined that chondrocytes behave as ideal osmometers and SDSCs do not. Accord-
ing to the ideal BVH line, the normalized inactive osmotic volume (νb) was determined
to be 58% of the chondrocyte cell volume (Figure 4.7B).
Figure 4.7: Boyle-van’t Hoff (BVH) plots of average normalized (± std dev) data for
(A) chondrocytes (4% deviation from BVH line) and (B) SDSCs (8% deviation from
BVH line). True Boyle-van’t Hoff line (red) (vBVH = (1− vb)x + vb ) (Equation 4.3)
plotted to determine inactive cell volume (vb).
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4.3.4 Discussion
The normalized cell volume results in this study confirm that chondrocytes behave as
ideal osmometers. In contrast, SDSCs did not behave as perfect osmometers along the
entire range tested, and therefore do not satisfy the BVH law. The SDSC normalized
cell volume measurements deviated from linear behavior at extreme hypotonic (200
mOsM) and hypertonic (600 mOsM) conditions. Possible causes for this disparate
cellular behavior warrant further study.
Overall, our results supported that chondrocytes behave as a perfect osmometer,
even though the osmotically active volume fraction for chondrocytes in our study was
found to be 42%, which is lower than the 61% found in previous studies [Guilak et al.,
2002]. Differences in the active volume fraction could be due to species, age, or method
of determining Boyle van’t Hoff line. To support the claim that different mechanisms
may be responsible for the results seen in this study, previously MSCs were isolated from
umbilical cord blood due to their resistance to extended hypotonic lysis. MSCs were
determined to have a higher ineffective cell volume (˜60%) relative to other mammalian
cell types (˜30%) [Parekkadan et al., 2007].
Deviation from the BVH law may occur due to temporal cell volume response (reg-
ulatory volume increase (RVI) or regulatory volume decrease (RVD)) following osmotic
loading. However, upon testing this hypothesis, it was found that the experimental vol-
ume response in the suspended cell system was monotonic and therefore not explained
by RVI or RVD. Therefore, another potential explanation is that the assumption of
the BVH law that only water transports across the cell membrane may not hold true
for SDSCs. Further investigation is necessary to elucidate the mechanisms respon-
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sible for deviation from the BVH law. Future work includes repeating studies with
a non-ionic osmolyte, sucrose. However, the results found in this study indicate the
potential to correlate osmotic volume data of suspended cells to the response of 3D
tissue engineered cartilage constructs comprised of chondrocytes and SDSCs in order
to understand mechanisms responsible for osmotic response.
4.4 Study 4D-Response of Engineered Tissue to Hy-
potonic Loading
4.4.1 Introduction
The promising results from our static osmotic loading experiments led us to investigate
some potential mechanisms that may contribute to our observations [Sampat et al.,
2013]. Much research has implicated the ion channel transient receptor potential vanil-
loid 4 (TRPV4), that is present in chondrocytes, as a key mechano-osmosensing chan-
nel [Strotmann et al., 2003, Phan et al., 2009]. Immunohistochemical staining showed
positive expression of TRPV4 in our physiologically loaded SDSC- and chondrocyte-
seeded constructs (Figure 4.5D,H). This motivated our efforts to further investigate the
role of this channel in our tissue engineered constructs comprised of SDSCs.
TRPV4 is a membrane-bound ion channel [OConor et al., 2014,Vriens et al., 2009,
Watanabe et al., 2002,Clark et al., 2010,Liedtke et al., 2000,Strotmann et al., 2003] that
is activated by hypotonicity, warm temperatures, kinases, and lipophilic ligands [Nilius
et al., 2004]. The chondrocytes’ TRPV4 channel is osmotically sensitive and is involved
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in the regulatory volume decrease (RVD) response [Phan et al., 2009]. Calcium is
the primary ion traversing the channel [Liedtke et al., 2000] and chondrocytes exhibit
a rise in intracellular calcium in response to changes in extracellular osmolarity. It
has been previously shown that intracellular calcium concentration is a determinant
of matrix synthesis rates [Sanchez et al., 2003]. Clinically, loss of TRPV4 function is
associated with joint arthropathy and osteoarthritis and was confirmed experimentally
via a TRPV4-knockout mouse model [Venkatachalam and Montell, 2007, Clark et al.,
2010].
Several compounds have been investigated for targeting TRPV4. TRPV4 can be
noncompetitively blocked by ruthenium red, and more selectively by RN1734 and
GSK205 [OConor et al., 2014, Vriens et al., 2009, Phan et al., 2009, Sanchez et al.,
2003,Thorneloe et al., 2008,Watanabe et al., 2002]. In contrast, chemical agonists typi-
cally used include the phorbol ester 4α-phorbol-12,13-didecanoate (4αPDD) [Eleswarapu
and Athanasiou, 2013, Watanabe et al., 2002], GSK1016790A (GSK101) [Thorneloe
et al., 2008,OConor et al., 2014], and RN1747 [Vincent et al., 2009].
Recently, the role of TRPV4 in transducing dynamic loading in articular chondro-
cytes was investigated [OConor et al., 2014]. In this study, TRPV4 inhibition dur-
ing loading using the antagonist GSK205 resulted in blocking loading-induced matrix
production. In addition, activation of TRPV4 with GSK101 during static culture re-
sulted in increased matrix synthesis similar to that seen under applied dynamic load-
ing [OConor et al., 2014]. Utilizing the inhibitor RN1734 (Figure 4.8B), Vincent, et
al. demonstrated the ability of this antagonist to fully selectively inhibit hypotonic,
4αPDD, and RN1747 induced activation of TRPV4 [Vincent et al., 2009].
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Previously in the lab, we have studied the response of our chondrocyte-seeded neo-
cartilage to physical (deformational loading) and chemical (growth factors or cytokines)
stimuli and observed similarities between engineered and native tissue. In the follow-
ing study, we sought to further characterize our engineered tissue by investigating the
hypotonic loading response of engineered tissues as a biological assay to determine
the similarity of our neocartilage tissues to that of native cartilage. Previously it has
been shown that changes to extracellular osmolarity have a negative effect on matrix
metabolism of cartilage explants [Urban et al., 1993, Urban, 1994, Korhonen et al.,
2010, Bush and Hall, 2001]. In this study, we accomplished our aim by assessing the
properties of SDSC-seeded constructs in response to both a step-wise hypoosmotic load
as well as selective blocking of the TRPV4 cell membrane channel, utilizing RN1734
(Sigma Aldrich). More specifically, we cultured SDSC-seeded constructs in 330 or 400
mOsM media for 35 days, at which time constructs either remained in control media
conditions, were switched to 250 mOsM hypoosmotic media, and/or were supplemented
with RN1734 for the final 14 days of culture (Figure 4.8A).
4.4.2 Materials and Methods
4.4.2.1 Cell Culture
Synovial tissue was harvested according to the methods outlined in 2.1.2.1. SDSCs
were negatively isolated following the first passage according to the method outlined
in 2.1.2.2. After passaging, SDSCs were encapsulated at a concentration of 60 x 106
cells/mL as outlined in 2.1.2.3. The gel was maintained in serum-free chondrogenic
media (2.1.2.3) plus 50 μg/mL ascorbate and 10 ng/mL TGF-β3 overnight (330 mOsM)
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and then discs were cored to final dimensions (4 mm diameter, 2.34 mm thickness).
Constructs were cultured in 330 mOsM or 400 mOsM media plus 50 μg/mL ascorbate
and 10 ng/mL TGF-β3. TGF-β3 was removed at day 21, as previously established
[Sampat et al., 2011,Sampat et al., 2013].
4.4.2.2 Osmotic Media Preparation
Osmotic medium (400 mOsM) was prepared according to the protocol outlined in
2.1.2.4. Standard chondrogenic media of 330 mOsM was kept as the isotonic con-
trol condition. Medium of 250 mOsM was made by diluting DMEM (337 mOsM) to
250 mOsM with deionized water.
4.4.2.3 Step-Wise Hypoosmotic Loading and Selective TRPV4 Inhibition
Constructs were cultured for 35 days in 330 or 400 mOsM media, at which time the
effect of hypoosmotic conditions (250 mOsM media) and selective inhibition of TRPV4
with RN1734 were evaluated (Figure 4.8). The constructs cultured in 330 mOsM were
divided into the following groups for 14 days (n=3-5 constructs/group): (1) 330 mOsM
control, (2) 330 mOsM (+) RN1734 (100 μM) (Sigma), (3) 330 to 250 mOsM control
(media switched to 250 mOsM for final two weeks), and (4) 330 to 250 mOsM (+)
RN1734 (100 μM) (Figure 4.8A). Similarly, the constructs cultured in 400 mOsM media
were divided into the following groups for 14 days (1) 400 mOsM control, (2) 400 mOsM
(+) RN1734 (100 μM) (Sigma), (3) 400 to 250 mOsM control (media switched to 250
mOsM for final two weeks), and (4) 400 to 250 mOsM (+) RN1734 (100 μM) (Figure
4.8A). All constructs were assessed for mechanical properties and biochemical analyses
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at day 49.
Figure 4.8: Schematic of experimental groups. Constructs were cultured for 35 days
in 330 or 400 mOsM media, at which point the effect of hypoosmotic conditions (250
mOsM media) and selective inhibition of TRPV4 with RN1734 were evaluated. The
constructs cultured in 330 mOsM were divided into the following groups for 14 days:
(1) 330 mOsM control, (2) 330 mOsM (+) RN1734 (100 μM) (Sigma), (3) 330 to 250
mOsM control (media switched to 250 mOsM for final two weeks), and (4) 330 to 250
mOsM (+) RN1734 (100 μM). Similarly, the constructs cultured in 400 mOsM media
were divided into the following groups for 14 days (1) 400 mOsM control, (2) 400 mOsM
(+) RN1734 (100 μM) (Sigma), (3) 400 to 250 mOsM control (media switched to 250
mOsM for final two weeks), and (4) 400 to 250 mOsM (+) RN1734 (100 μM). (B)
Chemical structure of TRPV4 antagonist RN1734 [Vriens et al., 2009].
4.4.2.4 Mechanical Testing
The equilibrium Young’s modulus (EY) and dynamic modulus (G* at 0.01 Hz) were
determined according to the methods outlined in 2.1.2.5.
4.4.2.5 Biochemical Composition




Statistical analysis was performed with Statistica software using a two-way ANOVA
with α < 0.05 and Tukey’s HSD post hoc test, with statistical significance achieved
when p ≤ 0.05. Statistics were performed individually on constructs cultured in 330
mOsM media and 400 mOsM media. The two factors analyzed in the ANOVA were
Factor 1 = osmotic media condition and Factor 2 = supplementation of RN1734. Factor
1 and 2 each had two levels. All data are presented as mean ± standard deviation.
4.4.3 Results
4.4.3.1 Regulation of Mechanical Properties
The impact of selective blocking of the TRPV4 ion channel and a step hypoosmotic
change in media, both separately and concurrently was evaluated in this study. For
constructs cultured in 330 mOsM media for the first 35 days in culture, supplementation
of media with 100 μM RN1734 for the final 14 days resulted in a slight 13% reduction
in modulus (330 mOsM (+) RN1734: 315 ± 33 kPa) relative to the 330 mOsM control
(364 ± 52 kPa) group (Figure 4.9A,C). When 330 mOsM constructs were subjected
to 250 mOsM media for the final 14 days, the modulus dropped significantly by 40%
(330 to 250 mOsM: 221 ± 31 kPa) relative to the 330 mOsM control (364 ± 52 kPa)
(p < 0.05) condition (Figure 4.9A,C) (n=3-4 constructs/group).
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Figure 4.9: (A) Equilibrium Young’s modulus (kPa) at day 49 of constructs originally
cultured in 330 mOsM media and applied treatment(s) at day 35, (B) equilibrium
Young’s modulus (kPa) at day 49 of constructs originally cultured in 400 mOsM media
and applied treatment(s) at day 35, and (C) normalized modulus of each treatment
group by the modulus of its isoosmotic control group (330 mOsM or 400 mOsM) (*p <
0.05).
For constructs cultured in 400 mOsM media for the first 35 days in culture, supple-
mentation of media with 100 μM RN1734 for the final 14 days resulted in a significant
40% reduction in modulus (400 mOsM (+) RN1734: 245 ± 75 kPa) relative to 400
mOsM control (404 ± 70 kPa) (p < 0.05) group (Figure 4.9B,C). Similarly, 400 mOsM
constructs cultured in 250 mOsM media for the final 14 days concurrently with 100 μM
RN1734 supplementation resulted in a significant 40% reduction in modulus (400 to
250 mOsM (+) RN1734: 195 ± 37 kPa) relative to the 400 to 250 mOsM control (343
± 70 kPa) (p < 0.05) (n=3-4 constructs/group) group (Figure 4.9B,C). The dynamic
modulus (G* at 0.01 Hz) followed the same trend, resulting in a roughly 40% decrease
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relative to both control groups (data not shown).
Regardless of initial osmotic culture condition, following the simultaneous hypoos-
motic culture and antagonist supplementation (250 mOsM (+) RN1734 groups), final
equilibrium moduli at day 49 were between 200-250 kPa (Figure 4.9A,B). In addition,
the reduction in stiffness as a function of absolute osmotic change was roughly the same
for both groups (330 to 250 (+) RN1734: 1.68 kPa per mOsM reduction vs 400 to 250
(+) RN1734: 1.40 kPa per mOsM reduction) (Figure 4.9A).
4.4.3.2 Regulation of Matrix Production
DNA content was similar regardless of group and not significantly affected by osmolarity
or RN1734 supplementation (data not shown). Absolute GAG content was similar
regardless of condition for constructs cultured initially in 330 mOsM media (Figure
4.10A). On the other hand, for constructs cultured initially in 400 mOsM media absolute
GAG content was significantly higher in the 400 to 250 mOsM (2.72 ± 0.30 mg) group
relative to 400 to 250 mOsM (+) RN1734 (1.71 ± 0.05 mg) (p < 0.05) (Figure 4.10B).
No significant differences were seen when GAG was normalized by ww, dw, and DNA.
When normalized by day 0 full construct wet weight (%day 0 ww), both 250 mOsM
(+) RN1734 groups exhibited GAG content between 6.3-6.7 (%day 0 ww), whereas all
other groups were within 8-10 (%day 0 ww) (data not shown).
Absolute collagen content was higher in 330 mOsM (+) RN1734 (0.58 ± 0.13 mg)
relative to 330 to 250 mOsM (+) RN1734 (0.32 ± 0.11 mg), albeit not significantly
(Figure 4.10C). In addition, mirroring the absolute GAG content, absolute collagen
was significantly higher in the 400 to 250 mOsM (0.53 ± 0.03 mg) group relative to
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400 to 250 mOsM (+) RN1734 (0.36 ± 0.02 mg) (p < 0.05) (Figure 4.10D). These
trends were also reflected when collagen was normalized to ww, dw, and DNA, albeit
not significantly.
Figure 4.10: (A) Absolute GAG content (mg) at day 49 of constructs originally cultured
in 330 mOsM media and applied treatment(s) at day 35, (B) Absolute GAG content
(mg) at day 49 of constructs originally cultured in 400 mOsM media and applied treat-
ment(s) at day 35, (C) Absolute collagen content (mg) at day 49 of constructs originally
cultured in 330 mOsM media and applied treatment(s) at day 35, and (D) Absolute
collagen content (mg) at day 49 of constructs originally cultured in 400 mOsM media
and applied treatment(s) at day 35 (*p < 0.05).
The water content (%) at day 49 was significantly higher in groups cultured in
hypoosmotic media supplemented with RN1734 than all other groups, regardless of
initial osmotic condition (Table 4.3) (p < 0.05). For the 330 mOsM cultures, the
highest percentage water content was seen in the 330 to 250 (+) RN1734 (88.94 ± 0.47
%) group and was statistically higher than all other conditions (Table 4.3A). Similarly,
for the 400 mOsM cultures, the highest percentage water content was seen in the 400
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to 250 (+) RN1734 (89.42 ± 0.27 %) group and was statistically higher than all other
groups (Table 4.3B). The controls for each condition had the lowest water content (330
mOsM: 86.69± 0.18 % and 400 mOsM: 86.71± 0.17 %) (Table 4.3). The water content
of each group was similar to one another when comparing across 330 and 400 mOsM
conditions.
Table 4.3: Water content (%) at day 49 for constructs originally cultured in (A) 330
mOsM media and (B) 400 mOsM media (# p < 0.05 vs control, *p < 0.05 vs cntrl (+)
RN1734, % p < 0.05 vs 250 cntrl, $ p < 0.05 vs 250 (+) RN1734).
4.4.4 Discussion
In this study, constructs were cultured for 35 days in 330 and 400 mOsM media con-
ditions, at which time media osmolarity was adjusted and a chemical antagonist for
TRPV4 was introduced. Constructs were initially cultured under the 330 and 400
mOsM conditions to allow for matrix elaboration. Our results show that the intro-
duction of hypoosmotic culture conditions for 14 days decreased the stiffness of the
constructs relative to control conditions (p < 0.05 for 330 to 250 mOsM group). In
addition, it was found that prolonged 250 mOsM culture plus RN1734 supplementation
resulted in the most significant impact on tissue properties.
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Upon hypoosmotic insult, calcium is released from intracellular stores as well as
influx from the extracellular environment through multiple pathways. From the extra-
cellular solution, calcium influx following hypoosmotic shock can occur through both
opening of stretch activated cation channels and opening of TRPV4 channels [Sanchez
et al., 2003]. On the other hand, activation of phospholipase C initiates the release of
Ca2+ from intracellular stores [Sanchez et al., 2003]. However, the transient behavior
of these responses to hypotonic shock may not fully explain the responses seen when
cells are exposed to a more sustained hypotonic challenge.
Osteoarthritis is characterized by increased water content resulting in a lower tissue
osmolarity as well as loss of extracellular matrix components and decreased matrix syn-
thesis as the cells swell [Buckwalter et al., 1997, Hopewell and Urban, 2003, McArthur
and Gardner, 1992]. Previous work has shown that isolated chondrocytes are unable
to adapt to long-term decreases in osmolarity [Hopewell and Urban, 2003] which has
implications for OA conditions. More specifically, sustained hypoosmotic challenge, like
in the present study, has been shown in a mouse model to exhibit loss of osmotically
activated calcium signaling in TRPV4-null mice [Clark et al., 2010]. In this study, the
250 mOsM hypoosmotic media was used to simulate conditions of long term decreases
in osmolarity and it was seen that sustained changes in osmolarity affected the hy-
dration and stiffness of the constructs. The increased collagen content in response to
hypoosmotic culture for the 400 to 250 mOsM group could be due to increased collagen
production as a result of tension under swelling conditions.
Although TRPV4 is permeable to Ca2+, Sr2+, Ba2+, and Mg2+, it has been shown
that Ca2+is the primary ion traversing the channel. Previous work in the field has
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shown that hypoosmotic stress leads to calcium signaling and volume regulation (RVD)
and that this can be nonspecifically attenuated through ruthenium red and gadolinium
chloride [Phan et al., 2009,Sanchez et al., 2003]. In this study, we used a more selective
antagonist for TRPV4, RN1734. Our study is a long term application of hypotonic
osmolarity so it is not entirely clear whether blocking of TRPV4 results in an RVD
deficiency or some other downstream effect [Phan et al., 2009].
TRPV4-mediated Ca2+influx stimulated by 4αPDD has been shown experimentally
to upregulate SOX9 expression which is essential for chondrocyte differentiation [Mu-
ramatsu et al., 2007]. Furthermore, it was shown that TRPV4 functions in “cartilage
maintenance and chondroprotection” since blocking TRPV4 inhibits chondrogenesis to
some degree [Clark et al., 2010].
Previously, it was shown that addition of GSK205, another selective TRPV4 an-
tagonist, to static culture decreased stiffness of chondrocyte-seeded tissue engineered
constructs, albeit not significantly [OConor et al., 2014]. We showed in our 400 mOsM
conditions that blocking TRPV4 with RN1734 can further decrease tissue properties.
In a separate study in the lab, we saw the same 40% decrease with the addition of
ruthenium red (100 μM) for juvenile bovine chondrocyte constructs that were changed
to 250 mOsM media at day 35 (from 400 mOsM) (data not shown), similar to the
findings reported in this study.
The results observed for groups supplemented with RN1734 could be due to the
method of preparing our osmotic medias. In 330 mOsM media, the base concentration
of calcium in the culture media is higher than in 250 and 400 mOsM media since the
latter were prepared from diluted DMEM stock. The higher calcium concentration in
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the media for 330 mOsM groups during static culture could have resulted in a lower level
response when RN1734 was added, but a larger drop in modulus when the media was
changed to 250 mOsM, compared with the 400 to 250 mOsM group which was already in
a reduced calcium environment (relative to 330 mOsM). Therefore, when both the 330
and 400 mOsM conditions were subject to both hypoosmotic media with the addition
of the TRPV4 antagonist, the reduction in stiffness as a function of absolute osmotic
change was roughly the same for both groups (330 to 250 (+) RN1734: 1.68 kPa per
mOsM reduction vs 400 to 250 (+) RN1734: 1.40 kPa per mOsM reduction), regardless
of initial osmolarity. In addition, both groups settled between 200-250 kPa (Young’s
modulus) at the final time point (Figure 4.9). In Phan et al, it was shown that the
response of cells to the TRPV4 agonist, 4αPDD, was dependent on the extracellular
calcium present, since only 6% of cells in Ca2+-free media signaled when exposed to
4αPDD [Phan et al., 2009].
The low heat activation threshold of TRPV4 results in an increased basal activity
of TRPV4 at body temperature [Watanabe et al., 2002,Nilius et al., 2003,Nilius et al.,
2004,Thorneloe et al., 2008]. In Eleswarapu, et al. TRPV4 was activated with 4αPDD
under isoosmotic conditions [Eleswarapu and Athanasiou, 2013]. In this regard, there
is some rationale for the modulation of properties seen with RN1734 under isoosmotic
conditions.
From this study, it was seen that a combination of hypoosmotic loading and RN1734
has a potent influence on the mechanical properties of SDSC-seeded constructs. Overall,
the sensitivity to RN1734 reflects participation of the TRPV4 channel in mechanoreg-
ulation of hypoosmotic challenge, although culture conditions may need to be further
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regulated to fully delineate the response. In addition, since calcium enters cells through
several pathways, a combination of blockers may be needed to fully inhibit the response.
Future work includes removing the antagonist and/or elevating osmolarity back to con-
trol conditions to see if the tissue regains pre-treatment properties. In order to better
understand the mechanotransduction pathways in the response of SDSCs and chondro-
cytes to osmotic loading, future studies include evaluating the response to activation
of the TRPV4 channel using a TRPV4 agonist like 4αPDD, which was recently used
to grow engineered cartilage with improved tensile properties [Eleswarapu and Athana-
siou, 2013] or GSK101, which has been shown to increase matrix synthesis [OConor
et al., 2014].
4.5 Study 4E-Concurrent Effect of Osmotic Load-
ing and Dynamic Deformational Loading
4.5.1 Introduction
Mechanical loading is important for the healthy maintenance of articular cartilage [Gray
et al., 1988]. Several studies have reported that mechanical loading regulates the main-
tenance of cartilage and that the resulting biosynthetic activity is dependent on the
magnitude and frequency of the applied cyclic load [Kim et al., 1994, Bian et al.,
2010, Buschmann et al., 1995, Sah et al., 1989]. On the other hand, static compres-
sive loads have been shown to result in decreased proteoglycan and protein synthesis
and increased catabolic activity [Gray et al., 1988,Guilak et al., 1997,Buschmann et al.,
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1995, Sah et al., 1989]. Our lab has previously utilized dynamic loading in the physi-
ologic range (˜1 Hz) to apply cyclic loads on chondrocyte-seeded agarose hydrogels to
promote tissue growth [Mauck et al., 2000, Lima et al., 2007, Bian et al., 2010, Kelly
et al., 2006,Ng et al., 2009c]. In these studies, we further demonstrated that chemical
and mechanical stimuli (dynamic deformational loading) can act synergistically to fur-
ther enhance cartilage tissue properties produced by juvenile bovine chondrocytes [Lima
et al., 2007,Bian et al., 2010]. Previous work in the lab that investigated the duty cycle
of continuous vs intermittent loading regimens on chondrocyte-seeded constructs deter-
mined that a loading cycle of 3 hours of continuous loading per day, 5 days/week for
the loading period resulted in increased COMP, type II collagen, and type IX collagen
production over both intermittent loading and free swelling controls [Ng et al., 2009c].
Dynamic compression of cartilage results in physical deformation of cells, streaming po-
tentials, hydrostatic pressure, and increased nutrient transport all of which can affect
matrix synthesis [Albro et al., 2008, Chahine et al., 2009, Mauck et al., 2003a, Mauck
et al., 2003b,Mow et al., 1999,Kim et al., 1995].
In the following study, our experimental aims were two-fold. Our first objective
was to apply dynamic deformational loading in conjunction with static osmotic loading
during long-term culture of SDSC-seeded constructs in order to determine if there is a
synergistic response of mechanical and physico-chemical factors. We utilized the 400
mOsM media condition as the baseline culture media based on the beneficial response
seen previously [Sampat et al., 2013], in which the hypertonic media condition resulted
in significantly better properties relative to isotonic 330 mOsM media (Study 4A).
Therefore, we established 400 mOsM as the isotonic condition in this study and all
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groups were cultured in this media during static culture. Our second objective was to
further determine the potential role of TRPV4 in modulating tissue growth. Therefore,
in addition to dynamic loading under 400 mOsM media, another group was switched to
hypoosmotic (330 mOsM) media only during dynamic loading, in order to potentially
activate TRPV4 (activated by transient hypoosmolarity) [Phan et al., 2009].
The study consisted of the following experimental groups: 400DL (cultured in 400
mOsM media and dynamically loaded (DL) in 400 mOsM media), 330DL (cultured
in 400 mOsM media and DL in 330 mOsM media), 400FS (free swelling (FS) control
in 400 mOsM media), 330FS (FS control cultured in 400 mOsM media and switched
to FS static 330 mOsM during the 3 hour loading period) (Figure 4.11A). Due to the
beneficial effects of loading on promoting tissue growth, we hypothesized that SDSC-
seeded constructs that were dynamically loaded over the culture period would result in
increased tissue properties over their free swelling controls.
4.5.2 Materials and Methods
4.5.2.1 Cell Culture
Synovial tissue was harvested according to the methods outlined in 2.1.2.1. SDSCs
were negatively isolated following the first passage according to the method outlined
in 2.1.2.2. After passaging, SDSCs were encapsulated at a concentration of 60 x 106
cells/mL as outlined in 2.1.2.3. The gel was maintained in serum-free chondrogenic
media (2.1.2.3) plus 50 μg/mL ascorbate and 10 ng/mL TGF-β3 overnight (330 mOsM)
and then discs were cored to final dimensions (4 mm diameter, 2.34 mm thickness).
Constructs were cultured in isoosmotic 400 mOsM plus 50 μg/mL ascorbate and 10
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ng/mL TGF-β3. TGF-β3 was removed at day 21, as previously established [Sampat
et al., 2011,Sampat et al., 2013].
4.5.2.2 Osmotic Media Preparation
Medium of 300 mOsM was made by diluting DMEM (337 mOsM) to 300 mOsM with
deionized water. Next, isoosmotic media was prepared at 400 mOsM by the addition of
NaCl and KCl at a ratio of 20.7 moles NaCl to 1 mole KCl, the same concentration as
in DMEM. Standard chondrogenic media of 330 mOsM was used as the hypoosmotic
media condition.
4.5.2.3 Dynamic Compressive Loading
Dynamic compressive loading was applied starting at day 21 for four weeks, following
the discontinuation of TGF-β3, and consisted of the following experimental groups:
400DL (cultured in 400 mOsM media and DL in 400 mOsM media), 330DL (cultured
in 400 mOsM media and DL in 330 mOsM media), 400FS (FS control in 400 mOsM
media), 330FS (FS control cultured in 400 mOsM media and switched to FS static 330
mOsM during the 3 hour loading period) (Figure 4.11A). The loading protocol consisted
of a nominal ±5% compressive sinusoidal strain at 1 Hz frequency, superimposed above
a 10% tare strain, in unconfined compression with impermeable loading platens, for 3
hours/day, 5 days/week (Figure 4.11B) [Mauck et al., 2000,Bian et al., 2010]. Dynamic
compressive loading was carried out at 37oC and 5% CO2 in a humidified incubator.
When not being loaded, all constructs were cultured in isoosmotic 400 mOsM media
(21 hours/day). Based on the results of Study A, this study was repeated with only the
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hypoosmotic groups, 330DL and 330FS (Study B). Constructs in Study A were loaded
for 28 days while in Study B they were loaded for 37 days. Time points for mechanical
and biochemical analyses for Study A was day 49 and days 49 and 58 for Study B.
Figure 4.11: Schematic of the experimental groups. (A) Dynamic compressive loading
was applied starting at day 21 and consisted of the following experimental groups:
400DL (cultured in 400 mOsM media and DL in 400 mOsM media), 330DL (cultured
in 400 mOsM media and DL in 330 mOsM media), 400FS (FS control in 400 mOsM
media), 330FS (FS control cultured in 400 mOsM media and switched to FS static
330 mOsM during the 3 hour loading period) and (B) image of deformational loading
bioreactor.
4.5.2.4 Mechanical Testing
The equilibrium Young’s modulus (EY) and dynamic modulus (G* at 0.01 Hz) were
determined according to the methods outlined in 2.1.2.5. In Study B, the viscoelastic
shear properties of the constructs were measured over a physiologic range of frequencies
(0.01 to 10 Hz) at a compressive strain of 10% and radial strain of 1% of 360o using a
rheometer testing device. The resulting storage modulus (G’), loss modulus (G”), and
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shear modulus (G*) were determined.
4.5.2.5 Biochemical Composition
DNA, GAG, and collagen content were determined using the protocols outlined in
2.1.2.6.
4.5.2.6 Statistical Analyses
Statistical analysis was performed with Statistica software using a two-way ANOVA
with α < 0.05 and Tukey’s HSD post hoc test, with statistical significance achieved
when p ≤ 0.05. In Study A, the two factors analyzed in the ANOVA were Factor 1
= presence or absence of dynamic loading and Factor 2 = osmotic media condition.
Factor 1 had two levels while Factor 2 had four levels. In Study B, the two factors
analyzed in the ANOVA were Factor 1 = presence or absence of dynamic loading and
Factor 2 = time. Factor 1 and 2 each had two levels. All data is presented as mean ±
standard deviation.
4.5.3 Results
4.5.3.1 Study A Results
At day 49, the DL constructs had a smaller average thickness than their corresponding
FS conditions (p < 0.05) (Figure 4.12). The thickness of the FS samples was similar
to one another and similarly for the DL groups (Figure 4.12). The constructs had the
following average dimensions: 330FS:  = 4.95 ± 0.16 mm, thickness = 3.23 ± 0.17
mm, 330DL:  = 4.96 ± 0.17 mm, thickness = 2.99 ± 0.08 mm, 400FS:  = 4.96 ±
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0.27 mm, thickness = 3.25 ± 0.07 mm, and 400DL:  = 4.88 ± 0.15 mm, thickness =
2.98 ± 0.07 mm (Figure 4.12).
Figure 4.12: Representative gross morphology of SDSC-seeded constructs at day 49.
At day 49, the constructs had the following average dimensions: 330FS:  = 4.95 ±
0.16 mm, thickness = 3.23 ± 0.17 mm, 330DL:  = 4.96 ± 0.17 mm, thickness = 2.99
± 0.08 mm, 400FS:  = 4.96 ± 0.27 mm, thickness = 3.25 ± 0.07 mm, and 400DL: 
= 4.88 ± 0.15 mm, thickness = 2.98 ± 0.07 mm.
With the concurrent application of osmotic and dynamic loading, at day 49, con-
structs cultured in 400 mOsM media and loaded in the same media (400DL) responded
most favorably to dynamic loading (EY = 483 ± 37 kPa) and were significantly stiffer
than the corresponding loaded group cultured in 330 mOsM media during loading
(330DL) (432 ± 26 kPa) (p < 0.05) (Figure 4.13A). For comparison, day 0 constructs
were 5.1 ± 0.5 kPa. In addition, dynamic loading led to mechanically superior prop-
erties for the 330DL group as compared to its 330FS control group (379 ± 38 kPa)
(p < 0.05) (Figure 4.13A). However, the same did not hold true for the 400DL con-
structs. While the 400DL group was stiffer than its FS control, the trend was not
significant (400FS: 457 ± 23 kPa) (Figure 4.13A). Unloaded constructs cultured in 400
mOsM media throughout (400FS) (457± 23 kPa) exhibited significantly higher mechan-
ical properties than constructs switched to 330 mOsM media during the 3 hour loading
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(330FS) period (Figure 4.13A). Young’s modulus values for all groups were within na-
tive values of immature bovine cartilage (˜400-1000 kPa) ( [Bian et al., 2009, Lima
et al., 2007, Mauck et al., 2002]). Dynamic moduli (G* 0.01 Hz) at day 49 were sim-
ilar amongst groups and ranged between 1.6-2.0 MPa (Figure 4.13B), although these
were not within native levels. In addition, construct water content was similar amongst
groups at ˜86% for all groups at day 49 (data not shown).
Figure 4.13: Mechanical and biochemical properties for dynamic loading Study A: (A)
Young’s modulus (kPa), (B) dynamic modulus (G* 0.01 Hz) (MPa), and (C) GAG
(%ww) for dynamically loaded and free swelling groups at day 49 in culture (*p < 0.05)
(n=4-9 constructs/group).
The increased stiffness in response to dynamic loading superimposed on 400 mOsM
media culture (400DL) was accompanied by corresponding increases in DNA content
(24.5 ± 2.86 μg) group as compared to the 330DL (21.5 ± 2.09 μg) group (p < 0.05)
(data not shown). GAG content, on the other hand, was within native levels for all
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groups at 6-7% as a function of tissue wet weight, and was statistically higher in the
330FS group (7.18 ± 0.40 %ww) than the 400FS group (6.24 ± 0.53 %ww) (p < 0.05)
(Figure 4.13C). However, absolute GAG content was similar amongst all groups (˜1.8
mg) (data not shown).
Collagen levels in all groups failed to reach native levels, unlike the mechanical
properties and GAG content. Overall, it was observed that free swelling groups had
higher collagen content when normalized to wet weight (%), dry weight (%), and DNA
(g/g), albeit not significantly in all cases (Table 4.4). When normalized to wet weight,
the 330FS group had significantly more collagen (1.73 ± 0.22 %ww) compared to its
corresponding DL group (330DL: 1.41 ± 0.15 %ww) (p < 0.05) (Table 4.4).
Collagen (%ww) Collagen (%dw) Collagen/DNA (g/g)
400FS 2.00 ± 0.28 15.54 ± 2.38 23.27 ± 4.81
400DL 1.60 ± 0.19 12.31 ± 1.03 17.12 ± 3.00
330FS 1.73 ± 0.22* 13.25 ± 1.79 21.11 ± 4.30
330DL 1.41 ± 0.15 10.84 ± 1.14 18.93 ± 3.04
Table 4.4: Collagen content (%ww, %dw, and /DNA) of 400FS, 400DL, 330FS, and
330DL groups in Study A at day 49. (*p < 0.05 vs corresponding DL group) (n=4-9
constructs/group)
4.5.3.2 Study B Results
Based on the results of Study A indicating a significant influence of dynamic loading
when constructs were loaded in hypoosmotic media (330DL), this study was repeated
with only the 330DL and 330FS groups (Study B). Constructs cultured under loading
were smaller in thickness than FS controls, similarly to Study A, however not signifi-
cantly in this study (330FS: 3.47 ± 0.13 mm, 330DL: 3.32 ± 0.04 mm). By day 49 in
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culture, the 330DL and 330FS groups had a similar mechanical stiffness with a Young’s
modulus of 377 kPa for both groups (Figure 4.14A). The modulus was consistent for the
330FS group between Study A and Study B at day 49 (˜377 kPa) (Figures 4.13A and
4.14A). It was not until the final time point that significant differences were seen be-
tween the two groups in Study B. From day 49 to 58 in culture, the modulus plateaued
for the FS group, while the DL group continued to stiffen (Figure 4.14A). At day 58,
the 330DL group (585 ± 94 kPa) was 75% stiffer than its 330FS control (335 ± 21 kPa)
(p < 0.05) (Figure 4.14A). The overall trends for equilibrium modulus were paralleled
in dynamic modulus (G* 0.01 Hz) values, although these were not within native levels
(Figure 4.14B).
Absolute GAG content was similar regardless of loading (data not shown). When
normalized to wet weight, GAG levels (%ww) of both groups were statistically similar
to one another at day 58 (330FS: 8.54 ± 0.63 %ww, 330DL: 8.84 ± 0.47 %ww) (Figure
4.14C). However, absolute collagen content was significantly higher for DL (639 ± 116
μg) constructs than FS (512 ± 80 μg) (p < 0.05) (data not shown). When normalized
to wet weight, this trend continued in which collagen content (%ww) of the DL group
was statistically higher than its FS control (330FS: 1.48 ± 0.21 %ww, 330DL: 1.82 ±
0.27 %ww) (Figure 4.14D).
No significant changes in DNA content were observed over culture time or between
the two groups (data not shown). As a measure of cell metabolic activity, GAG was
normalized to DNA content. The 330DL group was 223.5 ± 13.5 GAG/DNA on day 58
and was similar for the FS control (228.7 ± 14.4 g/g). The corresponding peak collagen
content achieved was 43.75 ± 8.13 collagen/DNA and was similar for the FS condition
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(41.36 ± 8.97 g/g) (data not shown).
Figure 4.14: Mechanical and biochemical properties for dynamic loading Study B: (A)
Young’s modulus (kPa), (B) dynamic modulus (G* 0.01 Hz) (MPa). (C) GAG (%ww),
and (D) collagen (%ww) for dynamically loaded and free swelling groups at day 49 and
58 in culture (*p < 0.05) (n=4-9 constructs/group).
At day 58, the shear properties of the 330FS and 330DL groups were assessed
to isolate the organization of the solid matrix from fluid flow. The storage modulus
(G’-solid-like component), loss modulus (G”-fluid-like component), and shear modulus
(G*) were determined. At a physiologic frequency of 1 Hz, all moduli were higher in the
330DL group than their free swelling control (Figure 4.15A), however only significantly
for G” (*p < 0.05). This is indicative of the increased mechanical and biochemical
properties of the dynamically loaded samples. Interestingly, the loss modulus (G”)
of the 330DL group showed a frequency dependence that the other group did not, in
which the modulus was greater at higher frequencies and diverged from the 330FS group
(Figure 4.15B).
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Figure 4.15: Shear properties for dynamic loading Study B at day 58. (A) Table of
storage modulus (G’ (1 Hz)), loss modulus (G”(1 Hz)), and shear modulus (G* (1 Hz))
at day 58 and (B) G” (MPa) measured over a range of physiologic frequencies (0.01-10
Hz) (*p < 0.05) (n=4-5 constructs/group).
4.5.4 Discussion
In this study, we aimed to further optimize culture conditions for growing functionally
relevant tissue engineered cartilage utilizing SDSCs. Unconfined compressive loading
was utilized in this study because it results in both compressive and tensile normal
strains, similar to the in situ cartilage environment. We chose to focus on 400 mOsM
media as our baseline isotonic media condition with the addition of transient hypotonic
loading during the deformational loading period. In Study A, we found that the 400DL
condition resulted in significantly stiffer tissue than the 330DL group, however the
400DL group was not statistically different from its FS control. However, in both
studies, we found that the 330DL was significantly stiffer than 330FS (p < 0.05) (Figures
4.13A and 4.14A). Therefore, our hypothesis was conditionally accepted for the groups
switched to hypoosmotic media during the duration of loading (330DL vs 330FS). From
these findings and based on our initial aims, we found that osmotic loading and dynamic
124
loading are not synergistic, since the sum of dynamic loading and osmotic influence did
not exceed the sum of each individual factor.
Since dynamic loading was not significantly better than free swelling for the 400
mOsM condition, it suggests that loading may not work for hypertonic conditions.
Overall, the differences due to dynamic loading were less pronounced in Study A than
Study B. Similar to our findings in Study A, previously published work in the lab
in which dynamic loading was applied to juvenile bovine chondrocyte-seeded scaffolds
also resulted in modest increases in stiffness, while not necessarily affecting the bulk
biochemical measures [Lima et al., 2007]. In both studies, loading was initiated at day
21, and while differences were seen between groups at day 49 in Study A, the time frame
was shifted in Study B due to inherent variability between cultures. At day 58, Study
B showed a much greater impact of dynamic loading (330DL) than Study A at day 49.
Regarding the potential role of TRPV4 in the response to dynamic loading, TRPV4
may be responding as a stretch activated cation channel to changes in cell shape and
stretch due to loading. Future studies combining dynamic loading and osmotic loading
together with TRPV4 modulators could provide further insight into the role of TRPV4
in mediating physical stimuli [OConor et al., 2014].
Study A further supported our previous findings that culturing constructs in a
physiologic osmolarity (400 mOsM) leads to better overall tissue production than hy-
poosmotic culture conditions [Sampat et al., 2013]. In addition, the reduced properties
of the 330 mOsM groups in this study showed similar trends to our TRPV4 mechanistic
studies (Study 4D) when media osmolarity was dropped at day 35 in culture. Three
hours a day in the reduced osmotic environment had a pronounced impact on tissue
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properties of the groups. Even though the reduction in osmolarity suppressed properties
to some degree, the dynamic loading may have helped to overcome that suppression.
From Study A, it was found that constructs cultured continuously in 400 mOsM
may not respond positively to dynamic loading. Therefore, based on the results of both
studies, in order to see the benefits of dynamic loading it may be necessary to switch
the media to a hypoosmotic culture during the loading period. However, in order to get
a more complete understanding of the impact of osmotic culture and dynamic loading,
additional studies would need to be conducted. The additional groups would include:
constructs cultured in 330 mOsM media and DL in 330 mOsM media (with FS control
condition) and constructs cultured in 330 mOsM media and DL in 400 mOsM media
(with FS control condition). This would determine whether the impact of dynamic
loading on SDSCs is influenced by the osmolarity itself or a step change in osmolarity,
and whether the step change is hyper- or hypo-osmotically dependant.
Future work includes elucidating the mechanisms responsible for the increased me-
chanical properties even though bulk biochemical properties didn’t always correlate. As
has been shown previously in the literature, dynamic loading may influence orientation
and organization of collagen fibrils due to constriction leading to reduced construct
swelling, or matrix components that weren’t measured, such as COMP or percentage of
type II collagen [Lima et al., 2007,Wong et al., 1999,Kiraly et al., 1998], although fur-
ther investigation is needed for our studies. Immunohistochemistry staining and ELISAs
will be utilized to determine if loaded groups contain more of these matrix molecules.
While the collagen content of the constructs in this study did not reach native values,
they were the highest reported to date in the lab for SDSC constructs [Sampat et al.,
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2011, Sampat et al., 2013], reaching 2.00 ± 0.28 (%ww). Therefore, further optimiza-
tion of culture conditions is needed to fully reproduce the native environment. From
this study, we conclude that dynamic loading can have significant benefits for growing
functionally relevant cartilage grafts under specified culture conditions.
4.6 Conclusions
Our success in utilizing biomimetic chemical factors for priming SDSCs to grow func-
tionally relevant cartilage grafts (Chapter 3) prompted us to manipulate another factor
endemic to in situ cartilage, namely altered extracellular osmolarity, as an additional
growth strategy. The influence of extracellular osmolarity on cartilage development
and homeostasis has been extensively studied over the years. In this chapter of the dis-
sertation, we focused on manipulating the extracellular osmolarity in order to further
optimize tissue growth and also to further characterize our tissue engineered constructs.
In the first study, by modifying the 3D culture media to a more physiologic osmolarity,
we were able to achieve mechanical and biochemical properties within the range of na-
tive immature bovine cartilage for SDSC-seeded constructs (EY: 400-1000 kPa; GAG
(%ww): 6-8%) [Sampat et al., 2011,Sampat et al., 2013].
Based on the encouraging results from Study 4A, in Study 4B we sought to determine
whether the osmotic influence was dependent on cell priming in 2D culture. It was
further confirmed that cell priming in 2D is essential to seeing the same level of osmotic
response in 3D culture. In response to osmotic loading, chondrocytes exhibit passive
volume changes which suggest that the chondrocyte behaves as a perfect osmometer. In
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Study 4C, the adherence of SDSCs to the BVH relationship was investigated and it was
found that SDSCs did not behave as perfect osmometers along the entire range tested,
and therefore do not satisfy the BVH law, although further investigation is needed. In
an effort to identify mechanisms that may be responsible for the osmotic results seen, in
Study 4D, we investigated the role of the osmo-mechanosensitive ion channel, TRPV4,
in modulating the osmotic response. We found that blocking TRPV4 in conjunction
with hypoosmotic loading resulted in significant decreases in mechanical stiffness of the
constructs. In the final study, we utilized dynamic deformational loading to further
optimize tissue growth of SDSC-seeded constructs. It was determined that loading
produced superior tissue when constructs were loaded in a hypoosmotic environment
relative to non-loaded conditions. Through the application of chemical, mechanical,
and physico-chemical signals, the results described in this chapter further support the








Elasmobranchs, including sharks, are a subclass of fishes that have five to seven lateral
to ventral gill openings on each side. Sharks have a skeleton composed of cartilage
instead of bone. Elasmobranch cartilage contains one third type I collagen and the
remaining two thirds is type II collagen [Rama and Chandrakasan, 1984]. Proteoglycans
(PGs) are the major noncollagenous organic component in the cartilage [Michelacci
and Horton, 1989,Porter et al., 2006]. Shark vertebral cartilage is composed of similar
constituents as mammalian cartilage, with PGs comprising 15-25% of the dry weight
and collagen comprising 20-25% of the dry weight [Porter et al., 2006]. While the
constituents are the same as cartilage in land vertebrates, the proportions in each are
different [Buckwalter et al., 1997].
Mammals are osmoregulators, meaning they use internal organs to regulate their
osmotic environment to roughly 400 mOsM. Unlike mammals, sharks are inherently
osmoconformers, meaning they use organic osmolytes to keep cellular osmotic pressure
equal to that of the external fluid environment [Yancey, 2005]. Ocean water is at an
osmolarity of ˜1000 mOsM due to the high salt content, primarily NaCl. Therefore,
in order to prevent shrinkage of the shark tissue, the extracellular fluid is dominated
by NaCl and maintained around 1000 mOsM while the intracellular environment is
comprised of organic osmolytes to maintain osmotic balance with the seawater [Yancey,
2005].
Of these osmolytes, urea functions as a protein destabilizer and is the major os-
molyte that accumulates in the shark, reaching a concentration as high as 0.4 M [Lutz
and Robertson, 1971]. Urea is essential for the metabolism of nitrogen-containing com-
pounds and serves to carry nitrogen out of the body in urine. In order to counteract
the deleterious denaturing effects of urea, sharks utilize a stabilizing methylamine os-
molyte, trimethylamine N-Oxide (TMAO) (CH3)3NO in a 2:1 urea:TMAO molar ratio
(400 mM: 200 mM physiologically) [Lin and Timasheff, 1994,Porter et al., 2006,Yancey,
2005].
Urea functions by binding to proteins thereby causing them to unfold, which exposes
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additional functional groups to further bind with the destabilizing urea [Yancey, 2005].
In the absence of urea, TMAO oxygen forms strong hydrogen bonds with two to three
water molecules. It is the strong hydrogen bonds to water and the lack of favorable
interactions with side chains that make TMAO an effective protecting osmolyte [Meers-
man et al., 2009]. When urea is present, the oxygen atom in TMAO preferentially forms
hydrogen bonds with urea [Meersman et al., 2009]. Therefore, there is no direct inter-
action between TMAO and proteins, unlike with urea [Soper et al., 2003, Meersman
et al., 2009].
Previous work in the lab showed a pronounced effect of low concentrations of TMAO
on the mechanical and biochemical properties of these chondrocyte-seeded agarose hy-
drogels [O’Connell et al., 2012]. Therefore, in an effort to capitalize on the stabilizing
properties of TMAO and its role in supporting the cartilaginous structure of sharks,
in this study, we assessed the response of SDSC-seeded constructs to TMAO media
supplementation, which has not yet been characterized [O’Connell et al., 2012]. We
hypothesized that SDSCs would increase their mechanical and biochemical content in
response to TMAO supplementation, similarly to chondrocytes [O’Connell et al., 2012].
To test this hypothesis, we added TMAO as a media supplement to cultures of SDSC-
seeded hydrogel constructs.
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5.2 Materials and Methods
5.2.1 Cell Culture
Synovium tissue was harvested according to the methods outlined in 2.1.2.1. Following
digestion, SDSCs were seeded on tissue-culture treated plastic (1760 cells/cm2) and
expanded for 2 passages with media containing αMEM, 10% FBS, pen/strep, and sup-
plemented with 5 ng/mL FGF-2. SDSCs were negatively isolated following the first
passage according to the method outlined in 2.1.2.2. After passaging, SDSCs were en-
capsulated at a concentration of 60 x 106 cells/mL as outlined in 2.1.2.3. The gel was
maintained in serum-free chondrogenic media (2.1.2.3) plus 50 μg/mL ascorbate and 10
ng/mL TGF-β3 overnight (330 mOsM) and then discs were cored to final dimensions (4
mm diameter, 2.34 mm thickness) and cultured in serum-free chondrogenic media (330
mOsM) plus ascorbate (50 µg/mL) and TGF-β3 (10 ng/mL). TGF-β3 was removed at
day 21, as previously established.
5.2.2 TMAO Supplementation
Both 5 mM and 50 mM TMAO concentrations were evaluated to determine an ideal
concentration for the culture media, based on previous results in the lab utilizing chon-
drocytes [O’Connell et al., 2012]. TMAO (Sigma-Aldrich) was dissolved in water, ster-
ilized, and supplemented fresh into the culture media during the first 21 days of culture
to coincide with TGF-β3 release. Constructs cultured without TMAO served as the
control.
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5.2.3 Mechanical and Biochemical Analyses
The equilibrium Young’s modulus (EY) and dynamic modulus (G* at 0.01 Hz) was
determined according to the methods outlined in 2.1.2.5. DNA, GAG, and collagen
content were determined using the protocols outlined in 2.1.2.6. Time points for me-
chanical and biochemical analyses occurred at days 0, 28, 42, 56.
5.2.4 Statistical Analysis
Statistical analysis was performed using a two-way ANOVA with α < 0.05 and Tukey’s
HSD post-hoc test, with statistical significance achieved when p ≤ 0.05. In addition,
a student’s t-test with α < 0.05 was used to test significance of the slopes of the
two independent regression lines in the correlation plot of Young’s modulus (kPa) vs.
GAG/ww (%).
5.3 Results
With the supplementation of TMAO to the media for the first 21 days in culture,
constructs seeded with SDSCs responded most favorably to culturing with 5 mM TMAO
(p < 0.05) as compared to both the control and 50 mM TMAO conditions. At day 56,
the 5 mM TMAO group exhibited significant increases in Young’s Modulus (Figure
5.1A) as compared to the control, with an average Young’s Modulus of 431 ± 57 kPa.
Dynamic modulus (G* at 0.01 Hz) for 5 mM TMAO was also higher (1.92 ± 0.24 MPa)
(p > 0.05) than the control group (1.71± 0.40 MPa) and both groups were significantly
higher compared to the 50 mM TMAO group (p < 0.05) (Table 5.1).
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(a) (b)
Figure 5.1: (A) Equilibrium Young’s modulus (EY) and (B) GAG (%ww) for SDSC-
seeded constructs cultured with and without TMAO supplementation (n=5 con-
structs/group at each time point) *p < 0.05.
The increases in modulus were accompanied by corresponding increases in GAG
content (Figure 5.1B). GAG content for both control (6.26 ± 1.24 %ww) and 5 mM
TMAO (7.19 ± 0.50 %ww) constructs were within native levels and while not statisti-
cally significant from one another, they were both significantly higher than the 50 mM
TMAO condition (3.61 ± 0.68 %ww) (p < 0.0005) (Figure 5.1B and Table 5.1). The
same trends were seen for absolute GAG content, as well as when GAG was normalized
by DNA and dry weight. A correlation plot of Young’s modulus (kPa) vs. GAG/ww
(%) for the control and 5 mM groups indicates a steeper regression line for the 5 mM
TMAO group, albeit not significant (p = 0.256), as compared to the control with both
correlation coefficients (r) ∼ 0.84 (Figure 5.2). While the 5 mM TMAO concentration
showed beneficial effects, the 50 mM TMAO condition resulted in lower mechanical
and biochemical properties at day 56 as compared to day 42, including DNA content
(p < 0.05) (Figure 5.1 and Table 5.1).
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Figure 5.2: Correlation plot of Young’s Modulus (EY) vs GAG (%ww) for SDSC-seeded
constructs cultured for 8 weeks (n=5 constructs/group).
Collagen content did not follow the same trend as Young’s modulus and GAG con-
tent, with the control having a greater collagen content (2.02 ± 0.52 %ww) than the 5
mM TMAO group (1.87 ± 0.26 %ww), albeit not significantly (Table 5.1). Similarly,
absolute collagent content was comparable between control and 5 mM TMAO groups
(data not shown). The osmolarity of the media was assessed at day 42 in culture
and was found to be between 330 and 333 mOsM, regardless of TMAO concentration
(Figure 5.1).
Table 5.1: DNA content, Young’s modulus (EY), dynamic modulus (G*), GAG content
(%ww), and collagen (%ww) at day 56 and osmolarity at day 42 in culture. *p < 0.05
vs control and ˆp < 0.05 vs 5 mM TMAO group (n=5 constructs/group).
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5.4 Discussion
In the current study, the potential of using TMAO to culture SDSCs for cartilage re-
placement was investigated in an effort to further optimize culture conditions. Our
results support the hypothesis that TMAO supplementation of the culture media im-
proves the mechanical and biochemical properties of SDSC-seeded engineered cartilage
tissue. The concentrations of TMAO evaluated in this study were chosen because they
produced the most favorable mechanical and biochemical properties on chondrocyte-
seeded constructs in our lab’s previously published work with TMAO [O’Connell et al.,
2012]. Although TMAO was only added to the culture media for the first 3 weeks,
significant differences between all groups were not seen until 8 weeks in culture. The
duration of exposure was chosen based on previous results indicating greatest impact
on properties with transient application of growth factors [Byers et al., 2008]. Future
studies will look at the impact of timing and duration of TMAO exposure to deter-
mine optimal conditions, including the influence of continuous supplementation. These
parameters are currently being evaluated in chondrocyte-seeded constructs in the lab.
In addition to counteracting the negative effects of urea, TMAO has also been
shown to protect against other stressors, including pressure and ice [Meersman et al.,
2009]. More recently in the lab, we investigated the potential chondroprotective role
of TMAO in restoring tissue growth of chondrocyte-seeded constructs initially cul-
tured under stress-induced conditions (limited nutrients) [Estell et al., 2014]. Under
these conditions, continuous TMAO supplementation was found to result in the highest
mechanical and biomechanical properties 28 days after stress-induction was released.
The role of TMAO in the counteraction of additional stressors, including mechanical
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or chemical, remains to be studied. The potential mechanisms of chondroprotection
remain to be elucidated [Estell et al., 2014].
TMAO is a known osmolyte [Yancey, 2005, Porter et al., 2006, O’Connell et al.,
2012, Lin and Timasheff, 1994], however, at low concentrations as used in this study,
there was no impact on media osmolarity (Table 5.1). The results of Figure 5.2 indicate
that while TMAO does not necessarily boost the construct properties by modulating
the relationship of mechanical properties on GAG/ww (%), it may implicate the effect
on other extracellular matrix molecules, such as cartilage oligomeric protein (COMP)
or collagen organization. Therefore, the increased mechanical properties with TMAO
application may be due to its protein stabilization effects, as a result of strong hydrogen
bonds with water [Meersman et al., 2009]. However, these underlying mechanisms
remain to be elucidated. In addition, while media osmolarity was not influenced by the
TMAO concentration, the higher concentration of TMAO clearly had adverse effects
on the cells. The results of this study suggest that supplementation of media with 5
mM TMAO is a straightforward 3D cultivation technique with significant benefits for
improving the compressive mechanical properties and increasing extracellular matrix
production of tissue engineered cartilage utilizing synovium-derived stem cells.
From a practical standpoint, osmolytes are being investigated and utilized for a
variety of applications, including agriculture and biotechnology. Crop plants are being
genetically engineered to have improved salt, drought, and cold tolerance [Cushman,
2001]. Medically, TMAO has been investigated to prevent conformational change of the




Translation of Culturing Techniques
to Clinically Relevant Human
Model
6.1 Introduction
Engineering of articular cartilage for repair strategies for injured or diseased tissue
remains challenging. While we have been able to successfully culture grafts with juvenile
SDSCs to native levels of mechanical properties and GAG content, these tissues are not
clinically relevant. Previously, variations in matrix production have been observed
based on age, species, and tissue condition [Bian et al., 2010, Giannoni et al., 2005,
Murphy et al., 2002]. Due to these variations, experimental treatments determined
successful for animal models may not translate to models that rely on human cell
sources.
Therefore, for the final chapter of this thesis, we investigated the potential of clin-
ically relevant human synovium and cartilage for growing tissue engineered cartilage
grafts. Robust de novo tissue growth from human cells has yet to be achieved.
While it has been previously shown that SDSCs from diseased joints are easily
obtainable and retain their chondrogenic capacity [Nagase et al., 2008, Fickert et al.,
2003], the levels of chondrogenic markers produced by normal and diseased (OA, RA)
synovium may differ in 3D in vitro culture. Similarly, waste cartilage from patients
undergoing total arthroplasty may represent a source of allogeneic chondrocytes for
fabrication of engineered cartilage. However, chondrocytes obtained from OA tissue
has been shown to have a reduced capacity for proliferation and matrix formation when
encapsulated in 3D [Wang et al., 2003,Tran-Khanh et al., 2005] and have been unable
to produce competent tissue for encapsulation [Hsieh-Bonassera et al., 2009,Tallheden
et al., 2005,Oswald, 2010].
For the following studies, we obtained human donor cells from non-diseased and OA
synovium and cartilage. In an effort to prime the donor cells for enhanced tissue pro-
duction in 3D culture, we employed the same cocktail of growth factors as in Chapters
3 and 4, previously shown to increase the proliferation rates and maintain the chon-
drogenic capacity of human articular chondrocytes and adult canine chondrocytes [Ng
et al., 2009b, Barbero et al., 2003] and produce robust tissue from passaged chondro-
cytes and SDSCs [Sampat et al., 2011,Sampat et al., 2013,Ng et al., 2009b]. We were
motivated by previous studies conducted in our lab utilizing adult canine chondrocytes,
in which 2D cell passaging with growth factors was necessary to create 3D tissue with
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native properties [Ng et al., 2009b]. For initial evaluation of the cells, micropellet cul-
ture was used due to limited cell number. This model allows for cell-to-cell contact,
a condition present in early tissue development that was shown in our juvenile bovine
micropellet studies to support cell matrix elaboration (Study 4A).
Through the following studies, we wanted to create a complete set of data in mi-
cropellet culture for human SDSCs and chondrocytes from both diseased and normal
tissue. In this chapter, we aimed to accomplish three objectives: (1) assess the inherent
growth potential of normal and osteoarthritic human SDSCs and chondrocytes to form
cartilage in vitro, (2) evaluate the long-term influence of media osmolarity on extra-
cellular matrix production in order to compare to previous work with juvenile bovine
cells, and (3) establish comparisons across osmolarity, tissue condition, and cell type,
both separately and collectively.
6.2 Materials and Methods
6.2.1 Human Normal and OA SDSCs
Human synovial cells were received from Columbia University Medical Center (Dr.
Robert Winchester). Cells from distinct normal synovium (NS) and osteoarthritic (OA)
donors were obtained. Frozen cells were received at passage 4. SDSCs were thawed
and expanded at a density of 5 x 103 cells/cm2 for 2 passages with media containing
αMEM, 10% FBS, and antibiotics (100 U/mL penicillin, 100 μg/mL streptomycin,
and amphotericin B) and a growth factor cocktail of 1 ng/mL TGF-β1, 10 ng/mL
PDGF-BB, and 5 ng/mL bFGF-2 (Figure 6.1) [Francioli et al., 2007, Sampat et al.,
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2011,Sampat et al., 2013,Ng et al., 2009b].
Figure 6.1: Schematic of experimental design. Cartilage tissue was harvested fresh
from femoral condyle tissue while SDSCs were obtained frozen and thawed for further
experimentation. Micropellets were made from both OA and normal SDSCs and chon-
drocytes, while 3D constructs were cultured from only normal SDSCs and chondrocytes.
6.2.1.1 Normal and OA SDSCs: Micropellet Formation
Following passaging, SDSCs from each condition (NS and OA) were trypsinized and
micropellets were formed from each. Briefly, 0.25 x 106 cells were centrifuged in screw-
top microcentrifuge tubes with 0.5 mL of chondrogenic media (DMEM, 1% ITS +
Premix, 50 µg/mL L-proline, 0.1 mM dexamethasone, 0.9 mM sodium pyruvate, and
antibiotics) with ascorbate (50 µg/mL) and TGF-β3 (10 ng/mL) added fresh during
each media change (Figure 6.1). Micropellets were cultured in normal 330 mOsM
media for 14 days before being split into 330 mOsM and 400 mOsM media groups for
the remainder of the study. Pellets were fed three times per week. Time points for
biochemical analyses were days 0 and 35.
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6.2.1.2 Normal SDSCs: 3D Agarose Culture
In addition, after passaging, SDSCs from the normal synovium donor were encapsulated
in 2% w/v agarose at a concentration of 60 x 106 cells/mL [Sampat et al., 2011,Sampat
et al., 2013]. The gel was maintained in serum-free CM plus 50 μg/mL ascorbate and
10 ng/mL TGF-β3 at an osmolarity of 330 mOsM overnight and then discs were cored
to final dimensions (3 mm diameter, 2.34 mm thickness) (Figure 6.1). Constructs were
divided into chondrogenic media of osmolarities 330 and 400 mOsM (with the addition
of NaCl and KCl) mOsM plus 50 μg/mL ascorbate and 10 ng/mL TGF-β3. TGF-β3
was applied continuously throughout the culture period. Cultures were fed three times
per week. Mechanical testing was performed at days 35 and 49.
6.2.2 Human Normal and OA Chondrocytes
Human cartilage tissue was harvested separately from a femoral condyle of a 17-year
old female (non-diseased) and both tibial plateaus of an 81-year old osteoarthritic donor
obtained from the University of Missouri (Dr. James Cook) and the Musculoskeletal
Transplant Foundation, respectively (Figure 6.2A) (Figure 6.1). Viability of cartilage
tissue was assessed via the Live/Dead cytotoxicity assay and determined to have living
cells throughout the tissue prior to harvesting (Figure 6.2B). Cartilage tissue from each
donor condition was digested using type IV (Worthington) (1000 U/mL) collagenase
for five hours in medium containing 10% (v/v) FBS at 37oC in a humidified 5% CO2
atmosphere. Donor specific chondrocytes were expanded for 2-3 passages with media
containing DMEM, 10% FBS, and antibiotics (100 U/mL penicillin, 100 μg/mL strep-
tomycin, and amphotericin B) and a growth factor cocktail of 1 ng/mL TGF-β1, 10
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ng/mL PDGF-BB, and 5 ng/mL bFGF-2 (Figure 6.1) [Francioli et al., 2007, Sampat
et al., 2011,Sampat et al., 2013,Ng et al., 2009b].
Figure 6.2: (A) Human cartilage tissue harvesting process and (B) Live/Dead cyto-
toxicity assay indicated presence of living cells throughout the cartilage tissue prior to
harvesting. Scale bar = 100 μm.
6.2.2.1 Normal and OA Chondrocytes: Micropellet Formation
Following passaging, chondrocytes from the two donors were trypsinized and micro-
pellets were formed from each. Briefly, 0.25 x 106 cells were centrifuged in screw-top
microcentrifuge tubes with 0.5 mL of chondrogenic media with ascorbate (50 μg/mL)
and TGF-β3 (10 ng/mL) added fresh during each media change (Figure 6.1). Mi-
cropellets were split into 330 mOsM and 400 mOsM media groups. Time points for
biochemical and histological analyses were days 0 and 35.
6.2.2.2 Normal Chondrocytes: 3D Agarose Culture
After passaging, chondrocytes from the normal cartilage donor were encapsulated in
2% w/v agarose at a concentration of 60 x 106 cells/mL (Figure 6.1). The gel was
maintained in serum-free chondrogenic media plus 50 μg/mL ascorbate and 10 ng/mL
TGF-β3 at an osmolarity of 330 mOsM overnight and then discs were cored to final
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dimensions (4 mm diameter, 2.34 mm thickness). Constructs were divided into chon-
drogenic media of osmolarities 330 and 400 mOsM (with the addition of NaCl and KCl)
mOsM plus 50 μg/mL ascorbate and 10 ng/mL TGF-β3. These constructs were fed
three times per week. Time points for analyses occurred at days 0, 14, 28, and 42.
6.2.3 Mechanical Testing
The equilibrium Young’s modulus (EY) was determined under unconfined compression
at 10% strain. The dynamic modulus (G*) was determined by applying an additional
±1% strain at 0.01 Hz.
6.2.4 Osmotic Media Preparation
Medium of 400 mOsM was made by diluting DMEM (337 mOsM) to 300 mOsM with
deionized water. Next, media was prepared at 400 mOsM by the addition of NaCl and
KCl at a ratio of 20.7 moles NaCl to 1 mole KCl, the same concentration as in DMEM.
Standard CM of 330 mOsM was kept as the isotonic control condition.
6.2.5 Biochemical and Histological Composition of Micropel-
lets
Biochemical composition of micropellets was assessed for DNA, GAG, and collagen
content, as previously described. GAG and collagen content were normalized by DNA
content to account for any differences in initial pelleting (g/g). In addition, qualitative
comparison of biochemical content was conducted between SDSC and chondrocyte pel-
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lets for each osmolarity [(+++) very similar, (++) somewhat similar, (+) almost not
similar, (-) not similar]. Samples for histological analysis were stained with Picrosirius
Red and Alcian Blue to visualize collagen and GAG distribution, respectively. In addi-
tion, polarized light microscopy was used to assess collagen fibril size, orientation, and
spatial distribution of Picrosirius Red samples.
6.2.6 Biochemical Composition of 3D Constructs
Biochemical composition of chondrocyte constructs were assessed for DNA, GAG, and
collagen content, as previously described.
6.2.7 Statistical Analyses
Statistical analysis was performed with Statistica software using a two-way ANOVA
with α < 0.05 and Tukey’s HSD post hoc test, with statistical significance achieved
when p ≤ 0.05. The two factors analyzed in the ANOVA were osmotic media condition
and time. All data is presented as mean ± standard deviation.
6.3 Results
6.3.1 Results: Normal SDSC and Chondrocyte Pellets
Gross morphology images of SDSC and chondrocyte pellets from normal tissue showed
overall increase in size and opacity from day 0 pellets, indicative of matrix deposition
(day 0 not shown) (Figure 6.3). At 330 mOsM, normal SDSC and chondrocyte pellets
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produced somewhat similar (++) values of GAG (SDSC: 20.42 ± 0.26 g/g, chondrocyte:
25.60 ± 2.64 g/g) and very similar values of collagen (+++) (SDSC: 14.88 ± 4.47 g/g,
chondrocyte: 16.03 ± 2.17 g/g) when normalized by DNA (g/g) (Table 6.1). However,
at 400 mOsM, normal SDSC and chondrocyte pellets produced dissimilar (-) values of
GAG (SDSC: 17.39 ± 3.75 g/g, chondrocyte: 32.26 ± 3.66 g/g) while still producing
equal levels of collagen (+++) (SDSC: 15.25 ± 0.83 g/g, chondrocyte: 16.57 ± 1.91
g/g) when normalized by DNA (g/g) (Table 6.1). Overall, regardless of osmolarity,
SDSCs and chondrocytes produced very similar values of collagen/DNA (g/g) (+++)
(Table 6.1).
For normal SDSCs, no significant differences in GAG or collagen content (normal-
ized by DNA) were seen between pellets cultured in 330 mOsM or 400 mOsM (Table
6.1). Similarly, in normal chondrocyte pellets, there were no significant differences in
collagen/DNA as a function of osmolarity (Table 6.1). In contrast, GAG/DNA content
was statistically higher in 400 mOsM pellets (p < 0.05).
Figure 6.3: Gross morphology of human normal SDSC and chondrocyte pellets at day
35 for 330 and 400 mOsM media conditions.
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Table 6.1: GAG and collagen content normalized by DNA (g/g) for normal SDSC and
chondrocyte micropellets at day 35 (#p < 0.05 400 mOsM condition statistically higher
than 330 mOsM condition) (n=3-6 pellets/condition). Qualitative comparison of bio-
chemical content conducted between SDSC and chondrocyte pellets for each osmolarity
[(+++) very similar, (++) somewhat similar, (+) almost not similar, (-) not similar].
Histological staining of normal chondrocyte pellets indicated strong GAG staining
uniformly throughout the pellet, regardless of osmolarity (Figure 6.4). Collagen staining
was primarily distributed around the periphery for both conditions, however, there was
more red banding centrally within the pellet as well in the 330 mOsM condition (Figure
6.4). Polarized light microscopy further supported the differences observed, with a more
random distribution in the hypoosmotic group. Qualitatively, the outer edge of both
groups had the thickest fibrils (red) with the inner fibrils thinner as evidenced by the
green and yellow fibril colors (Figure 6.4) [Rich and Whittaker, 2005]. However, overall
the 330 mOsM pellets appeared more fibrous compared to the 400 mOsM group.
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Figure 6.4: Representative Alcian Blue (GAG) staining, Picrosirius Red (collagen)
staining, and polarized light microscopy images of Picrosirius Red-stained sections of
human OA chondrocyte pellets for 330 and 400 mOsM media conditions.
6.3.2 Results: Osteoarthritic SDSC and Chondrocyte Pellets
Gross morphology images of SDSC and chondrocyte pellets from OA tissue showed an
increase in size and opacity relative to day 0 pellets, indicative of matrix deposition
(day 0 not shown) (Figure 6.5). At 330 mOsM, OA SDSC and chondrocyte pellets
produced somewhat similar (++) values of GAG (SDSC: 7.08 ± 0.90 g/g, chondrocyte:
4.95 ± 0.78 g/g) and collagen (++) (SDSC: 13.70 ± 1.26 g/g, chondrocyte: 15.19 ±
2.75 g/g) when normalized by DNA (g/g) (Table 6.2). The similarity (++) between
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SDSCs and chondrocytes was also seen in 400 mOsM culture for GAG (SDSC: 5.99 ±
0.72 g/g, chondrocyte: 7.22 ± 0.32 g/g) and collagen content (normalized by DNA)
(SDSC: 11.34 ± 1.94 g/g, chondrocyte: 9.99 ± 1.17 g/g) (Table 6.2).
Figure 6.5: Gross morphology of human OA SDSC and chondrocyte pellets at day 35
and day 21, respectively, for 330 and 400 mOsM media conditions.
Table 6.2: GAG and collagen content normalized by DNA (g/g) for OA SDSC and
chondrocyte micropellets at day 35 (#p < 0.05 400 mOsM condition statistically higher
than 330 mOsM condition) (*p < 0.05 330 mOsM condition statistically higher than
400 mOsM condition) (n=3-6 pellets/condition). Qualitative comparison of biochemical
content conducted between SDSC and chondrocyte pellets for each osmolarity [(+++)
very similar, (++) somewhat similar, (+) almost not similar, (-) not similar].
For OA SDSCs, no significant differences in GAG/DNA or collagen/DNA were
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observed between pellets cultured in 330 or 400 mOsM media (Table 6.2). In contrast,
in OA chondrocyte pellets, GAG/DNA content was statistically higher in 400 mOsM
pellets (p < 0.05) (Table 6.2). Unlike the results for GAG/DNA, levels of collagen/DNA
were statistically higher in 330 mOsM culture (p < 0.05) (Table 6.2).
Histological staining for GAG and collagen distribution for OA chondrocyte pellets
cultured in 330 mOsM media indicated more central GAG staining with a thick re-
gion of strong peripheral collagen staining, further corroborating biochemical measures
(Figure 6.6) (Table 6.2). While overall collagen staining was also distributed around
the periphery of 400 mOsM pellets, only a thin outer band of staining was seen around
the edge of the pellet. Polarized light microscopy further supported the differences
observed, with a much greater abundance of collagen fibrils in the 330 mOsM group
(Figure 6.6). Qualitatively, the outer edge of both groups had the thickest fibrils (red)
with the inner fibrils thinner as evidenced by the green and yellow fibril colors (Figure
6.6) [Rich and Whittaker, 2005]. However, overall the 330 mOsM pellets appeared con-
tracted and more fibrous compared to the 400 mOsM group. GAG distribution for 400
mOsM pellets was observed to have a thick band of strong staining around the edge of
the pellet, further supporting biochemical measures (Figure 6.6) (Table 6.2).
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Figure 6.6: Representative Alcian Blue (GAG) staining, Picrosirius Red (collagen)
staining, and polarized light microscopy images of Picrosirius Red-stained sections of
human OA chondrocyte pellets at day 35 for 330 and 400 mOsM media conditions.
6.3.3 Overall Observations Across Tissue Condition, Osmolar-
ity, and Cell Type in Micropellet Culture
For SDSC cultures, regardless of tissue condition (normal or OA), there were no signifi-
cant differences observed between 330 and 400 mOsM cultures (Tables 6.1, 6.2). Across
cell types and conditions, the levels of collagen/DNA were similar (++) for the 330
mOsM pellets (13-16 g/g) (Tables 6.1, 6.2). The GAG (normalized by DNA) produc-
tion was higher in normal cultures (SDSC and chondrocyte, 330 and 400 mOsM) than
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in the OA groups (Tables 6.1, 6.2). In addition, for both normal and OA chondrocytes,
the GAG/DNA production was found to be higher in groups cultured in 400 vs 330
mOsM media (Tables 6.1, 6.2). Media GAG analysis indicated greater GAG release in
400 mOsM micropellets in all groups except OA SDSCs (data not shown). Polarized
light microscopy for both normal and OA chondrocytes indicated more fibrous tissue
in the 330 mOsM condition.
6.3.4 Results: Normal SDSC and Chondrocyte 3D Constructs
Human normal SDSCs were encapsulated in a 3D agarose hydrogel and cultured for
49 days in 330 and 400 mOsM media conditions. Gross morphology of constructs at
day 49 showed an increased opacity for constructs cultured in 330 mOsM media for
the culture duration (Figure 6.7A). At day 49, the SDSC constructs had the following
average dimensions: 330 mOsM:  = 3.16 ± 0.03 mm, thickness = 2.57 ± 0.04 mm
and 400 mOsM:  = 3.10 ± 0.02 mm, thickness = 2.49 ± 0.04 mm (Figure 6.7A).
Constructs cultured in 330 mOsM media continued to grow from day 35 to 49, reaching
a peak modulus of 61.9 ± 4.4 kPa and were statistically stiffer than the 400 mOsM
group (18.9 ± 3.7 kPa) (p < 0.05) (Figure 6.7B). In contrast, constructs cultured in
400 mOsM media plateaued in stiffness from day 35 to 49 at a modulus of ˜19 kPa
(Figure 6.7B). Dynamic modulus (G*) followed the same trend as the Young’s modulus
(Figure 6.7C).
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Figure 6.7: Gross morphology and mechanical properties of normal SDSC constructs.
(A) Gross morphology of human SDSC constructs at day 49 for 330 and 400 mOsM
media conditions, (B) Young’s modulus (kPa), and (C) dynamic modulus (G*) across
culture time (*p < 0.05) (n=4-5 constructs/condition at each time point).
Similarly to SDSCs, at day 42, human normal chondrocytes cultured in 330 mOsM
media (27.6 ± 4.8 kPa) were stiffer than those cultured in 400 mOsM media, albeit not
significantly (19.1 ± 2.8 kPa) (Figure 6.8A). This was mirrored in dynamic modulus
(G*) (data not shown). When normalized to DNA, GAG content was 24.1 ± 4.0 g/g
(330 mOsM) and was not significantly higher than the 400 mOsM condition (Figure
6.8B). This was similar to the GAG content in the normal chondrocyte pellet culture
from the same donor cells (Table 6.1). When normalized to wet weight, GAG content
was 1.7 ± 0.3 %ww for the 330 mOsM condition and was not statistically different from
the 400 mOsM group (data not shown).
153
Figure 6.8: Mechanical and biochemical properties of human chondrocyte constructs.
(A) Young’s modulus (kPa) throughout the culture period and (B) GAG content nor-
malized by DNA at day 49 (n=4-5 constructs/condition at each time point).
6.4 Discussion
As has been shown in the literature, observed results in other species (bovine or canine)
may not always correlate to findings using human cell sources [Giannoni et al., 2005].
In Chapter 4, we sought not only to determine the persistence of osmotic effects in long-
term culture, but also to examine the influence of extracellular osmolarities hyper-, iso-,
and hypoosmotic to standard culture media on the growth of SDSCs in 3D culture. In
this chapter, we investigated the translation of treatment modalities, from our previous
work with bovine SDSCs and chondrocytes, to clinically relevant human cell sources. In
particular, we sought to determine whether osmolarity influenced normal and diseased
cells similarly, across tissue condition as well as across cell type.
Through this work, we created a thorough experimental data set for normal and
diseased tissue conditions. We were able to promote cell proliferation and matrix
production with the utilization of the growth factor priming cocktail during 2D cell
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expansion. Overall, our micropellet results indicate that tissue condition (non-diseased
vs OA) is the primary determinant of matrix synthesis, since SDSCs and chondrocytes
from normal, non-diseased tissue behaved similarly to one another, while SDSCs and
chondrocytes from OA tissue behaved similarly to one another. While cells from an
OA environment still retained their chondrogenic potential when placed in micropellet
culture, these tissues showed reduced propensity to produce GAG, as compared to cells
from normal tissues (Tables 6.1, 6.2).
The results showing that GAG production was higher in chondrocyte micropellets
cultured in 400 mOsM media regardless of tissue condition support shorter term studies
in the literature showing an increase in PG-associated sulfate incorporation rate at os-
molarities closer to the in vivo environment (400 mOsM) [Urban et al., 1993,Hopewell
and Urban, 2003]. This finding further supports our previous results (Chapter 4) show-
ing increased matrix production when cells are cultured at a more physiologic osmo-
larity. The decreased GAG content in the 330 mOsM chondrocyte micropellets and
collagen staining indicate the appearance of a more fibrous (rather than hyaline) tissue.
Future work includes immunohistochemical staining for type II collagen to evaluate
this possibility. This highlights the importance of thorough evaluation of samples; even
though biochemical measures may be numerically similar, the actual distribution of
matrix may be varied based on the treatment applied.
When comparing findings for pellets from our normal SDSCs in this study to our
previous bovine SDSCs (Table 4.2), overall collagen content was greater in the human
studies (Table 6.1), while GAG content was higher in bovine SDSCs cultured in the 400
mOsM media condition. It has been shown experimentally that GAG content in human
155
cartilage decreases with age, from ˜50% by dry weight at birth to 15% by dry weight
during adulthood and then decreasing to around 7% by age 70 [Elliott and Gardner,
1979]. These juvenile values for GAG content were similarly seen in our bovine SDSC
pellets in Section 4A (Table 4.2). Our human normal chondrocyte (17-year old donor)
constructs in this study deposited ˜25% GAG (%dw), higher but still similar to that
calculated from the native tissue [Elliott and Gardner, 1979].
Previously in the lab, chondrocytes from OA tissue were cultured in 3D agarose
constructs which reached mechanical properties of 150 kPa after 77 days in culture
[Oswald et al., 2009]. In addition, micropellet culture of OA chondrocytes under slightly
modified osmotic conditions led to similar GAG/DNA levels as achieved in the present
study [Oswald, 2010]. In a more recent study in the lab, OA chondrocytes reached 100
kPa after 56 days in agarose culture in standard 330 mOsM chondrogenic media.
While no significant impact of osmolarity was observed in SDSC micropellet culture,
there was a greater sensitivity to osmolarity when SDSCs were encapsulated in 3D
agarose hydrogel culture. Preliminary work in the lab assessing the impact of osmotic
culture conditions on adult bovine SDSCs indicated a similar benefit of 330 mOsM
media over the 400 mOsM condition. Future work includes completing biochemical
analyses for the SDSC constructs to further characterize the tissue. This highlights
the fundamental differences between pellet culture and hydrogel encapsulation. While
direct cell-cell communication may promote differentiation and matrix production, it
may not be fully required for chondrogenesis [Buxton et al., 2010]. This has been
previously shown for MSC chondrogenesis in various scaffold-based systems [Buxton
et al., 2007, Buxton et al., 2010, Mauck et al., 2006, Salinas et al., 2007]. In addition,
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these findings for osmotic loading are not the same observed in juvenile bovine SDSCs,
thus highlighting the differences between species and age to consider when evaluating
optimization of culture parameters.
To our knowledge, we believe this to be the first account of matrix production
(relative to day 0 properties) utilizing SDSCs from a human source (˜60 kPa) (native
cartilage: 400-600 kPa) (Figure 6.7B) [Treppo et al., 2000, Jurvelin et al., 2003]. Syn-
ovium is attractive since it is less invasively obtained during arthroscopy procedures
than harvesting OA diseased cartilage from defect sites. While autologous chondrocytes
would be ideal for creating functional cartilage replacement, the findings presented here
support SDSCs as a promising cell source for cartilage repair strategies.
From these studies, we showed that there is potential for growing clinically relevant
tissue engineered cartilage grafts using human synovium and cartilage. However, further
optimization of protocols for cartilage repair are needed. Therefore, there is increased
emphasis on proper pre-clinical models for experimentation.
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Chapter 7
Conclusions and Future Directions
The need for cell-based tissue replacements has led to the development of functional
tissue engineering, which utilizes applied physiologic stimuli to produce viable tissue
substitutes. The limitations of using chondrocytes led us to investigate SDSCs as a rel-
evant clinical substitute. We were motivated to investigate the potential of SDSCs for
cartilage replacement for several reasons. SDSCs are easily harvested from arthroscopy
procedures and show high chondrogenic potential compared to other MSC sources [Sak-
aguchi et al., 2005]. In addition, they retain their chondrogenic potential for several
passages unlike chondrocytes, which can only be passaged a few times before losing
their utility. Therefore, towards the ultimate goal of using cells from an autologous
or allogeneic source for cartilage therapies, SDSCs may be a better clinical option.
Therefore, in order to determine the potential of SDSCs for growing clinically relevant
cartilage grafts, this dissertation had four primary aims: (1) to initially promote tis-
sue growth utilizing synovium-derived stem cells, (2) to utilize chemical, physical, and
physico-chemical factors to further optimize properties of tissue engineered cartilage
using SDSCs, (3) to characterize the response of SDSCs to the factors applied, and (4)
to utilize the optimized culture techniques to translate the findings to clinically-relevant
human cells. The findings in this dissertation accomplished our goal of producing tissue
growth using SDSCs, as well as building upon our initial findings by further optimiz-
ing the resulting tissue. We utilized physiologically relevant exogenous factors in both
2D and 3D culture to promote growth. In this chapter, we present a summary of the
findings from each study and discuss them in the context of using SDSCs to create
functionally relevant tissue for cartilage repair. Following a presentation of the major
findings, future work is proposed based on the studies in this dissertation.
7.1 Conclusions
While several studies have investigated the clinical potential of SDSCs and have shown
potential to produce extracellular matrix components similar to chondrocytes (i.e., col-
lagen II and aggrecan), few studies have demonstrated that SDSCs can be used to
achieve a tissue-engineered material with mechanical properties similar to native car-
tilage [Pei et al., 2008b,Pei et al., 2008a]. We created tissue engineered cartilage with
mechanical properties and biochemical content matching native properties of imma-
ture bovine cartilage. To accomplish this, we exogenously applied chemical, physical,
and physico-chemical factors in both 2D and 3D culture to determine optimal culture
conditions. In addition, throughout the studies presented, we showed comparison of
our SDSCs to the response of native chondrocytes to the same stimuli. Therefore, our
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results support the chondrogenic differentiation potential of SDSC-seeded constructs.
7.1.1 Exogenous Chemical Factors for Cartilage Tissue Engi-
neerig Using SDSCs
Our initial motivation for investigating the clinical potential of SDSCs was based on
their propensity to undergo chondrogenic differentiation and tissue specific proximity
within the articular joint space. Previous studies in the literature have shown the
chondrogenic differentiation potential of SDSCs and have been able to produce limited
matrix synthesis primarily in micropellet culture, however none have been able to ac-
complish physiologically relevant properties [Sakaguchi et al., 2005,Pei et al., 2008a,Pei
et al., 2008b]. We aimed to fill this gap through our SDSC studies.
In our initial studies assessing the chondrogenic potential of SDSCs (Chapter 3), we
investigated the use of exogenous chemical factors in both 2D and 3D culture to promote
tissue growth. In order to overcome the limitations of using chondrocytes for creating
functionally relevant cartilage, juvenile bovine SDSCs were investigated for their chon-
drogenic potential and use in repairing or replacing damaged cartilage. To guide this
effort, we first assessed the resultant response of SDSCs in 3D to initial growth factor
priming in 2D culture. In addition, we also investigated the effect of transient versus
continuous growth factor supplementation in 3D culture. We found that growth factor
priming in 2D was essential for enhancing chondrogenesis and matrix production of
the encapsulated cells [Sampat et al., 2011], similarly to previous work utilizing adult
canine chondrocytes [Ng et al., 2009b]. We also determined that transient applica-
tion of TGF-β3 during 3D culture developed tissue with the most robust properties,
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similarly to previous work in the lab with juvenile bovine chondrocytes [Lima et al.,
2007, Byers et al., 2008]. Our initial findings were promising; within seven weeks of
culture, constructs achieved mechanical and biochemical properties approaching native
immature bovine cartilage levels. We filled a large void in the field by promoting tissue
growth with SDSCs to near native levels of immature bovine cartilage, paving the way
for further optimization and potential for clinical translation. These results direct the
use of physiologically relevant growth factors in both 2D and 3D for promoting matrix
synthesis of SDSC-seeded constructs and established our underlying culture protocol
for the remaining studies.
In the second study (Chapter 3-Study 3B), we utilized proteomics as a tool to charac-
terize these priming responses in a more clinically relevant canine animal model. In par-
ticular, growth factor priming modulated the proteins associated with the extracellular
matrix in monolayer cultures of chondrocytes and SDSCs, inducing a partial dediffer-
entiation of chondrocytes (most proteins associated with cartilage were down-regulated
in primed chondrocytes) and a partial differentiation of SDSCs (some collagen-related
proteins were up-regulated in primed SDSCs). However, when chondrocytes and SDSCs
were grown in pellet culture, growth factor-primed cells maintained their chondrogenic
potential with respect to glycosaminoglycan and collagen production. The results from
this study could potentially be used to identify predictors of cells’ utility in cartilage
tissue engineering protocols.
Together, the findings from the studies in Chapter 3 support Hypothesis 1, that
SDSCs that have been primed in 2D with growth factors result in superior mechanical
and biochemical properties compared to unprimed engineered tissue constructs.
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In an effort to further optimize tissue growth through the addition of chemical fac-
tors, in Chapter 5, we investigated the potential of using TMAO to culture SDSCs
for cartilage replacement. The concentrations of TMAO evaluated in this study were
chosen because they produced the most favorable mechanical and biochemical prop-
erties on chondrocyte-seeded constructs in our lab’s previously published work with
TMAO [O’Connell et al., 2012]. Our results support Hypothesis 3 in that TMAO
supplementation of the culture media improved the mechanical and biochemical prop-
erties of SDSC-seeded engineered cartilage tissue, albeit conditionally for the 5 mM
group. These findings show the utility of TMAO as a culture supplement, however the
mechanisms responsible remain to be determined.
7.1.2 Exogenous Physical and Physico-Chemical Factors for
Promoting Development of Engineered Cartilage
Our success in utilizing biomimetic chemical factors for priming SDSCs to grow func-
tionally relevant cartilage grafts (Chapter 3) prompted us to manipulate another factor
endemic to in situ cartilage, namely altered extracellular osmolarity, as a physico-
chemical growth strategy. Based on our functional tissue engineering approach, we
were motivated by the discrepancy between standard chondrogenic culture media os-
molarity (330 mOsM) and that of the native environment (400 mOsM). Therefore, in
Chapter 4, we focused on manipulating the extracellular osmolarity in order to further
optimize tissue growth and also to further characterize our tissue engineered constructs.
In the first study (Chapter 4-Study 4A), by modifying the 3D culture media to a more
physiologic osmolarity (400 mOsM), we were the first group to achieve robust tissue
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growth with mechanical and biochemical properties within the range of native imma-
ture bovine cartilage for SDSC-seeded constructs (EY: 400-1000 kPa; GAG (%ww):
6-8%) [Sampat et al., 2011, Sampat et al., 2013]. As a result, we established static
osmotic loading as a straightforward 3D cultivation strategy.
Based on the encouraging results from Study 4A, in Study 4B we sought to de-
termine whether the osmotic influence was dependent on cell priming in 2D culture.
It was further confirmed that cell priming in 2D is essential for seeing the benefit of
physiologic osmolarity in 3D culture. Although chondrocytes are known to behave as
perfect osmometers when exposed to extracellular stimuli, the adherence of SDSCs has
not been investigated. Therefore, in Study 4C, the adherence of SDSCs to the BVH
relationship was investigated and it was found that SDSCs did not behave as perfect
osmometers along the entire range tested, and therefore do not satisfy the BVH law, al-
though further investigation is needed. This study sought to characterize the biological
response of SDSCs, as this information is still lacking in the literature.
In an effort to further characterize our SDSC-seeded constructs, we investigated the
hypotonic loading response of our neocartilage as a biological assay in order to compare
the response to that of native tissue. Previously it has been shown that changes to
extracellular osmolarity have a negative effect on matrix metabolism of cartilage ex-
plants [Urban et al., 1993,Urban, 1994,Korhonen et al., 2010,Bush and Hall, 2001]. In
Study 4D, we additionally investigated the role of the ion channel, TRPV4, in modu-
lating the osmotic response in SDSCs. Much research has implicated TRPV4, which
is present in chondrocytes, as a key mechano-osmosensing channel [Strotmann et al.,
2003, Phan et al., 2009]. In this study, we utilized a chemical antagonist for TRPV4,
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RN1734. Our results found that blocking TRPV4 in conjunction with hypoosmotic
loading resulted in significant decreases in mechanical stiffness of the constructs. In
the final study of Chapter 4 (Study 4E), we utilized dynamic deformational loading
to further optimize tissue properties of SDSC-seeded constructs. Mechanical loading is
important for the healthy maintenance of articular cartilage [Gray et al., 1988] and has
been utilized previously to apply cyclic loads on chondrocyte-seeded agarose hydrogels
to promote tissue growth [Mauck et al., 2000,Lima et al., 2007,Bian et al., 2010,Kelly
et al., 2006]. For our SDSC-seeded constructs, it was determined that loading produced
superior tissue when constructs were loaded in a hypoosmotic environment relative to
free swelling conditions. This finding further implicates the potential role of TRPV4 in
the response to dynamic loading, similarly to recent studies with chondrocytes [OConor
et al., 2014]. Through the application of chemical, physical, and physico-chemical sig-
nals, the results described in Chapter 4 further support the potential of SDSCs as a
clinically relevant cell source for articular cartilage repair. By creating a more physio-
logic culture environment, we were able to culture constructs with improved properties
relative to hypotonic or isotonic media conditions which led to the acceptance of Hy-
pothesis 2. As a result, we are now able to consistently grow juvenile bovine SDSCs
with native mechanical and biochemical (GAG) properties.
7.1.3 Translation to Clinically Relevant Human Models
As has been shown in the literature, observed results in other species (bovine or canine)
may not always correlate to findings using human cell sources [Giannoni et al., 2005],
thereby prompting the emphasis for more relevant pre-clinical models. Therefore, in
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Chapter 6, we sought to translate our treatment strategies from our earlier studies to
clinically relevant human cells from normal and diseased SDSCs and chondrocytes in
order to determine their utility. We utilized our expansion protocol from Chapter 3
prior to cell encapsulation and additionally sought to determine whether osmolarity
influenced normal and diseased cells similarly, across tissue condition as well as across
cell type. While no significant impact of osmolarity was observed in SDSC micropellet
culture, there was a greater sensitivity to osmolarity when SDSCs were encapsulated
in 3D agarose hydrogel culture. However, the sensitivity to hypertonic culture was
observed to translate to human chondrocyte micropellets.
Through this work, we created a thorough experimental data set for normal and
diseased tissue conditions. Overall, our micropellet results indicate that tissue condition
(non-diseased vs OA) is the primary determinant of matrix synthesis, since SDSCs and
chondrocytes from normal, non-diseased tissue behaved similarly to one another with
higher propensity to synthesize matrix compared to cells from OA tissue.
To our knowledge, we believe this to be the first account of matrix synthesis (relative
to day 0) utilizing SDSCs from a human source (˜60 kPa) (native cartilage: 400-600
kPa) [Treppo et al., 2000, Jurvelin et al., 2003]. From these studies, we showed that
there is potential for growing clinically relevant tissue engineered cartilage grafts from
human synovium and cartilage. The findings in Chapter 6 support the clinical potential
of human SDSCs as a cell source for cartilage repair strategies.
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7.2 Future Directions
The limitations of using chondrocytes for clinically relevant tissue repair were the pri-
mary motivation for the work in this dissertation, which examined the general utility
of SDSCs as a cell-based therapy. The findings in this dissertation demonstrated not
only the importance of tailored culture techniques to promote matrix production of
SDSCs, but also the need for functional characterization of the tissue. Therefore, based
on the findings related to biochemical and functional characterization of our engineered
tissue, future studies are proposed to further manipulate culture conditions to optimize
growth.
7.2.1 Enhancing Collagen Production
The findings described in Chapters 3-5 indicate that although we were able to produce
robust tissue with mechanical properties and glycosaminoglycan content within native
levels of immature bovine cartilage, we were unable to recapitulate native levels of
collagen and its distribution patterns. While reproducing the collagen content is still
a major hurdle for functional tissue engineering of both chondrocytes and SDSCs, the
progression of studies with SDSCs throughout the dissertation increasingly resulted in
higher collagen content. Native collagen levels are essential to producing functional
engineered cartilage tissue with sufficient integrity for in vivo replacement [Bian et al.,
2009].
Previous studies with cultured chondrocytes have shown that since cells have a
greater propensity to rapidly produce GAG from the onset, reaching native levels within
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4-6 weeks, it results in less room for collagen fibrils in the matrix [Bian et al., 2009].
As a result, several studies have used the chemical factor, chondroitinase ABC (cABC),
to deplete cartilage of GAGs in order to suppress GAG formation and make room for
collagen to be produced within the scaffold. Results with chondrocyte-seeded scaffolds
have indicated an increase in collagen production, with GAG levels and mechanical
properties returning to pre-treatment levels after three weeks [Bian et al., 2009].
Motivated by the above, we performed a similar study on our SDSC-seeded con-
structs in an effort to promote collagen production. Preliminary findings did indicate
a recovery of properties following digestion, however, due to extensive cell death from
the cABC dosage (0.15 U/mL for 2 days), clear benefits and comparisons could not be
established. Therefore, future studies are proposed to assess dosage as well as duration
of exposure to determine if an optimum balance exists to promote collagen production
without compromising cell viability in order to determine the general utility of cABC
for SDSC growth strategies.
7.2.2 Response to Proinflammatory Cytokines
Towards the goal of creating functional tissue in vitro that is better able to withstand
the joint environment when implanted, it is important to assess the tissue’s response
to chemical factors found within the native joint space due to chronic inflammation
or surgical intervention [Goldring, 1999, Goldring and Goldring, 2004, Schmal et al.,
2009]. Several studies have been conducted in the lab for the response of both native
and engineered tissue using chondrocytes to these catabolic factors, primarily IL-1α, an
important mediator of MMP production [Lima et al., 2008b, Lima et al., 2008a, Lima
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et al., 2009]. Studies showed that more mature tissue is able to better withstand the
catabolic degradation of properties in response to cytokine exposure.
In an effort to better further characterize our engineered tissue with SDSCs, we
sought to determine the effects of IL-1α (10 ng/mL, 7 days) exposure on resulting
tissue properties, both in the presence and absence of the anti-inflammatory steroid
dexamethasone. Due to extremely limited sample size (n=2), the results are very pre-
liminary. Both groups, with (˜190 kPa) or without (˜130 kPa) dexamethasone present,
exhibited significant decreases in mechanical properties from their control prior to treat-
ment (˜377 kPa). However, the impact was slightly reduced when dexamethasone was
included, thereby providing some chondroprotection to the constructs, as has been pre-
viously shown with chondrocytes [Lima et al., 2008b]. This motivates the potential for
preconditioning strategies with a lower dose of IL-1α prior to insult, similar to current
strategies being explored for both bovine and canine models [Tan et al., tion], but this
remains to be investigated.
7.2.3 TRPV4 Modulation
In Studies 4D and 4E, we began to investigate the role of TRPV4 in modulating osmotic
response. In addition to evaluating the response to inhibiting TRPV4, another strat-
egy to consider is activation of the channel. This can be achieved with a specific syn-
thetic activator of TRPV4, 4α-phorbol-12,13-didecanoate (4α-PDD) [Eleswarapu and
Athanasiou, 2013], which was recently used to grow self-assembled engineered cartilage
with improved tensile properties or GSK101, recently shown to promote matrix syn-
thesis in 3D porcine tissue in isoosmotic culture [Vriens et al., 2009, Watanabe et al.,
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2002, OConor et al., 2014]. However, due to TRPV4’s hypoosmotic activation, the
mechanism by which the agonist increases synthesis under isoosmotic culture condi-
tions is unclear [OConor et al., 2014].
Preliminary work in juvenile bovine SDSCs and chondrocytes in our lab showed
widespread cell death in response to GSK101 treatment using a similar exposure pro-
tocol (3 hours per day) to O’Conor, et al. [OConor et al., 2014]. This finding in chon-
drocytes was also observed in studies conducted by members of our collaborating lab.
Differences exist in species (bovine vs porcine) between the two studies which may con-
tribute to the catabolic results seen in our bovine culture system. In addition, dosage
and duration of exposure are also factors to consider for future studies. Additional
TRPV4 modulators like 4α-PDD or RN1747 could be investigated for their utility, as
well as concurrent exposure during osmotically activating conditions. However, while
a drug could affect matrix synthesis it may not affect the organization of the matrix
molecules. Even with the use of pharmacologic agents to modulate tissue properties,
other factors, like physical loading or osmotic loading may also be necessary to enhance
tissue properties to functional levels.
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